KUSTOM ENTERTAINMENT, INC. 10-K

Item 9A. Controls and Procedures. Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures to provide reasonable assurance of achieving the control objectives, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on their evaluation as of December 31, 2025, the end of the period covered by this Annual Report on Form 10-K, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective at a reasonable assurance level to ensure that the information required to be disclosed in reports filed or submitted under the Exchange Act, including this Annual Report on Form 10-K, was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and was accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Management’s Report on Internal Control Over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: ● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets; ● Provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and ● Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. In connection with the filing of this Annual Report on Form 10-K, our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2025. In making this assessment, our management used the criteria set forth by the 2013 Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our assessment using the framework in the 2013 Internal Control – Integrated Framework, management believes that, as of December 31, 2025, our internal control over financial reporting is not effective. Material Weakness In connection with the audit of our consolidated financial statements as of December 31, 2025 and 2024, we identified a material weakness in our internal control over financial reporting related to timely review and detection of potential accounting misstatements, which in the aggregate, constitute a material weakness. Remediation Activities As part of our plan to remediate this material weakness, we are performing a full review of our internal control procedures. We have implemented, and plan to continue to implement, new controls and new processes. We have established and plan to continue to develop more robust processes to support our internal control over financial reporting, including clearly defined roles and responsibilities. The Company anticipates time being required to complete the implementation and to assess and ensure the sustainability of these controls. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. Changes in Internal Control Over Financial Reporting During the year ended December 31, 2025, the Company completed the divestiture of its Revenue Cycle Management Segment through the sale of Nobility Healthcare, which resulted in changes to the scope of entities subject to the Company’s internal control over financial reporting. Other than matters related to this divestiture, there have been no changes in our internal control over financial reporting during the year ended December 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We are continually monitoring and assessing our internal controls to ensure the appropriate design and operating effectiveness. Item 9B. Other Information. None of the Company’s directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the Company’s fiscal quarter ended December 31, 2025. Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. Not applicable. 34 PART III Item 10. Directors, Executive Officers and Corporate Governance . The names of the members of our Board and our executive officers and certain information about them as of December 31, 2025, are set forth below: Name of Board of Director Member (4) Positions Age Director Since Stanton E. Ross Chairman, President and Chief Executive Officer 64 2005 Leroy C. Richie (1)(2)(3) Lead Independent Director, Chairman of the Nominating Committee and Compensation Committee and attorney 84 2005 D. Duke Daughtery (1)(2)(3) Independent Director; Chairman of Audit Committee 61 2023 Charles M. Anderson (1)(2)(3) Independent Director 67 2024 Name of Executive Officer (4) Positions Age Executive Officer Since Thomas J. Heckman Vice President, Chief Financial Officer, Treasurer & Secretary 66 2007 Peng Han Chief Operating Officer 52 2021 (1) Member of Audit Committee (2) Member of Compensation Committee (3) Member of Nominating Committee (4) The address of each executive officer and director listed is 6366 College Blvd., Overland Park, Kansas 66211. The Board has determined that Messrs. Richie, Daughtery and Anderson are “independent directors,” as defined by the rules and listing standards of Nasdaq. In making this determination, the Board considered the transactions and relationships disclosed under “Certain Relationships and Related Transactions” below. Biographical Information - Directors Stanton E. Ross has served as Chairman, President and Chief Executive Officer (“CEO”) of the Company since September 2005. From March 1992 to June 2005, Mr. Ross was the Chairman and President of American Noble Gas Inc. (formerly known as Infinity Energy Resources, Inc.), a publicly held oil and gas exploration and development company (“AMGAS”) and served as an officer and director of each of AMGAS’s subsidiaries. He resigned from all his positions with AMGAS in June 2005, except Chairman, but was reappointed President in October 2006. From 1991 until March 1992, he founded and served as President of Midwest Financial, a financial services corporation involved in mergers, acquisitions, and financing for corporations in the Midwest. From 1990 to 1991, Mr. Ross was employed by Duggan Securities, Inc., an investment banking firm in Lenexa, Kansas, where he primarily worked in corporate finance. From 1989 to 1990, he was employed by Stifel, Nicolaus & Co., a member of the New York Stock Exchange, where he was an investment executive. From 1987 to 1989, Mr. Ross was self-employed as a business consultant. From 1985 to 1987, Mr. Ross was President and founder of Kansas Microwave, Inc., which developed a radar detector product. From 1981 to 1985, he was employed by Birdview Satellite Communications, Inc., which manufactured and marketed home satellite television systems, initially as a salesman and later as National Sales Manager. Mr. Ross estimates he devoted most of his time to Digital Ally and the balance to AMGAS in 2020. In late 2007, AMGAS sold a substantial portion of its operating assets and has not required a substantial amount of his time since such point. Mr. Ross holds no public company directorships other than with the Company and AMGAS and has not held any others during the previous five years. The Company believes that Mr. Ross’s broad entrepreneurial, financial, and business expertise and his experience with micro-cap public companies and his role as President and Chief Executive Officer give him the qualifications and skills to serve as a Director. 35 Leroy C. Richie has been the Lead Independent Director of the Company since September 2005. He is also the Chairman of the Compensation Committee and Nominating Committee and a member of the Audit Committee. Since June 1, 1999, Mr. Richie has been a director of AMGAS. Additionally, until 2017, Mr. Richie served as a member of the board of directors of Columbia Mutual Funds, (or mutual fund companies acquired by or merged with Columbia Mutual Funds), a family of investment companies managed by Ameriprise Financial, Inc. From 2004 to 2015, he was of counsel to the Detroit law firm of Lewis & Munday, P.C. From 2007 to 2014, Mr. Richie served as a member of the board of directors of OGE Energy Corp. He holds no other public directorships and has not held any others during the previous five years. Until 2019, Mr. Richie served as the Vice-Chairman of the Board of Trustees and Chairman of the Compensation Committee for the Henry Ford Health System, in Detroit. Mr. Richie was formerly Vice President of Chrysler Corporation and General Counsel for automotive legal affairs, where he directed all legal affairs for its automotive operations from 1986 until his retirement in 1997. Before joining Chrysler, he was an associate with the New York law firm of White & Case (1973-1978) and served as director of the New York office of the Federal Trade Commission (1978-1983). Mr. Richie received a B.A. from City College of New York, where he was valedictorian, and a J.D. from the New York University School of Law, where he was awarded an Arthur Garfield Hays Civil Liberties Fellowship. The Company believes that Mr. Richie’s extensive experience as a lawyer and as an officer or director of public companies gives him the qualifications and skills to serve as a Director. D. Duke Daughtery joined the board of directors of the Company in October 2024 and he is also the chairman of the Audit Committee, and a member of the Compensation Committee and Nominating Committee. From 1987 to 2019, Mr. Daughtery was an assurance partner and audit practice leader with Grant Thornton and Deloitte & Touche in Kansas City. Mr. Daughtery was instrumental in the significant growth of Grant Thornton’s Kansas City audit practice. Mr. Daughtery served numerous companies ranging from high growth private equity backed clients, to multi-billion revenue private companies to public companies ranging from smaller public companies to the Fortune 500. Mr. Daughtery brings to the board of directors many years of leadership experience as an assurance partner at major accounting firms and extensive experience in developing and executing growth strategies, acquisitions and capital transactions. The Company considers Mr. Daughtery to be an audit committee financial expert. Mr. Daughtery obtained his Bachelor of Arts in Accounting and in Management and Business Administration from Saint Ambrose University. Mr. Daughtery holds no public company directorships other than with the Company and has only held the aforementioned position in Digital Ally during the previous five years. From 2019 to 2024 Mr. Daughtery was not employed by any company. The Company believes that Mr. Daughtery’s extensive experience as an accountant of public companies gives him the qualifications and skills to serve as a director. Charles “Chopper” Anderson joined the board of directors of the Company in December 2024. Mr. Anderson has served as Chief Executive Officer at Alien Audio since 2007. He is a renowned bass player known for his exceptional talent and versatility in the music industry. Mr. Anderson graduated from Belmont College in 1977 as one of the first graduates of their newly found music program. Moving to Nashville, Tennessee in 1975, Mr. Anderson became a sought-after session musician, collaborating with a wide range of artists across genres like rock, pop, country, and R&B. Through a variety of tours, records, and sessions, Mr. Anderson played the bass guitar with numerous notable artists such as Dolly Parton, Dottie West, Kenny Rogers, Marie Osmond, Lee Roy Parnell, and Edwin McCain. From 1991 to 2001 Mr. Anderson was on tour with Reba McIntire. In 2007, he founded his own bass guitar manufacturing company, Alien Audio, still doing business to date. His dynamic bass lines have featured on numerous hit albums, earning him a reputation for innovation and reliability. His contributions to music have earned him several awards and accolades, celebrating his technical proficiency and creative approach. His lasting impact on the music world continues to inspire both current and future generations of musicians. Mr. Anderson holds no public company directorships, nor has he held any public company directorships within the past five years, and the Company believes that Mr. Anderson’s extensive experience in the entertainment industry gives him the qualifications and skills to serve as a director. 36 Our Directors are elected annually and hold office until the next annual meeting of our stockholders or until their successors are elected and qualified. Officers are elected annually and serve at the discretion of the Board. There is no family relationship between any of our directors, director nominees and executive officers. Board vacancies are filled by a majority vote of the Board. Biographical Information - Executive Officers Thomas J. Heckman has served as our Chief Financial Officer, Secretary and Treasurer since September 2007. During the years 2001-2007, Mr. Heckman provided consulting and business investment services to publicly traded and private companies. He has been involved in the successful completion of a number of initial public offerings (IPOs), reverse mergers and other transactions; drafted, filed and achieved SEC effectiveness for Form SB-2 filings; assisted in the raising of capital for private companies in a variety of industries; and developed multiple private placement memorandums. From 1983 until 2001, Mr. Heckman was employed by Deloitte and Touche, LLP, a subsidiary of Deloitte Touche Tohmatsu, one of the largest auditing, consulting, and financial advisory, risk management, and tax services organizations in the world. During his 18 years with Deloitte and Touche, LLP, including six years as Accounting and Auditing Partner in the Kansas City office, Mr. Heckman specialized in IPOs and public reporting entities. He served as partner in charge of a high-technology and emerging/high-growth company market segment for cross-discipline marketing efforts, assisted companies in preparing for public offerings and other liquidity events, and was involved in numerous initial/secondary financings and merger / acquisition transactions for public and private companies. He is experienced in all facets of SEC financial reporting and compliance matters. Mr. Heckman earned his Bachelor of Arts degree in Accounting at the University of Missouri - Columbia. Peng Han has served as Chief Operating Officer since November 2021. Joining the Company in February 2010, Mr. Han served as Lead Software Engineer, Software Manager, Vice President of Engineering, and CTO. With over two decades of experience in spearheading the development of innovative and cutting-edge software and hardware products, Mr. Han’s expertise lies in large-scale software development, video technology, real-time embedded systems, telecommunications, and intellectual property management. From 2005 to 2010, Mr. Han worked as Senior Staff Engineer for Ingenient Technologies, a leading provider of embedded multimedia system solutions. From 2004 to 2005, Mr. Han was employed by WMS Gaming, an electronic game entertainment company, where he worked as Core Software Engineer. From 2001 to 2003, he was employed as a Software Engineer by Tellabs, a telecommunication software and hardware solution provider. Mr. Han received his Master of Science degree in Computer Science at Iowa State University in Ames, Iowa. Involvement in Certain Legal Proceedings None. Board of Directors and Committee Meetings Our Board of Directors held four meetings and acted a number of times by unanimous consent resolutions during the fiscal year ended December 31, 2025. Each of our directors attended at least 75% of the meetings of the Board of Directors and the committees on which he served in the fiscal year ended December 31, 2025. Our directors are expected, absent exceptional circumstances, to attend all Board meetings and meetings of committees on which they serve and are also expected to attend our annual meeting of stockholders. All directors then in office attended the 2025 annual meeting of stockholders. Committees of the Board of Directors Our Board of Directors currently has three committees: an Audit Committee, a Compensation Committee, and a Nominating and Governance Committee. Each committee has a written charter approved by the Board of Directors outlining the principal responsibilities of the committee. All of our directors, other than our Chairman and Chief Executive Officer, have met in executive sessions without management present on a regular basis in 2025 and year-to-date 2026. Audit Committee Our Audit Committee appoints the Company’s independent auditors, reviews audit reports and plans, accounting policies, financial statements, internal controls, audit fees, and certain other expenses and oversees our accounting and financial reporting process. Specific responsibilities include selecting, hiring and terminating our independent auditors; evaluating the qualifications, independence and performance of our independent auditors; approving the audit and non-audit services to be performed by our auditors; reviewing the design, implementation, adequacy and effectiveness of our internal controls and critical accounting policies; overseeing and monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to financial statements or accounting matters; reviewing any earnings announcements and other public announcements regarding our results of operations in conjunction with management and our public auditors; conferring with management and the independent auditors regarding the effectiveness of internal controls, financial reporting processes and disclosure controls; consulting with management and the independent auditors regarding Company policies governing financial risk management; reviewing and discussing reports from the independent auditors on critical accounting policies used by the Company; establishing procedures, as required under applicable law, for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters and the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; reviewing and approving related-person transactions in accordance with the Company’s policies and procedures with respect to related-person transactions and applicable rules; reviewing the financial statements to be included in our Annual Report on Form 10-K; discussing with management and the independent auditors the results of the annual audit and the results of quarterly reviews and any significant changes in our accounting principles; and preparing the report that the SEC requires in our annual proxy statement. The report of the Audit Committee for the year-ended December 31, 2025 was included in our annual proxy statement for 2024. 37 The Audit Committee is currently comprised of three Directors, each of whom is independent, as defined by the rules and regulations of the SEC and The Nasdaq Stock Market LLC (“Nasdaq”) Rule 5605(a)(2). The Audit Committee held four meetings during the year-ended December 31, 2025. On September 22, 2005, the Company created the Audit Committee and adopted a written charter for it. The current members of our Audit Committee are D. Duke Daughtery, who serves as Chairman, Leroy C. Richie, and Charles M. Anderson. The Board determined that Mr. Daughtery qualifies as an “audit committee financial expert,” as defined under the applicable rules and listing standards of Nasdaq and SEC rules and regulations and is independent as noted above. Under the Sarbanes-Oxley Act of 2002, all audit and non-audit services performed by the Company’s independent registered public accounting firm must be approved in advance by the Audit Committee to assure that such services do not impair the auditor’s independence from the Company. Accordingly, the Audit Committee has adopted an Audit and Non-Audit Services Pre-Approval Policy (the “Policy”) that sets forth the procedures and the conditions pursuant to which services to be performed by the independent auditors are to be pre-approved. Pursuant to the Policy, certain services described in detail in the Policy may be pre-approved on an annual basis together with pre-approved maximum fee levels for such services. The services eligible for annual pre-approval consist of services that would be included under the categories of Audit Fees, Audit-Related Fees and Tax Fees in the table, as well as services for limited review of actuarial reports and calculations. If not pre-approved on an annual basis, proposed services must otherwise be separately approved prior to being performed by the independent registered public accounting firm. In addition, any services that receive annual pre-approval but exceed the pre-approved maximum fee level also will require separate approval by the Audit Committee prior to being performed. The Audit Committee may delegate authority to pre-approve audit and non-audit services to any member of the Audit Committee but may not delegate such authority to management. Compensation Committee Our Compensation Committee assists our Board of Directors in determining the development plans and compensation of our officers, directors and employees. Specific responsibilities include approving the compensation and benefits of our executive officers; reviewing the performance objectives and actual performance of our officers; administering our stock option and other equity compensation plans; and reviewing and discussing with management the compensation discussion and analysis that the SEC requires in our future Form 10-Ks and proxy statements. Our Compensation Committee is currently comprised of three Directors, whom the Board considers to be independent under the applicable rules and listing standards of Nasdaq and the SEC rules and regulations. The current members of our Compensation Committee are Leroy C. Richie, Chairman, D. Duke Daughtery, and Charles M. Anderson. The Compensation Committee held two meetings and acted several times by unanimous written consent resolutions during the year ended December 31, 2025. Mr. Ross, our Chief Executive Officer, does not participate in the determination of his own compensation or the compensation of directors. However, he makes recommendations to the Compensation Committee regarding the amount and form of the compensation of the other executive officers and key employees, and he often participates in the Compensation Committee’s deliberations about such persons’ compensation. Thomas J. Heckman, our Chief Financial Officer, also assists the Compensation Committee in its deliberations regarding executive officer, director and employee compensation. No other executive officers participate in the determination of the amount or the form of the compensation of executive officers or directors. The Compensation Committee does not utilize the services of an independent compensation consultant to assist in its oversight of executive and director compensation. On September 22, 2007, the Board of Directors adopted a written charter for the Compensation Committee. Nominating and Governance Committee Our Nominating and Governance Committee assists our Board of Directors by identifying and recommending individuals qualified to become members of our Board of Directors, reviewing correspondence from our stockholders, and establishing, evaluating, and overseeing our corporate governance guidelines. Specific responsibilities include the following: evaluating the composition, size and governance of our Board of Directors and its committees and making recommendations regarding future planning and appointing directors to our committees; establishing a policy for considering stockholder nominees for election to our Board of Directors; and evaluating and recommending candidates for election to our Board of Directors. Our Nominating and Governance Committee strives for a Board composed of individuals who bring a variety of complementary skills, expertise, or background and who, as a group, will possess the appropriate skills and experience to oversee our business. The diversity of the members of the Board relates to the selection of its nominees. While the Committee considers diversity and variety of experiences and viewpoints to be important factors, it does not believe that a director nominee should be chosen or excluded solely or largely because of race, color, gender, national origin or sexual orientation or identity. In selecting a director nominee for recommendation to our Board, our Nominating and Governance Committee focuses on skills, expertise or background that would complement the existing members on the Board. Accordingly, although diversity may be a consideration in the Committee’s process, the Committee and the Board of Directors do not have a formal policy regarding the consideration of diversity in identifying director nominees. 38 When the Nominating and Governance Committee has either identified a prospective nominee or determined that an additional or replacement director is required, the Nominating and Governance Committee may take such measures as it considers appropriate in connection with its evaluation of a director candidate, including candidate interviews, inquiry of the person or persons making the recommendation or nomination, engagement of an outside search firm to gather additional information, or reliance on the knowledge of the members of the Board of Directors or management. In its evaluation of director candidates, including the members of the Board eligible for re-election, the Nominating and Governance Committee considers a number of factors, including: the current size and composition of the Board of Directors, the needs of the Board of Directors and the respective committees of the Board, and such factors as judgment, independence, character and integrity, age, area of expertise, diversity of experience, length of service and potential conflicts of interest. The Nominating and Governance Committee selects director nominees and recommends them to the full Board of Directors. In relation to such nomination process, the Nominating and Governance Committee: ● determines the criteria for the selection of prospective directors and committee members; ● reviews the composition and size of the Board and its committees to ensure proper expertise and diversity among its members; ● evaluates the performance and contributions of directors eligible for re-election; ● determines the desired qualifications for individual directors and desired skills and characteristics for the Board; ● identifies persons who can provide needed skills and characteristics; ● screens possible candidates for Board membership; ● reviews any potential conflicts of interests between such candidates and the Company’s interests; and ● shares information concerning the candidates with the Board and solicits input from other directors. The Nominating and Governance Committee has specified the following minimum qualifications that it believes must be met by a nominee for a position on the Board: the highest personal and professional ethics and integrity; proven achievement and competence in the nominee’s field and the ability to exercise sound business judgment; skills that are complementary to those of the existing Board; the ability to assist and support management and make significant contributions to our success; the ability to work well with the other directors; the extent of the person’s familiarity with the issues affecting our business; an understanding of the fiduciary responsibilities that are required of a member of the Board; and the commitment of time and energy necessary to diligently carry out those responsibilities. A candidate for director must agree to abide by our Code of Ethics and Conduct. After completing its evaluation, the Nominating and Governance Committee makes a recommendation to the full Board of Directors as to the persons who should be nominated to the Board, and the Board determines the nominees after considering the recommendation and report of the Committee. Our Nominating and Governance Committee is currently comprised of three Directors, whom the Board considers to be independent under the applicable rules and listing standards of Nasdaq and the SEC rules and regulations. The Nominating and Governance Committee held one meeting during the year ended December 31, 2025. The current members of our Nominating and Governance Committee are Leroy C. Richie, who serves as Chairman, D. Duke Daughtery, and Charles M. Anderson. The Committee was created by our Board of Directors on December 27, 2007, when the Board of Directors adopted a written charter, which was amended in February 2010. Board of Directors’ Role in the Oversight of Risk Management We face a variety of risks, including credit, liquidity, and operational risks. In fulfilling its risk oversight role, our Board of Directors focuses on the adequacy of our risk management process and overall risk management system. Our Board of Directors believes that an effective risk management system will (i) adequately identify the material risks that we face in a timely manner; (ii) implement appropriate risk management strategies that are responsive to our risk profile and specific material risk exposures; (iii) integrate consideration of risk and risk management into our business decision-making; and (iv) include policies and procedures that adequately transmit necessary information regarding material risks to senior executives and, as appropriate, to the Board or relevant committee. The Board of Directors has designated the Audit Committee to take the lead in overseeing risk management at the Board of Directors level. Accordingly, the Audit Committee schedules time for periodic review of risk management, in addition to its other duties. In this role, the Audit Committee receives reports from management, independent registered public accounting firm, outside legal counsel, and other advisors, and strives to generate serious and thoughtful attention to our risk management process and system, the nature of the material risks we face, and the adequacy of our policies and procedures designed to respond to and mitigate these risks. Although the Board of Directors has assigned the primary risk oversight to the Audit Committee, it also periodically receives information about our risk management system and the most significant risks that we face. This is principally accomplished through Audit Committee reports to the Board of Directors and summary versions of the briefings provided by management and advisors to the Audit Committee. In addition to the formal compliance program, our Board of Directors and the Audit Committee encourage management to promote a corporate culture that understands risk management and incorporates it into our overall corporate strategy and day-to-day business operations. Our risk management structure also includes an ongoing effort to assess and analyze the most likely areas of future risk for us. As a result, the Board of Directors and the Audit Committee periodically ask our executives to discuss the most likely sources of material future risks and how we are addressing any significant potential vulnerability. 39 Board Leadership Structure Our Board of Directors does not have a policy on whether the roles of Chief Executive Officer and Chairman of the Board of Directors should be separate and, if they are to be separate, whether the Chairman of the Board should be selected from the non-employee directors or be an employee. Our Board of Directors believes that it should be free to make a choice from time to time in any manner that is in the best interest of us and our stockholders. The Board of Directors believes that Mr. Ross’s service as both Chief Executive Officer and Chairman of the Board is in the best interest of us and our stockholders. Mr. Ross possesses detailed and in-depth knowledge of the issues, opportunities and challenges we face and is thus best positioned to develop agendas, with the input of Mr. Richie, the lead independent director, to ensure that the Board’s time and attention are focused on the most critical matters. His combined role enables decisive leadership, ensures clear accountability, and enhances our ability to communicate our message and strategy clearly and consistently to our stockholders, employees, customers, and suppliers, particularly during times of turbulent economic and industry conditions. Our Board of Directors also believes that a lead independent director is part of an effective Board leadership structure. To this end, the Board has appointed Leroy C. Richie as the lead independent director. The independent directors meet regularly in executive sessions at which only they are present, and the lead independent director chairs those sessions. As the lead independent director, Mr. Richie calls meetings of the independent directors as needed; sets the agenda for meetings of the independent directors; presides at meetings of the independent directors; is the principal liaison on Board issues between the independent directors and the Chairman and between the independent directors and management; provides feedback to the Chairman and management on the quality, quantity and timeliness of information sent to the Board; is a member of the Compensation Committee that evaluates the CEO’s performance; and oversees the directors’ evaluation of the Board’s overall performance. The Nominating and Governance Committee and the Board believe that its leadership structure, which includes the appointment of a lead independent lead director, is appropriate because it, among other things, provides for an independent director who gives board member leadership and each of the directors, other than Mr. Ross, is independent. Our Board of Directors believes that the independent directors provide effective oversight of management. Stockholder Communications with the Board of Directors Stockholders may communicate with the Board of Directors by writing to us as follows: Kustom Entertainment, Inc., attention: Corporate Secretary, 6366 College Blvd., Overland Park, KS 66211. Stockholders who would like their submission directed to a member of the Board of Directors may so specify and the communication will be forwarded as appropriate. Policy for Director Recommendations and Nominations Our Nominating and Governance Committee will consider candidates for Board membership suggested by Board members, management and our stockholders. The policy of our Nominating and Governance Committee is to consider recommendations for candidates to the Board of Directors from any stockholder of record in accordance with our Bylaws. A director candidate recommended by our stockholders will be considered in the same manner as a nominee recommended by a Board member, management or other sources. In addition, a stockholder may nominate a person directly for election to the Board of Directors at an annual meeting of stockholders, provided the stockholder meets the requirements set forth in our Bylaws. We do not pay a fee to any third party to identify or evaluate or assist in identifying or evaluating potential nominees. 40 Stockholder Recommendations for Director Nominations. Stockholder recommendations for director nominations may be submitted to the Company at the following address: Kustom Entertainment, Inc., Attention: Corporate Secretary, 6366 College Blvd., Overland Park, KS 66211. Such recommendations will be forwarded to the Nominating and Governance Committee for consideration, provided that they are accompanied by sufficient information to permit the Board to evaluate the qualifications and experience of the nominees, and they are in time for the Nominating and Governance Committee to do an adequate evaluation of the candidate before the Annual Meeting. The submission must be accompanied by a written consent of the individual to stand for election if nominated by the Board of Directors and to serve if elected and to cooperate with a background check. Stockholder Nominations of Directors. Our Bylaws provide that, in order for a stockholder to nominate a director at an annual meeting of stockholders, the stockholder must give timely written notice to our Secretary and such notice must be received at our principal executive offices not less than one-hundred-and-twenty (120) days before the date of our release of the Proxy Statement to stockholders in connection with our previous year’s annual meeting of stockholders. Such stockholder’s notice shall include, with respect to each person whom the stockholder proposes to nominate for election as a director, all information relating to such nominee that is required under the Exchange Act, including such person’s written consent to being named in the Proxy Statement as a nominee and serving as a director, and cooperating with a background investigation. In addition, the stockholder must include in such notice the name and address, as they appear on our records, of the stockholder proposing the nomination of such person, and the name and address of the beneficial owner, if any, on whose behalf the nomination is made, the class and number of shares of our capital stock that are owned beneficially and of record by such stockholder of record and by the beneficial owner, if any, on whose behalf the nomination is made, and any material interest or relationship that such stockholder of record and/or the beneficial owner, if any, on whose behalf the nomination is made may respectively have in such business or with such nominee. At the request of the Board of Directors, any person nominated for election as a director shall furnish to our Secretary the information required to be set forth in a stockholder’s notice of nomination that pertains to the nominee. To be timely in the case of a special meeting or if the date of the annual meeting is changed by more than thirty (30) days from such anniversary date, a stockholder’s notice must be received at our principal executive offices no later than the close of business on the tenth (10 th ) day following the earlier of the day on which notice of the meeting date was mailed or public disclosure of the meeting date was made. Compensation Committee Interlocks and Insider Participation None of our executive officers serves, or in the past has served, as a member of the Compensation Committee. None of the members of our Compensation Committee is, or has ever been, an officer or employee of the Company. Code of Ethics and Conduct Our Board of Directors has adopted a Code of Ethics and Conduct that is applicable to all of our employees, officers and directors. Our Code of Ethics and Conduct is intended to ensure that our employees, officers and directors act in accordance with the highest ethical standards. The Code of Ethics and Conduct is available on the Investor Relations page of our website at https://kustoment.com/ and the Code of Ethics and Conduct was filed as an exhibit to our Annual Report on Form 10-K filed on March 4, 2008. Delinquent Section 16(a) Reports Under the securities laws of the United States, our directors, executive (and certain other) officers, and any persons holding ten percent or more of our outstanding shares of Common Stock must report on their ownership of the Company’s securities and any changes in such ownership to the SEC. Specific due dates for these reports have been established. During such fiscal year, we believe that all reports required to be filed by such persons pursuant to Section 16(a) were filed on a timely basis, with the exception of the reports listed in the table below: Name Number of Late Reports Description Charles M. Anderson 2 Charles Anderson’s Form 3 was not filed on a timely basis; Charles Anderson’s Form 4 was not filed on a timely basis. Thomas Heckman 1 Thomas Heckman’s Form 4 was not filed on a timely basis. Insider Trading Arrangements and Policies We have a written insider trading policy that applies to our directors, officers, employees and contractors, including our principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions. We intend to disclose future amendments to such policy, or any waivers of its requirements, applicable to any principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions or our directors on our website identified above or in a current report on Form 8-K that we would file with the SEC. Our directors and executive officers may adopt written plans, known as Rule 10b5-1 plans, in which they will contract with a broker to buy or sell shares of our Common Stock on a periodic basis. Under a Rule 10b5-1 plan, a broker executes trades pursuant to parameters established by the director or officer when entering into the plan, without further direction from them. The director or officer may amend a Rule 10b5-1 plan in some circumstances and may terminate a plan at any time. Our directors and executive officers also may buy or sell additional shares outside of a Rule 10b5-1 plan when they are not in possession of material non-public information subject to compliance with the terms of our insider trading policy. 41 Item 11. Executive Compensation. The Company’s Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information We do not have any formal policy that requires the Company to grant, or avoid granting, equity-based compensation at certain times. We do not grant equity awards in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our Common Stock, and do not time the public release of such information based on award grant dates. The timing of any equity grants to executive officers or directors in connection with new hires, promotions, or other non-routine grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment or promotion effective date). During the year ended December 31, 2025, there were no equity grants made to our executive officers during any period beginning four business days before the filing of a periodic report or current report disclosing material non-public information and ending one business day after the filing or furnishing of such report with the Securities and Exchange Commission. The following table presents information concerning the total compensation of the Company’s Chief Executive Officer, Chief Financial Officer and Chief Operating Officer (the “Named Executive Officers”) for services rendered to the Company in all capacities for the years ended December 31, 2025 and 2024: Summary Compensation Table Name and principal position Year Salary ($) Bonus ($) Stock awards ($) Option awards ($) (1) All other compensation ($) (2) Total ($) Stanton E. Ross 2025 $ 256,216 $ 150,000 $ - $ - $ 15,326 $ 421,542 Chairman, CEO and President 2024 $ 112,885 $ - $ 42,600 (3) $ - $ 6,175 $ 161,660 Thomas J. Heckman 2025 $ 125,646 $ - $ - $ - $ 3,122 $ 128,768 CFO, Treasurer and Secretary 2024 $ 51,923 $ - $ - $ - $ 2,885 $ 54,808 Peng Han 2025 $ 259,385 $ - $ - $ - $ 8,567 $ 267,952 COO 2024 $ 112,885 $ - $ 31,950 (4) $ - $ 5,706 $ 150,541 (1) Represents aggregate grant date fair value pursuant to ASC Topic 718 for the respective year for stock options granted. (2) Amounts included in all other compensation include the following items: the employer contribution to the Company’s 401(k) Retirement Savings Plan (the “401(k) Plan”) on behalf of the named executive. We are required to provide a 100% matching contribution for all who elect to contribute up to 3% of their compensation to the plan and a 50% matching contribution for all employees’ elective deferral between 4% and 5%. The employee (i) is 100% vested at all times in the employee contributions and employer matching contributions; (ii) receives Company paid healthcare insurance; (iii) receives Company paid contributions to health savings accounts; and (iv) receives Company paid life, accident and disability insurance. See “All Other Compensation Table” below. (3) Stock awards include the following restricted stock granted during 2024 to Mr. Ross: 4 shares at $10,650.00 per share that vested 100% on January 31, 2025, subject to Mr. Ross remaining an employee of the Company at that point in time. (4) Stock awards include the following restricted stock granted during 2024 to Mr. Han: 3 shares at $10,650.00 per share, of which 1 shares vested immediately on January 31, 2024 at $10,650.00 per share and the remaining to vest annually beginning on January 31, 2025 through January 31, 2028, subject to Mr. Han remaining an employee of the Company at that point in time. All Other Compensation Table 401(k) Plan Company paid Flexible & health savings account Company paid life, accident & Other Name Year contribution by Company healthcare insurance contributions by Company disability insurance Contractual payments Total Stanton E. Ross 2025 $ 8,048 $ 5,562 $ 895 $ 821 $ - $ 15,326 Chairman, CEO and President 2024 $ 4,635 $ - $ 719 $ 821 $ - $ 6,175 Thomas J. Heckman 2025 $ 2,600 $ - $ - $ 522 $ - $ 3,122 CFO, Treasurer and Secretary 2024 $ 1,869 $ - $ 379 $ 637 $ - $ 2,885 Peng Han 2025 $ 7,746 $ - $ - $ 821 $ - $ 8,567 COO 2024 $ 4,885 $ - $ - $ 821 $ - $ 5,706 Compensation Policy. Our executive compensation plan is based on attracting and retaining qualified professionals who possess the skills and leadership necessary to enable us to achieve earnings and profitability growth to satisfy its stockholders. We must, therefore, create incentives for these executives to achieve both our and individual performance objectives using performance-based compensation programs. No one component is considered by itself, but all forms of the compensation package are considered in total. Wherever possible, objective measurements will be utilized to quantify performance, but many subjective factors still come into play when determining performance. Compensation Components. The main elements of its compensation package consist of base salary, stock options or restricted stock awards and bonus. Base Salary. The base salary for each executive officer is reviewed and compared to the prior year, with considerations given for increase or decrease. The review is generally on an annual basis but may take place more often in the discretion of the Compensation Committee. 42 On January 31, 2024, the Compensation Committee approved the annual base salaries of Stanton E. Ross, Chief Executive Officer, Thomas J. Heckman, Chief Financial Officer, Treasurer and Secretary, and Peng Han, Chief Operating Officer, at $250,000, $120,000, and $250,000, respectively, for 2024. However, the officers voluntarily reduced their salaries throughout 2024 to the amounts indicated in the Summary Compensation Table to support the Company’s cash flow position. During 2025, the officers voluntarily reduced their salaries throughout 2025 to the amounts indicated in the Summary Compensation Table to support the Company’s cash flow position. On January 27, 2026, the Compensation Committee approved the annual base salaries of Stanton E. Ross, Chief Executive Officer, Thomas J. Heckman, Chief Financial Officer, Treasurer and Secretary, and Peng Han, Chief Operating Officer, at $200,000, $90,000, and $200,000, respectively, for 2026. The Compensation Committee plans to review the base salaries for possible adjustments on an annual basis. Base salary adjustments will be based on both the individual and our performances and will include both objective and subjective criteria specific to each executive’s role and responsibility with us. Stock Options and Restricted Stock Awards. The Compensation Committee determined stock option and restricted stock awards based on numerous factors, some of which include responsibilities incumbent with the role of each executive with us, tenure with us, as well as our performance. The vesting period of options and restricted stock is also tied, in some instances, to our performance directly related to certain executives’ responsibilities with us. The Compensation Committee determined that Messrs. Ross and Han were eligible for awards of stock options or restricted stock in 2025 based on their performance however, no awards were made during 2025 based on the Company’s financial results and cash flow position, Refer to the “Grants of Plan-Based Awards” table below for restricted stock awards made in 2025. The Committee also determined that Messrs. Ross, Heckman, and Han would be eligible in 2025 for awards of restricted stock or stock options, however, no awards were made during 2025 based on the Company’s financial results and cash flow position. Bonuses. During the year ended December 31, 2025, a discretionary bonus of $150,000 was paid to Stanton E. Ross. No bonuses were awarded to Mr. Heckman or Han for 2025, or to any executive officer for 2024. Refer to the “Summary Compensation Table” above. Other. In July 2008, we amended and restated our 401(k) Plan. The amended 401(k) Plan requires us to provide a 100% matching contribution for employees who elect to contribute up to 3% of their compensation to the plan and a 50% matching contribution for employees’ elective deferrals between 4% and 5%. We have made matching contributions for executives who elected to contribute to the 401(k) Plan during 2024. Each participant is 100% vested at all times in employee and employer matching contributions. Mr. Heckman, as trustee of the 401(k) Plan, holds the voting power as to the shares of our Common Stock held in the 401(k) Plan. We have no profit-sharing plan in place for our employees. However, we may consider adding such a plan to provide yet another level of compensation to our compensation plan. The following table presents information concerning the grants of plan-based awards to the Named Executive Officers during the year ended December 31, 2025: Grants of Plan-Based Awards Name Grant date Date approved by Compensation Committee All other stock awards: Number of shares of stock or units: (#) (1) (2) Exercise or base price of option awards ($/Share) Grant date fair value of stock awards ($) (2) Stanton E. Ross Chairman and CEO - - - $ - $ - Thomas J. Heckman CFO, Treasurer and Secretary - - - $ - $ - Peng Han COO - - - $ - $ - Employment Contracts; Termination of Employment and Change-in-Control Arrangements We do not have any employment agreements with any of our executive officers. However, on December 23, 2008, we entered into retention agreements with the following executive officers: Stanton E. Ross and Thomas J. Heckman. In April 2018 we amended these agreements. Retention Agreements - Potential Payments upon Termination or Change of Control The following table sets forth for each named executive officer potential post-employment payments and payments on a change in control and assumes that the triggering event took place on December 31, 2025 and that the amendments to the retention agreements of each person were in effect. 43 Retention Agreement Compensation Name Change in control payment due based upon successful completion of transaction Severance payment due based on termination after Change of Control occurs Total Stanton E. Ross $ 50,000 $ 200,000 $ 250,000 Thomas J. Heckman $ 25,000 $ 90,000 $ 115,000 Total $ 75,000 $ 290,000 $ 365,000 The retention agreements guarantee the executive officers’ specific payments and benefits upon a Change in Control of the Company. The retention agreements also provide for specified severance benefits if, after a Change in Control of the Company occurs, the executive officer voluntarily terminates employment for Good Reason or is involuntarily terminated without Cause. Under the retention agreements, a “Change in Control” means (i) one party alone, or acting with others, has acquired or gained control over more than 50% of the voting shares of the Company; (ii) the Company merges or consolidates with or into another entity or completes any other corporate reorganization, if more than 50% of the combined voting power of the surviving entity’s securities outstanding immediately after such merger, consolidation or other reorganization is owned by persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization; (iii) a majority of the Board of Directors is replaced and/or dismissed by the stockholders of the Company without the recommendation of or nomination by the Company’s current Board of Directors; (iv) the Company’s Chief Executive Officer the CEO is replaced and/or dismissed by stockholders without the approval of the Board of Directors; or (v) the Company sells, transfers or otherwise disposes of all or substantially all of the consolidated assets of the Company and the Company does not own stock in the purchaser or purchasers having more than 50% of the voting power of the entity owning all or substantially all of the consolidated assets of the Company after such purchase. “Good Reason” means either (i) a material adverse change in the executive’s status as an executive or other key employee of the Company, including without limitation, a material adverse change in the executive’s position, authority, or aggregate duties or responsibilities; (ii) any adverse change in the executive’s base salary, target bonus or benefits; or (iii) a request by the Company to materially change the executive’s geographic work location. “Cause” means (i) the executive has acted in bad faith and to the detriment of the Company; (ii) the executive has refused or failed to act in accordance with any specific lawful and material direction or order of his or her supervisor; (iii) the executive has exhibited, in regard to employment, unfitness or unavailability for service, misconduct, dishonesty, habitual neglect, incompetence, or has committed an act of embezzlement, fraud or theft with respect to the property of the Company; (iv) the executive has abused alcohol or drugs on the job or in a manner that affects the executive’s job performance; and/or (v) the executive has been found guilty of or has plead nolo contendere to the commission of a crime involving dishonesty, breach of trust, or physical or emotional harm to any person. Prior to termination for Cause, the Company shall give the executive written notice of the reason for such potential termination and provide the executive a 30-day period to cure such conduct or act or omission alleged to provide grounds for such termination. If any Change in Control occurs and the executive continues to be employed as of the completion of such Change in Control, upon completion of such Change in Control, as payment for the executive’s additional efforts during such Change in Control, the Company shall pay the executive a Change in Control benefit payment equal to three months of the his base salary at the rate in effect immediately prior to the Change in Control completion date, payable in a lump sum net of required tax withholdings. If any Change in Control occurs, and if, during the one-year period following the Change in Control, the Company terminates the executive’s employment without Cause or the executive submits a resignation for Good Reason (the effective date of such termination or resignation, the “Termination Date”), then: (a) The Company shall pay the executive severance pay equal to 12 months of his base salary at the higher of the rate in effect immediately prior to the Termination Date or the rate in effect immediately prior to the occurrence of the event or events constituting Good Reason, payable on the Termination Date in a lump sum net of required tax withholdings, plus all other amounts then payable by the Company to the executive less any amounts then due and owing from the executive to the Company; (b) The Company shall provide continuation of the executive’s health benefits at the Company’s expense for 18 months following the Termination Date; and (c) The executive’s outstanding employee stock options shall fully vest and be exercisable for a 90-day period following the Termination Date. The executive is not entitled to the above severance benefits for a termination based on death or disability, resignation without Good Reason or termination for Cause. Following the Termination Date, the Company shall also pay the executive all reimbursements for expenses in accordance with the Company’ policies, within ten days of submission of appropriate evidence thereof by the executive. 44 The following table presents information concerning the outstanding equity awards for the Named Executive Officers as of December 31, 2025: Outstanding Equity Awards at Fiscal Year-End Option Awards Stock Awards Name Number of securities underlying unexercised options (#) exercisable (1) Number of securities underlying unexercised options (#) unexercisable Equity incentive plan awards: Number of securities underlying unexercised unearned options (#) Option exercise price ($) Option expiration date Number of shares or units of stock that have not vested (1) Market value of shares or units of stock that have not vested (2) Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested Equity incentive plan awards: Market or Payout value of unearned shares, units or other rights that have not vested Stanton E. Ross Chairman and CEO - - - - - $ - - $ - Thomas J. Heckman CFO, Treasurer and Secretary - - - - - - $ - - $ - Peng Han COO - - - - - 8 $ 15 - $ - (1) These stock option and restricted stock awards were made under the Kustom Entertainment, Inc. Stock Option and Restricted Stock Plans and vest over the prescribed period contingent upon whether the individual is still employed by the Company at that point. (2) Market value based upon the closing market price of $1.88 on December 31, 2025. The following table presents information concerning the stock options exercised and the vesting of restricted stock awards during 2025 for the Named Executive Officers for the year ended December 31, 2025: Option Exercises and Restricted Stock Vested Option Awards Stock Awards Number of Shares acquired realized on exercise (#) Value realized on exercise ($) Number of Shares acquired on vesting (#) Value on vesting ($) Stanton E. Ross Chairman and CEO - $ - 7 $ 12,957.73 (1) Thomas J. Heckman CFO, Treasurer and Secretary - $ - - $ - Peng Han COO - $ - 3 $ 6,585.67 (2) (1) Based on the closing market price of our Common Stock of $2,580.03 on January 10, 2025, the date of vesting for 3 shares of Common Stock, and the closing market price of our Common Stock of $1,304.41on January 31, 2025, the date of vesting for 4 share of Common Stock for Mr. Ross. (2) Based on the closing market price of our Common Stock of $1,304.41 on January 31, 2025, the date of vesting for 1 share of Common Stock, the closing market price of our Common Stock of $2,701.23 on January 7, 2025, the date of vesting for and the closing market price of our Common Stock of $2,580.03 on January 10, 2025, the date of vesting for 1 share of Common Stock for Mr. Han. The number of stock options and restricted stock awards that an employee, director, or consultant may receive under our Plans (defined below under “Information Regarding Plans and Other Arrangements Not Subject to Security Holder Action”) is in the discretion of the administrator and therefore cannot be determined in advance. The Board’s policy in 2024 was to grant officers an award of 10 restricted shares of Common Stock to our CEO and 8 restricted shares of Common Stock to our COO and each non-employee director no award of options or restricted stock, all subject to vesting requirements. The following table sets forth (a) the aggregate number of shares of Common Stock subject to options granted under the Plans during the year ended December 31, 2025 and (b) the average per share exercise price of such options. 45 Stock Option and Restricted Stock Grants Number of Restricted Shares of Number of Average per Common Options Share Exercise Name of Individual or Group Stock Granted Granted Price Stanton E. Ross, Chairman of the Board of Directors & CEO - - $ - Leroy C. Richie, Director - - $ - Thomas J. Heckman, Vice President, CFO, Treasurer & Secretary - - $ - Peng Han, COO - - $ - All executive officers, as a group - - $ - All directors who are not executive officers, as a group - - $ - All employees who are not executive officers, as a group - - $ - Director Compensation Our non-employee directors received the stock option grants noted in the “Director Compensation” table below for their service on the Board of Directors in 2025, including on the Audit, Nominating and Governance, and Compensation Committees. Director compensation for the year ended December 31, 2025 was as follows: Director Compensation Name Fees earned or paid in cash ($) Stock awards ($) Option awards ($) Total ($) Stanton E. Ross, Chairman of the Board of Directors (1) $ — $ — $ — $ — Leroy C. Richie (2) $ 157,000 $ — $ — $ 157,000 D. Duke Daughtery (2) $ 105,000 $ — $ — $ 105,000 Charles M. Anderson (2) $ 54,167 $ — $ — $ 54,167 (1) As a Named Executive Officer, Mr. Ross’s compensation and option awards are fully reflected in the “Summary Compensation” table, and elsewhere under “Executive Compensation.” He did not receive compensation or stock options for his services as a director. (2) The amounts shown include payments of director fees that were accrued and unpaid as of December 31, 2024, cash fees paid during the first and second quarters of 2025, and accrued but unpaid fees for the third and fourth quarters of 2025. Outstanding Stock Options Held by Directors The following table presents information concerning the outstanding equity awards for the Directors as of December 31, 2025: Outstanding Equity Awards at Fiscal Year-End Equity incentive plan awards: Number of Number of Number of securities securities securities underlying underlying underlying Option unexercised unexercised unexercised exercise Option options (#) options (#) unearned price expiration Name exercisable unexercisable options (#) ($) date Stanton E. Ross Chairman, CEO and President - - - $ - - Leroy C. Richie Lead Outside Director (1) 1 $ 200,400.00 7/8/2031 1 $ 250,800.00 5/1/2030 2 $ 361,200.00 5/24/2029 1 $ 264,000.00 7/5/2028 2 $ 360,000.00 8/14/2027 2 - - $ 470,400.00 5/11/2026 D Duke Daughtery Director - - $ - - Charles M Anderson Director - - $ - - (1) On March 23, 2026, Mr. Richie and the Company mutually agreed to cancel/forfeit all of his outstanding options to acquire Common Stock that were outstanding as of December 31, 2025. Therefore, Mr. Richie no longer holds these outstanding options to acquire Common Stock as of the date of this Annual Report on Form 10-K. Mr. Richie did not receive any compensation for the forfeiture and cancellation of these outstanding options to acquire Common Stock. 46 Pay Versus Performance The following table sets forth compensation information for our Chief Executive Officer, Stanton E. Ross, referred to in the tables below as the PEO, and our Chief Financial Officer, Thomas J. Heckman, and our Chief Operating Officer, Peng Han, referred to in the tables below as the Non-PEO NEOs, for purposes of comparing their respective compensation to our net loss, calculated in accordance with SEC regulations, for the fiscal years ended December 31, 2025 and 2024. Year Summary Compensation Table Total for PEO Compensation Actually Paid to PEO Average Summary Compensation Table Total for Non-PEO NEOs Average Compensation Actually Paid to Non-PEO NEOs Net Income (Loss) (1) (2) (3) (4) 2025 $ 421,542 $ 412,437 $ 198,360 $ 184,400 $ (7,359,024 ) 2024 $ 161,660 $ 116,097 $ 102,675 $ 88,325 $ (21,715,725 ) (1) The dollar amounts reported are the amounts of total compensation reported for Mr. Ross in the Summary Compensation Table for the fiscal years ended December 31, 2025 and 2024. (2) The dollar amounts reported represent the amount of “compensation actually paid”, as computed in accordance with SEC rules. The dollar amounts reported are the amounts of total compensation reported for Mr. Ross during the applicable year, but also include (i) the year-end fair value of equity awards granted during the reported year that are outstanding and unvested, (ii) the change in the fair value of equity awards that were outstanding and unvested at the end of the prior year, measured through the date on which the awards vested, or through the end of the reported fiscal year, and (iii) the fair value of equity awards that were issued and vested during the reported fiscal year. See the table under “PEO Equity Award Adjustment Breakout” below for further information. (3) The dollar amounts reported are the average total compensation reported for our Non-PEO NEO in the Summary Compensation Table for the fiscal years ended December 31, 2025 and 2024. (4) The dollar amounts reported represent the average amount of “compensation actually paid”, as computed in accordance with SEC rules, for our Non-PEO NEOs. The dollar amounts reported are the average total compensation reported for our Non-PEO NEOs in the Summary Compensation Table for the fiscal years ended December 31, 2025 and 2024, but also include (i) the year-end fair value of equity awards granted during the reported year that are outstanding and unvested, (ii) the change in the fair value of equity awards that were outstanding and unvested at the end of the prior year, measured through the date on which the awards vested, or through the end of the reported fiscal year, and (iii) the fair value of equity awards that were issued and vested during the reported fiscal year. See the table under “Non-PEO NEOs Equity Award Adjustment Breakout” below for further information. PEO Equity Award Adjustment Breakout To calculate the amounts in the “Compensation Actually Paid to PEO” column in the table above, the following amounts were deducted from and added to (as applicable) our PEO’s “Total” compensation as reported in the Summary Compensation Table: Year Summary Compensation Table Total for PEO Reported Value of Equity Awards for PEO(1) Fair Value as of Year End for Awards Granted During the Year Fair Value Year over Year Increase or Decrease in Unvested Awards Granted in Prior Years Fair Value of Awards Granted and Vested During the Year Fair Value Increase or Decrease from Prior Year end for Awards that Vested during the Year Compensation Actually Paid to PEO 2025 $ 421,542 $ (-0- ) $ -0- $ (-0- ) $ -0- $ (9,105 ) $ 412,437 2024 $ 161,660 $ (42,600 ) $ 10,600 $ (13,913 ) $ -0- $ 350 $ 116,097 (1) Represents the grant date fair value of the equity awards to our PEO, as reported in the Summary Compensation Table. Non-PEO NEOs Equity Award Adjustment Breakout To calculate the amounts in the “Compensation Actually Paid to Non-PEO NEOs” column in the table above, the following amounts were deducted from and added to (as applicable) the “Total” compensation of our Non-PEO NEOs as reported in the Summary Compensation Table: Year (1) Summary Compensation Table Total for Non-PEO NEOs Reported Value of Equity Awards for Non-PEO NEOs(2) Fair Value as of Year End for Awards Granted During the Year Fair Value Year over Year Increase or Decrease in Unvested Awards Granted in Prior Years Fair Value of Awards Granted and Vested During the Year Fair Value Increase or Decrease from Prior Year end for Awards that Vested during the Year Compensation Actually Paid to Non-PEO NEOs 2025 $ 198,360 $ (-0- ) $ 75 $ (12,600 ) $ -0- $ (1,435 ) $ 184,400 2024 $ 102,675 $ (15,975 ) $ 3,975 $ (5,565 ) $ 3,195 $ 20 $ 88,325 (1) All the amounts are average for Non-PEO NEOs. (2) Represents the grant date fair value of the equity awards to our Non-PEO NEOs, as reported in the Summary Compensation Table. 47 Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. The following table sets forth, as of April 10, 2026, information regarding beneficial ownership of our Common Stock for: ● each person, or group of affiliated persons, known by us to beneficially own more than 5% of our Common Stock; ● each of our executive officers; ● each of our directors; and ● all of our current executive officers and directors as a group. Beneficial ownership is determined according to the rules of the United States Securities and Exchange Commission (the “SEC”) and generally means that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power of that security, including securities that are currently exercisable or exercisable within sixty (60) days of April 10, 2026. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that the persons named in the table below have sole voting and investment power with respect to all shares of Common Stock shown that they beneficially own, subject to community property laws where applicable Common Stock subject to securities currently exercisable or exercisable within sixty (60) days April 10, 2026 are deemed to be outstanding for computing the percentage ownership of the person holding such securities and the percentage ownership of any group of which the holder is a member but are not deemed outstanding for computing the percentage of any other person. Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o Kustom Entertainment, Inc., 6366 College Blvd., Overland Park, KS, 66211. Number of Shares of Common Stock Beneficially Owned (1) % of Total Shares % Voting Power 5% or Greater Stockholders: None Executive Officers and Directors: Stanton E. Ross 27 * * Leroy C. Richie -0- * * D. Duke Daughtery 1 * * Thomas J. Heckman (2) 604 * * Peng Han (3) 15 * * Charles M. Anderson -0- * * All executive officers and directors as a group (Six individuals) 647 * % * % * Represents less than 1%. (1) Based on 2,633,063 shares of Common Stock issued and outstanding as of April 10, 2026 and, with respect only to the ownership by all executive officers and directors as a group (2) Mr. Heckman’s total shares of Common Stock include 602 shares of common stock held in the Company’s 401(k) Retirement Savings Plan the 401(k) Plan (on April 6, 2026) as to which Mr. Heckman has voting power as trustee of the 401(k) Plan. (3) Mr. Han’s total shares of Common Stock include 5 restricted shares that are subject to forfeiture to us. Securities Authorized for Issuance under Equity Compensation Plans As of December 31, 2025, the Company had adopted ten separate stock option and restricted stock plans: (i) the 2005 Stock Option and Restricted Stock Plan (the “2005 Plan”), (ii) the 2006 Stock Option and Restricted Stock Plan (the “2006 Plan”), (iii) the 2007 Stock Option and Restricted Stock Plan (the “2007 Plan”), (iv) the 2008 Stock Option and Restricted Stock Plan (the “2008 Plan”), (v) the 2011 Stock Option and Restricted Stock Plan (the “2011 Plan”), (vi) the 2013 Stock Option and Restricted Stock Plan (the “2013 Plan”), (vii) the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”), (viii) the 2018 Stock Option and Restricted Stock Plan (the “2018 Plan”), (ix) the 2020 Stock Option and Restricted Stock Plan (the “2020 Plan”), and (x) the 2022 Stock Option and Restricted Stock Plan (the “2022 Plan”). The 2005 Plan, 2006 Plan, 2007 Plan, 2008 Plan, 2011 Plan, 2013 Plan, 2015 Plan, 2018 Plan, 2020 Plan and 2022 Plan are referred to as the “Plans.” Stock option grants . The Company believes that such awards better align the interests of our employees with those of its stockholders. Option awards have been granted with an exercise price equal to the market price of its stock at the date of grant with such option awards generally vesting based on the completion of continuous service and having ten-year contractual terms. These option awards typically provide for accelerated vesting if there is a Change in Control (as defined in the Plans). The Company has registered all shares of Common Stock that are issuable under its Plans with the SEC. A total of 125,021 shares remained available for awards under the various Plans as of December 31, 2025. The Plans authorize us to grant (i) to the key employees incentive stock options (except for the 2007 Plan) to purchase shares of Common Stock and non-qualified stock options to purchase shares of Common Stock and restricted stock awards, and (ii) to non-employee directors and consultants’ non-qualified stock options and restricted stock. The Compensation Committee of our Board (the “Compensation Committee”) administers the Plans by making recommendations to the Board or determinations regarding the persons to whom options or restricted stock should be granted and the amount, terms, conditions and restrictions of the awards. The Plans allow for the grant of incentive stock options (except for the 2007 Plan), non-qualified stock options and restricted stock awards. Incentive stock options granted under the Plans must have an exercise price at least equal to 100% of the fair market value of the Common Stock as of the date of grant. Incentive stock options granted to any person who owns, immediately after the grant, stock possessing more than 10% of the combined voting power of all classes of our stock, or of any parent or subsidiary corporation, must have an exercise price at least equal to 110% of the fair market value of the Common Stock on the date of grant. Non-statutory stock options may have exercise prices as determined by our Compensation Committee. The Compensation Committee is also authorized to grant restricted stock awards under the Plans. A restricted stock award is a grant of shares of the Common Stock that is subject to restrictions on transferability, risk of forfeiture and other restrictions and that may be forfeited in the event of certain terminations of employment or service prior to the end of a restricted period specified by the Compensation Committee. We have filed various registration statements on Form S-8 and amendments to previously filed Form S-8’s with SEC, which registered Common Stock issued or to be issued underlying the awards under the Plans. 48 The following table sets forth certain information regarding the Plans as of December 31, 2025: Equity Compensation Plan Information Plan category Number of securities to be issued upon exercise of outstanding options, warrants and rights (a) Weighted-average exercise price of outstanding options, warrants and rights (b) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c) Equity compensation plans approved by stockholders 9 $ 270,840.00 125,021 Equity compensation plans not approved by stockholders — $ — — Total all plans 9 $ 270,840.00 125,021 Item 13. Certain Relationships and Related Transactions, and Director Independence. Other than compensation arrangements for our directors and executive officers, the following is a summary of transactions since the beginning of the last two fiscal years ended December 31, 2025 and 2024 to which we have been a party in which the amount involved exceeded the lesser of (i) $120,000 or (ii) one percent of the average of our total assets at year-end for the last two completed fiscal years, and in which any of our then directors, executive officers or holders of more than 5% of any class of our stock at the time of such transaction, or any members of their immediate family, had or will have a direct or indirect material interest. Transactions with Managing Member of Nobility Healthcare The Company accrued reimbursable expenses payable to Nobility, LLC totaling $0 and $245,716 as of December 31, 2025 and 2024, respectively. Total management fees accrued and payable in accordance with the operating agreement totaled $19,496 and $38,625 as of December 31, 2025 and 2024, respectively. The Company recorded management fee expense of $0 and $67,905 for the years ended December 31, 2025 and 2024, respectively. Nobility Healthcare was classified as a discontinued operation as of December 31, 2025. Accordingly, amounts reflected for 2025 represent the full year of Nobility Healthcare’s operations, presented as discontinued operations following its classification as of December 31, 2025 and subsequent sale in January 2026. See Note 23, Discontinued Operations , to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for additional information regarding the discontinued operation. Transactions with Related Party of TicketSmarter Note payable – related party is comprised of the following: December 31, 2025 December 31, 2024 Note payable – related party $ 2,000,000 $ 2,840,000 Unamortized discount (1,599,890 ) — Debt obligations 400,110 2,840,000 Less: current maturities of note payable-related party — 2,840,000 Note payable -related party, long-term $ 400,110 $ — Accrued interest – related party was $0 and $492,176 at December 31, 2025 and 2024, respectively. Debt obligations mature on an annual basis as follows as of December 31, 2025: Gross Principal Unamortized Discount Net Carrying Value 2026 $ — $ — $ — 2027 — — — 2028 — — — 2029 — — — 2030 and thereafter 2,000,000 (1,599,890 ) 400,110 Total $ 2,000,000 $ (1,599,890 ) $ 400,110 49 Original Loan and Amendments On September 22, 2023 and October 2, 2023, a trust (the “Goodman Trust”), the beneficiaries of which are an officer of TicketSmarter, Inc. (“TicketSmarter”) and his spouse, advanced a total of $2,700,000 to TicketSmarter to resolve outstanding payables at discounted rates. The officer serves as CEO of TicketSmarter and continues in that capacity as of December 31, 2025. The officer has no role at the parent company and is not an officer or director of Kustom Entertainment, Inc. The note originally bore interest at 13.25% per annum with weekly principal payments of $54,000 beginning January 2, 2024. The proceeds were used to settle outstanding vendor payables at negotiated discounts; the discounts received were recognized as a gain on extinguishment of liabilities in the consolidated statement of operations for the year ended December 31, 2023. The note was amended four times between August 2024 and June 2025: Amendment 1 (August 19, 2024). The repayment start date was extended to January 2, 2025. All other terms, including the 13.25% interest rate and $54,000 weekly payment, remained unchanged. The Company determined the change in present value of cash flows was less than 10% and accordingly accounted for the amendment as a modification with no gain or loss recognized. The effective interest rate was adjusted prospectively. Payments of $22,000 were made during the year ended December 31, 2024. Amendment 2 (March 20, 2025). The interest rate was reduced from 13.25% to 8% per annum, weekly payments were reduced from $54,000 to $11,000, the repayment term was extended to 247 weeks, and all accrued interest of $582,203 was eliminated. The change in present value of cash flows exceeded 10% and accordingly the amendment was accounted for as an extinguishment and reissuance of a new note. The new note was recorded at its estimated fair value of $2,032,831, determined as the present value of future cash flows discounted at 13.5%, resulting in a debt discount of $667,169. Because the holder is a related party, the difference between the carrying amount of the old note and the fair value of the new note, together with the forgiven accrued interest, was recognized as a deemed capital contribution of $1,249,372 to additional paid-in capital rather than as a gain in earnings. Amendment 3 (April 18, 2025) and Amendment 4 (June 4,2025). On April 18, 2025, the outstanding principal was reduced from $2,678,000 to $2,000,000, weekly payments were reduced from $11,000 to $9,600, all accrued interest was eliminated, and the interest rate remained at 8%. On June 4, 2025, a subordination clause was added providing that the note will only be repaid once the Company’s intercompany line of credit with TicketSmarter has been fully satisfied, effectively deferring all payments until satisfaction of that obligation (see “Subordination” below). Both amendments were accounted for as extinguishments and recorded as a combined entry on June 4, 2025, resulting in a deemed capital contribution of $622,622 to additional paid-in capital. Subordination and Fair Value Amendment 4 subordinated all payments on the Goodman Trust note to the Company’s $3,000,000 line of credit with TicketSmarter, which was established in connection with the September 2021 acquisition and is secured by a first lien on all TicketSmarter assets. As of December 31, 2025, $2,743,179 was outstanding on the line of credit. Based on management’s cash flow projections for TicketSmarter, the line of credit is not expected to be fully satisfied until approximately 2036. Accordingly, the first payment on the Goodman Trust note is not expected until January 2037. The fair value of the note as of the modification date was determined to be $372,548, calculated as the present value of $9,600 per week for 209 weeks beginning January 2037, discounted at 13.25% per annum, which represents the Company’s estimated incremental borrowing rate for a subordinated obligation of similar credit quality and term. The resulting debt discount of $1,627,452 is being amortized to non-cash interest expense using the effective interest method over the remaining term of the note through 2041. An additional deemed capital contribution of $1,111,304 was recognized to additional paid-in capital to reflect the increase in discount resulting from the deferral of all payments to 2037. Non-Cash Interest Expense For the year ended December 31, 2025, the Company recognized total non-cash interest expense of $35,332 related to amortization of the debt discount on the Goodman Trust note, consisting of $7,770 for the period prior to the March 2025 amendment and $27,562 for the period following the June 2025 amendment. The unamortized discount balance was $1,599,890 as of December 31, 2025. 50 Deemed Capital Contributions During the year ended December 31, 2025, the Company recognized total deemed capital contributions of $2,983,298 to additional paid-in capital arising from the modifications of the Goodman Trust note. The second amendment on March 20, 2025 resulted in a deemed capital contribution of $1,249,372, representing the forgiveness of $582,203 in accrued interest and the economic benefit of the reduced interest rate. The combined third and fourth amendments, recorded on June 4, 2025, resulted in a deemed capital contribution of $622,622, representing the excess of the carrying value of the extinguished note over the fair value of the restructured note after giving effect to the $678,000 principal reduction and $43,515 in accrued interest forgiveness. An additional deemed capital contribution of $1,111,304 was recognized at December 31, 2025 to reflect the increase in debt discount resulting from the subordination of all payments to 2037. Because the holder of the note is a related party, all amounts were recognized as equity contributions rather than gains in earnings, consistent with the accounting treatment for related party transactions. Balance Sheet Classification Because all payments under the note are subordinated to the intercompany line of credit and deferred to 2037, no amounts are classified as current as of December 31, 2025. The note is presented entirely within long-term liabilities at its net carrying value of $400,110. No accrued interest was outstanding as of December 31, 2025, as all previously accrued interest was eliminated pursuant to the amendments described above. Company Related Party Note On August 22, 2024, the Company’s Chief Executive Officer, made a loan in the amount of $100,000 to the Company to support its operations. In addition, on October 24, 2024, the Company’s Chief Executive Officer, made an additional loan in the amount of $40,000 to the Company to support its operations. These transactions were recorded as related party notes payable (the “Company Related Party Notes”). The Company Related Party Notes bear interest at prime rate (8.00% as of December 31, 2025 and 2024) per annum with repayment due on demand. The Company paid off the Company Related Party Notes in full during the year ended December 31, 2025. Related Person Transaction Policy Our Audit Committee considers and approves or disapproves any related person transaction as required by Nasdaq regulations. The Company’s policies and procedures on related party transactions cover any transaction, arrangement or relationship or series of similar transactions, arrangements or relationships (including any indebtedness or guarantee of indebtedness) in which: (i) the Company (or any subsidiary) is a participant; (ii) any related party has or will have a direct or indirect interest; and (iii) the aggregate amount involved (including any interest payable with respect to indebtedness) will or may be expected to exceed $120,000, except that there is no $120,000 threshold for members of the Audit Committee. A related party is any: (i) person who is or was (since the beginning of the two fiscal years preceding the last fiscal year, even if they do not presently serve in that role) an executive officer, director or nominee for election as a director; (ii) greater than five percent (5%) beneficial owner of the Company’s Common Stock or any other class of the Company’s voting equity securities; or (iii) immediate family member of any of the foregoing. An immediate family member includes a person’s spouse, parents, stepparents, children, stepchildren, siblings, mothers- and fathers-in-law, sons- and daughters-in-law, and brothers- and sisters-in-law and any person (other than a tenant or employee) sharing the same household as such person. In determining whether to approve or ratify a related party transaction, the Audit Committee, or disinterested directors, as applicable, will take into account, among other factors it deems appropriate: (i) whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances; (ii) the nature and extent of the related party’s interest in the transaction; (iii) the material terms of the transactions; (iv) the importance of the transaction both to the Company and to the related party; (v) in the case of a transaction involving an executive officer or director, whether the transaction would interfere with the performance of such person’s duties to the Company; and (vi) in the case of a transaction involving a non-employee director or a nominee for election as a non-employee director (or their immediate family member), whether the transaction would disqualify the director or nominee from being deemed an “independent” director, as defined by Nasdaq, and whether the transaction would disqualify the individual from serving on the Audit Committee or the Compensation Committee or other committees of the Board under applicable Nasdaq and other regulatory requirements. The Audit Committee only approves those related party transactions that are on terms comparable to, or more beneficial to us than, those that could be obtained in arm’s length dealings with an unrelated third party. 51 Item 14. Principal Accountant Fees and Services. Audit and Related Fees The following table is a summary of the fees for the fiscal years ended December 31, 2025 and 2024: Fee Category Fiscal 2025 fees Fiscal 2024 fees Audit fees $ 282,500 $ 275,000 Audit-related fees — 165,000 Tax fees — — All other fees — — Total fees $ 282,500 $ 440,000 Fiscal year 2025 fees were billed by Victor Mokuolu CPA PLLC (“VMCPA”), the Company’s current independent registered public accounting firm. Fiscal year 2024 fees were billed by RBSM LLP, the Company’s former independent registered public accounting firm. The Company engaged VMCPA as its independent registered public accounting firm effective May 5, 2025. Audit Fees. Such amount consists of fees billed for professional services rendered in connection with the audit of our annual financial statements and review of the interim financial statements included in our quarterly reports. It also includes services that are normally provided by our independent registered public accounting firms in connection with statutory and regulatory filings or engagements. Audit-Related Fees. Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include employee benefit plan audits, consents issued for certain filings with the SEC, accounting consultations in connection with acquisitions, attest services that are not required by statute or regulation, and consultations concerning financial accounting and reporting standards. Tax Fees. Tax fees consist of fees billed for professional services related to tax compliance, tax advice and tax planning. These services include assistance regarding federal, state and international tax compliance, tax audit defense, customs and duties, mergers and acquisitions, and international tax planning. All Other Fees. Consists of fees for products and services other than the services reported above. The Audit Committee’s practice is to consider and approve in advance all proposed audit and non-audit services to be provided by our independent registered public accounting firm. All the fees shown above were pre-approved by the Audit Committee. 52 PART IV Item 15. Exhibits and Financial Statement Schedules. (a) The following documents are filed as part of this Annual Report on Form 10-K: 1. Consolidated Financial Statements : The consolidated financial statements required to be included in Part II, Item 8, Financial Statements and Supplementary Data, begin on Page F-1 and are submitted as a separate section of this Annual Report on Form 10-K. 2. Financial Statement Schedules : All schedules are omitted because they are not applicable or are not required, or because the required information is included in the consolidated financial statements or notes in this Annual Report on Form 10-K. 3. Exhibits : Exhibit Number Description of Exhibit 2.1 Agreement and Plan of Merger, dated August 23, 2022, between Digital Ally, Inc. and DGLY Subsidiary. (19) 2.2 Agreement and Plan of Merger, dated June 1, 2024, by and among Clover Leaf Capital Corp., CL Merger Sub, Inc., Yntegra Capital Investments LLC, in the capacity as the Purchaser Representative, Kustom Entertainment, Inc. and Digital Ally, Inc. (27) 3.1(i)(a) Articles of Incorporation. (19) 3.1(i)(b) Articles of Merger. (19) 3.1(i)(c) Certificate of Amendment to the Registrant’s Articles of Incorporation, effective December 8, 2022. (22) 3.1(i)(d) Certificate of Amendment to Articles of Incorporation of Digital Ally, Inc., dated February 6, 2024. (23) 3.1(i)(e) Certificate of Amendment to Articles of Incorporation of the Registrant, effective May 6, 2025. (31) 3.1(i)(f) Certificate of Amendment to Articles of Incorporation of the Registrant, effective May 23, 2025. (32) 3.1(i)(g) Certificate of Change to the Articles of Incorporation of the Registrant, effective January 8, 2026. (36) 3.1(i)(h) Certificate of Amendment to the Articles of Incorporation of the Registrant, effective January 8, 2026. (36) 3.1(ii)(a) Amended and Restated Bylaws (19) 3.1(ii)(b) Amendment to the Amended and Restated Bylaws of the Registrant, effective January 8, 2026. (36) 4.1 Form of Common Stock Certificate. (29) 4.2 Form of Certificate of Designation of Series A Convertible Redeemable Preferred Stock. (20) 4.3 Form of Certificate of Designation of Series B Convertible Redeemable Preferred Stock. (20) 4.4 Form of Common Stock Purchase Warrant of Digital Ally, Inc., dated August 5, 2019. (10) 4.5 Form of Pre-Funded Common Stock Purchase Warrant of Digital Ally, dated February 1, 2021. (13) 4.6 Form of Common Stock Purchase Warrant of Digital Ally, dated February 1, 2021. (29) 4.7 Form of Senior Secured Convertible Note, issued by Digital Ally, Inc., dated April 5, 2024. (26) 4.8 Form of Warrant of Digital Ally, Inc., dated April 5, 2024. (26) 4.9 Revolving Note, dated October 26, 2024, issued by Digital Ally, Inc.to Kompass Kapital Funding, LLC. (28) 4.10 Form of Pre-Funded Warrant, dated February 14, 2025 (30) 4.11 Form of Series A Warrant, dated February 14, 2025 (30) 4.12 Form of Series B Warrant, dated February 14, 2025 (30) 4.13 Form of Senior Secured Convertible Note, issued by Digital Ally, Inc., dated September 15, 2025 (33) 4.14 Form of Warrant issued by Digital Ally, Inc., dated September 15, 2025 (33) 4.15 Form of Senior Secured Convertible Note, issued by Digital Ally, Inc., dated December 19, 2025 (33) 4.16 Form of Warrant issued by Digital Ally, Inc., dated December 19, 2025 (35) 4.17 Promissory Note dated January 8, 2026. (37) 4.18 Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. (25) 10.1 2005 Stock Option and Restricted Stock Plan. (2) 10.2 2006 Stock Option and Restricted Stock Plan. (2) 10.3 Form of Stock Option Agreement (ISO and Non-Qualified) 2005 Stock Option Plan. (2) 10.4 Form of Stock Option Agreement (ISO and Non-Qualified) 2006 Stock Option Plan. (2) 10.9 Forms of Restricted Stock Agreement for 2005, 2006, 2007 and 2008 Stock Option and Restricted Stock Plans. (3) 10.11 2011 Stock Option and Restricted Stock Plan (4) 10.12 Form of Stock Option Agreement for 2011 Stock Option and Restricted Stock Plan (4) 10.13 Amended and Restated 2015 Stock Option and Restricted Stock Plan (5) 10.14 Form of 2015 Stock Option and Restricted Stock Plan Restricted Stock Grant Agreement. (25) 10.15 Digital Ally, Inc. 2018 Stock Option and Restricted Stock Plan. (9) 10.16 Form of 2018 Stock Option and Restricted Stock Plan Restricted Stock Grant Agreement. (25) 10.17 Digital Ally, Inc. 2020 Stock Option and Restricted Stock Plan. (11) 10.18 Amendment to Digital Ally, Inc. 2020 Stock Option and Restricted Stock Plan. (14) 10.19 Form of 2020 Stock Option and Restricted Stock Plan Restricted Stock Grant Agreement. (25) 10.20 Digital Ally, Inc. 2022 Stock Option and Restricted Stock Plan. (21) 10.21 Form of 2022 Stock Option and Restricted Stock Plan Restricted Stock Grant Agreement under the 2022 Stock Option and Restricted Stock Plan. (24) 53 10.22 Proceeds Investment Agreement, dated as July 31, 2018, by and between Digital Ally, Inc. and Brickell Key Investments LP. (8) 10.23 Letter Agreement, dated as July 31, 2018, by and between Digital Ally, Inc. and Brickell Key Investments LP. (8) 10.24 Form of Securities Purchase Agreement, dated as of January 11, 2021, by and between Digital Ally, Inc. and the Investors. (12) 10.25 Form of Placement Agency Agreement, dated January 27, 2021, by and between Digital Ally, Inc. and Kingswood Capital Markets, division of Benchmark Investments, Inc. (13) 10.26 Form of Securities Purchase Agreement, dated as of January 27, 2021, by and between Digital Ally, Inc. and the Investors. (13) 10.27 Commercial Real Estate Sales Contract, dated February 24, 2021, between Digital Ally, Inc. and DDG Holding, LLC. (15) 10.28 Form of Operating Agreement of Nobility Healthcare, LLC, dated June 1, 2021. (16) 10.29 Warrant Exchange Agreement, dated August 19, 2021, by and among Digital Ally, Inc. and the warrant holders who are signatories thereto. (17) 10.30 Unit Purchase Agreement, dated September 2, 2021. (18) 10.31 Form of Exchange Agreement, dated August 23, 2022. (19) 10.32 Form of Securities Purchase Agreement, dated October 13, 2022, between Digital Ally, Inc. and the investors thereto. (20) 10.33 Form of Registration Rights Agreement, dated October 13, 2022, by and among Digital Ally, Inc. and the investors named therein. (20) 10.34 Form of Securities Purchase Agreement, dated April 5, 2024, between Digital Ally, Inc. and certain Purchasers who are signatories thereto. (26) 10.35 Form of Security Agreement, dated April 5, 2024, between Digital Ally, Inc. and certain holders of Digital Ally, Inc.’s Senior Secured Convertible Notes who are signatories thereto. (26) 10.36 Form of Trademark Security Agreement, dated April 5, 2024, between Digital Ally, Inc. and a lender. (26) 10.37 Form of Patent Security Agreement, dated April 5, 2024, between Digital Ally, Inc. and between Digital Ally, Inc. and a lender. (26) 10.38 Form of Subsidiary Guaranty, dated April 5, 2024, by and among Digital Ally, Inc. and its direct and indirect subsidiaries and a lender. (26) 10.39 Form of Registration Rights Agreement, dated April 5, 2024, between Digital Ally, Inc. and certain Purchasers, who are signatories thereto. (26) 10.40 Loan and Security Agreement, dated October 26, 2024, by and between Digital Ally, Inc., Digital Ally Healthcare, LLC, and Kompass Kapital Funding, LLC. (28) 10.41 Mortgage, Assignment of Leases and Rents, Security Agreement and Fixture Filing, dated October 26, 2024, by and between Digital Ally, Inc. and Kompass Kapital Funding, LLC. (28) 10.42 Lock-Up Agreement, dated June 1, 2024, by and between Clover Leaf Capital Corp., Yntegra Capital Investments, LLC, and Digital Ally, Inc. (27) 10.43 Form of Underwriting Agreement by and between Digital Ally, Inc. and Aegis Capital Corp., dated February 13, 2025 (30) 10.44 Form of Securities Purchase Agreement between Digital Ally, Inc. and a certain Purchaser, dated September 15, 2025, relating to the Notes and Warrants (33) 10.45 Form of Security Agreement between Digital Ally, Inc. and a certain Purchaser, dated September 15, 2025 (33) 10.46 Form of Trademark Security Agreement between Digital Ally, Inc. and a certain Purchaser, dated September 15, 2025 (33) 10.47 Form of Patent Security Agreement between Digital Ally, Inc. and a certain Purchaser, dated September 15, 2025 (33) 10.48 Form of Subsidiary Guaranty by and among Digital Ally, Inc. and its direct and indirect subsidiaries, dated September 15, 2025 (33) 10.49 Form of Registration Rights Agreement between Digital Ally, Inc. and a certain Purchaser, dated September 15, 2025, relating to the Notes and Warrants (33) 10.50 Form of Leak-Out Agreement between Digital Ally, Inc. and a certain Purchaser, dated September 15, 2025 (33) 10.51 Form of Common Stock Purchase Agreement between Digital Ally, Inc. and a certain Purchaser, dated September 15, 2025, relating to the ELOC (33) 10.52 Form of Registration Rights Agreement between Digital Ally, Inc. and a certain Purchaser, dated September 15, 2025, relating to the ELOC (33) 10.53 Form of First Amendment to Common Stock Purchase Agreement between Digital Ally, Inc. and a certain Purchaser, dated November 7, 2025 (34) 10.54 Unit Purchase Agreement dated January 8, 2026, by and among Digital Ally Healthcare, Inc., Nobility LLC, and Nobility Healthcare, LLC (37) 14.1 Code of Ethics and Code of Conduct. (1) 21.1 Subsidiaries of Registrant (29) 23.1 Consent of Victor Mokuolu, CPA PLLC * 23.2 Consent of RBSM LLP * 24.1 Power of Attorney * 31.1 Certificate of Stanton E. Ross, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 * 31.2 Certificate of Thomas J. Heckman, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 * 32.1 Certificate of Stanton E. Ross, Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 * 32.2 Certificate of Thomas J. Heckman, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 * 97 Clawback Policy (29) 54 101.INS Inline XBRL Instance Document ** 101.SCH Inline XBRL Taxonomy Schema ** 101.CAL Inline XBRL Taxonomy Calculation Linkbase ** 101.LAB Inline XBRL Taxonomy Label Linkbase ** 101.PRE Inline XBRL Taxonomy Presentation Linkbase ** 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) *Filed herewith. ** The XBRL related information in Exhibit 101 to this Annual Report on Form 10-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that Section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document. (1) Filed as an exhibit to the Company’s Annual Report on Form 10KSB for the Year ended December 31, 2007. (2) Filed as an exhibit to the Company’s October 2006 Form SB-2. (3) Filed as an exhibit to the Company’s Annual Report on Form 10K for the Year ended December 31, 2009. (4) Filed as an exhibit to the Company’s Form 8-K filed June 1, 2011. (5) Filed as an exhibit to the Company’s Form S-8 filed May 23, 2016. (6) Filed as an exhibit to the Company’s Form 8-K filed August 25, 2017. (7) Filed as an exhibit to the Company’s Form 8-K filed April 4, 2018. (8) Filed as an exhibit to the Company’s Form 8-K filed August 2, 2018. (9) Filed as an exhibit to the Company’s Registration Statement on Form S-8 filed August 20, 2018. (10) Filed as an exhibit to the Company’s Form 8-K filed August 5, 2019. (11) Filed as an exhibit to the Company’s Registration Statement on Form S-8 filed November 16, 2020. (12) Filed as an exhibit to the Company’s Form 8-K filed January 12, 2021. (13) Filed as an exhibit to the Company’s Form 8-K filed January 28, 2021. (14) Filed as Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed April 27, 2021. (15) Filed as an exhibit to the Company’s Form 8-K filed May 3, 2021. (16) Filed as an exhibit to the Company’s Form 8-K filed June 9, 2021. (17) Filed as an exhibit to the Company’s Form 8-K filed August 19, 2021. (18) Filed as an exhibit to the Company’s Form 8-K filed September 9, 2021. (19) Filed as an exhibit to the Company’s Form 8-K filed August 23, 2022. (20) Filed as an exhibit to the Company’s Form 8-K filed October 19, 2022. (21) Filed as Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed October 28, 2022. (22) Filed as an exhibit to the Company’s Form 8-K filed December 8, 2022. (23) Filed as an exhibit to the Company’s Form 8-K filed February 7, 2023. (24) Filed as an exhibit to the Company’s Registration Statement on Form S-8 filed February 28, 2024. (25) Filed as an exhibit to the Company’s Annual Report on Form 10K for the Year ended December 31, 2022. (26) Filed as an exhibit to the Company’s Form 8-K filed April 7, 2023. (27) Filed as an exhibit to the Company’s Form 8-K filed June 6, 2023. (28) Filed as an exhibit to the Company’s Form 8-K filed October 27, 2023. (29) Filed as an Exhibit to the Company’s Annual Report on Form 10-K filed April 1, 2024 (30) (31) (32) (33) (34) (35) (36) (37) Filed as an Exhibit to the Company’s Form 8-K filed February 19, 2025. Filed as an Exhibit to the Company’s Form 8-K filed May 7, 2025. Filed as an Exhibit to the Company’s Form 8-K filed May 23, 2025. Filed as an Exhibit to the Company’s Form 8-K filed September 17, 2025. Filed as an Exhibit to the Company’s Form 8-K filed November 7, 2025. Filed as an Exhibit to the Company’s Form 8-K filed December 22, 2025. Filed as an Exhibit to the Company’s Form 8-K filed January 8, 2026. Filed as an Exhibit to the Company’s Form 8-K filed January 12, 2026. (b) No financial statement schedules have been provided because the information is not required or is shown either in the financial statements or the notes thereto. 55 Signatures Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. KUSTOM ENTERTAINMENT, INC., a Nevada corporation By: /s/ Stanton E. Ross   Stanton E. Ross Chief Executive Officer (Principal Executive Officer) Dated: April 10, 2026 Each person whose signature appears below authorizes Stanton E. Ross to execute in the name of each such person who is then an officer or director of the registrant, and to file, any amendments to this Annual Report on Form 10-K necessary or advisable to enable the registrant to comply with the Securities Exchange Act of 1934 and any rules, regulations and requirements of the Securities and Exchange Commission in respect thereof, which amendments may make such changes in such Report as such attorney-in-fact may deem appropriate. Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. Signature and Title Date /s/ Stanton E. Ross April 10, 2026 Stanton E. Ross, Director and Chief Executive Officer /s/ Leroy C. Richie April 10, 2026 Leroy C. Richie, Director /s / D. Duke Daughtery April 10, 2026 D. Duke Daughtery /s / Charles M. Anderson April 10, 2026 Charles M. Anderson /s/ Thomas J. Heckman April 10, 2026 Thomas J. Heckman, Chief Financial Officer, Secretary, Treasurer and Principal Accounting Officer (Principal Financial Officer and Principal Accounting Officer) 56 KUSTOM ENTERTAINMENT, INC. AND SUBSIDIARIES INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page(s) Report of Independent Registered Public Accounting Firm (PCAOB ID No: 6771 ) F-2 Report of Independent Registered Public Accounting Firm (PCAOB ID No: 587 ) F-4 Consolidated Financial Statements:  Consolidated Balance Sheets – December 31, 2025 and 2024 F-6 Consolidated Statements of Operations for the Years Ended December 31, 2025 and 2024 F-7 Consolidated Statements of Stockholders’ Equity (Deficit) for the Years Ended December 31, 2025 and 2024 F-8 Consolidated Statements of Cash Flows for the Years Ended December 31, 2025 and 2024 F-9 Notes to the Consolidated Financial Statements F-10 F- 1 Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders Kustom Entertainment, Inc. (formerly Digital Ally, Inc. and Subsidiaries) Opinion on the Financial Statements We have audited the accompanying consolidated balance sheet of Kustom Entertainment, Inc. (the “Company”) as of December 31, 2025, and the related consolidated statement of operations, stockholders’ equity (deficit), and cash flows for the year ended December 31, 2025, and the related notes (collectively referred to as the financial statements). In our opinion, the 2025 financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the year ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America. We also have audited the adjustments to the 2024 financial statements to retrospectively apply the change in the reverse stock split that became effective in 2025 and to reclassify certain assets and liabilities as held for sale related to the discontinued operations entered into on January 8, 2026, as described in Note 18 and Note 23. We have considered these adjustments as part of our audit of the 2025 consolidated financial statements. In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged to audit, review, or apply any procedures to the 2024 financial statements of the Company other than with respect to the adjustments and, accordingly, we do not express an opinion or any other form of assurance on the 2024 financial statements taken as a whole. Substantial doubt about the Company’s ability to continue as a Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1, Going Concern Matters and Management’s Plan, to the financial statements, the Company incurred substantial operating losses in the years ended December 31, 2025. The Company incurred operating losses of approximately $10,882,421 for the year ended December 31, 2025, and had an accumulated deficit of $144,184,436 as of December 31, 2025. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Basis for Opinion These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion. Critical Audit Matters The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate. F- 2 Goodwill, and Intangible Assets Description of the Critical Audit Matter As described in Note 8 to the consolidated financial statements, the Company recognized goodwill and intangible asset impairment charges of $2,533,667 during the year ended December 31, 2025, consisting of a $1,428,000 goodwill impairment charge, a $746,667 full write-off of the Sponsorship Agreement Network intangible asset, and $359,000 of trademark impairment, all attributable to the Entertainment reporting unit. The charges followed total impairment charges of $4,830,000 in the prior year. Management determined the fair value of the Entertainment reporting unit using an equal weighting of the income approach (discounted cash flow) and the market approach (guideline public company multiples). The income approach required management to estimate future revenue growth rates, gross margin improvement, a weighted average cost of capital ranging from 18.4% to 22.7%, and a terminal growth rate. These are unobservable inputs for which management has significant estimation latitude, and the terminal value — which represents a substantial portion of the total indicated value — is highly sensitive to small changes in the terminal growth rate and discount rate assumptions. We identified this as a critical audit matter because of the significant and subjective judgment required to evaluate these unobservable inputs, the consecutive-year impairment history of the Entertainment reporting unit, and the adverse performance indicators present during the year ended December 31, 2025 How We Addressed the Critical Audit Matter Our audit procedures included the following : ● We obtained management’s complete impairment analysis and agreed all base-year historical financial data used as Discounted Cash Flow (“DCF”) inputs to the audited financial statements, including the Country Stampede revenue, cost of revenue, and gross loss for year ended December 31, 2025. ● We evaluated management’s forecast and assessed whether the assumptions were consistent with the observable forward indicators available at December 31, 2025. ● We independently recomputed the DCF outputs —using both management’s inputs and our independently derived inputs and compared the results to management’s indicated value and to the impairment charge recorded in the financial statements. ● We evaluated the guideline company selection for the market approach, assessed the comparability of each selected company to the Entertainment reporting unit, and evaluated whether weighting of the income and market approaches was appropriate given the characteristics of the reporting unit. Derivative Liabilities Description of the Critical Audit Matter As described in Notes 10, 11, and 17 to the consolidated financial statements, the Company’s derivative liabilities consist of warrant derivative liabilities and a bifurcated embedded derivative liability arising from the 2025 Senior Secured Convertible Notes. Warrant derivative liabilities arise from warrants issued in the 2023, June 2024, and February 2025 equity offerings, as well as detachable warrants issued in connection with the September and December 2025 closings of the 2025 Senior Secured Convertible Notes. These warrants are classified as derivative liabilities at fair value under ASC 815-40 because their terms include provisions that could require net cash settlement upon a qualifying tender offer. The embedded conversion feature of the 2025 Senior Secured Convertible Notes, which carries a variable conversion price that does not meet the fixed-for-fixed requirement under ASC 815-40, was bifurcated from the host debt instrument and recognized as a derivative liability at fair value under ASC 815-15. All derivative liabilities are classified as Level 3 and measured at fair value using the Black-Scholes option pricing model at each reporting date, with changes recognized in the consolidated statements of operations. The aggregate fair value of the derivative liabilities recognized upon issuance of the 2025 Senior Secured Convertible Notes was $852,675. The aggregate Level 3 derivative liability balance decreased from $4,554,640 at December 31, 2024 to $852,844 at December 31, 2025, reflecting new issuances, reclassifications to equity upon exercise or termination of applicable warrant provisions, a gain of $3,331,616 from the change in fair value of warrant derivative liabilities, and a gain of $43,250 from the change in fair value of the bifurcated embedded derivative liability. We identified this as a critical audit matter because the income statement impact of fair value changes was material, and the Level 3 measurement required especially subjective auditor judgment in evaluating significant unobservable inputs, principally expected volatility, used in the Black-Scholes option pricing model. How We Addressed the Critical Audit Matter Our audit procedures included the following: ● We independently recalculated the fair value of the bifurcated embedded conversion feature and each warrant series at relevant measurement dates using the Binomial Option pricing model. We agreed market-observable inputs to independent data sources and independently developed expected volatility estimates from historical price data, comparing our results to management’s inputs and evaluating any differences. ● We independently evaluated the requirement to bifurcate the embedded conversion feature under ASC 815-15 and the classification of each warrant series as a derivative liability under ASC 815-40. We agreed all reclassifications from warrant derivative liabilities to additional paid-in capital to underlying exercise notices and warrant agreement terms and confirmed that each reclassification was recorded at fair value as of the applicable date, consistent with ASC 815. ● We evaluated the completeness and accuracy of the Level 3 fair value rollforward in Note 11, agreeing the beginning balance, additions, reclassifications to equity, and fair value changes to underlying computations and transaction documentation, and confirmed the ending balance of $852,844 to the remaining outstanding derivative liability positions. Victor Mokuolu, CPA PLLC We have served as the Company’s auditor since 2025 Houston, Texas April 10, 2026 PCAOB ID Number 6771 F- 3 New York Office: 805 Third Avenue New York, NY 10022 212.838-5100 www.rbsmllp.com Report of Independent Registered Public Accounting Firm To the Stockholders and the Board of Directors of Digital Ally, Inc. and subsidiaries Overland Park, KS Opinion on the Consolidated Financial Statements We have audited, before the effects of the adjustments to retrospectively apply (1) the effects of the reverse stock splits described in Note 1 – Nature of Business and Summary of Significant Accounting Policies – Reverse Stock Splits and (2) the effects of the reclassifications for Discontinued operations described in Note 1 – Nature of Business and Summary of Significant Accounting Policies – Discontinued Operations and Held for Sale and Note 23 – Discontinued Operations, the accompanying consolidated balance sheet of Digital Ally, Inc. and its subsidiaries (the Company) as of December 31, 2024, the related consolidated statement of operations, stockholders’ deficit and cash flow for the year ended December 31, 2024, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, before the effects of the adjustments to retrospectively apply (1) the effects of the reverse stock splits described in Note 1 – Nature of Business and Summary of Significant Accounting Policies – Reverse Stock Splits and (2) the effects of the reclassifications for Discontinued operations described in Note 1 – Nature of Business and Summary of Significant Accounting Policies – Discontinued Operations and Held for Sale and Note 23 – Discontinued Operations, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and the results of its operations and its cash flow for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America. Retrospective Adjustment for Reverse Stock Split and Discontinued Operations We were not engaged to audit, review, or apply any procedures to the adjustments for the retrospective effect of the reverse stock-split or discontinued operations described in Note 1, accordingly, we do not express an opinion or any other form of assurance about whether such adjustments are appropriate and have been properly applied. Those adjustments were audited by Victor Mokuolu, CPA PLLC. (The 2024 consolidated financial statements before the effects of the adjustments discussed in Note 1 – Reverse Stock Splits, Note 1 – Discontinued Operations and Held for Sale, Note 3 – Accounts Receivable and Subscription Receivables, Note 6 – Prepaid Expenses, Note 7 – Property, Plant and Equipment, Note 8 – Goodwill and Other Intangible Assets, Note 12 – Accrued Expenses, Note 14 – Operating Leases, Note 16 – Stock Based Compensation, Note 17 – Common Stock Purchase Warrants, Note 18 – Stockholders’ Equity, Note 19 – Related Party Transactions, Note 20 – Net Loss Per Share, Note 22 – Operating Segments and Note 23 – Discontinued Operations are not presented herein). The Company’s Ability to Continue as a Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has incurred substantial operating losses and will require additional capital to continue as a going concern. This raises substantial doubt about the Company’s ability to continue as a going concern. Management’s plans regarding these matters are also described in Note 1. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provide a reasonable basis for our opinion. Critical Audit Matters The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate. F- 4 Goodwill, Indefinite Life Intangibles and Other Intangibles Impairment Assessments – Entertainment Segment – Refer to Notes 1 and 8 to the consolidated financial statements Critical Audit Matter Description As described in Note 8 to the financial statements, the Company’s goodwill and indefinite life intangible asset balance was $5,805,507 and $699,000, respectively as of December 31, 2024. The Company also has amortizable identifiable intangible assets of $1,866,667 – sponsorship agreement network and $100,000 – SEO content, which are being amortized over 5 years and 4 years, respectively, and are related to the entertainment segment. Management tests these assets annually for impairment or more frequently when potential impairment triggering events are present. Goodwill is tested for impairment by comparing the estimated fair value of a reporting unit to its carrying value. Management uses a weighting of income and market approaches to estimate the fair value of its reporting unit. The key assumptions and estimates utilized in the weighting of income and market approaches primarily include future levels of revenue growth, gross profit margin, EBITDA as a percentage of revenue, cash-free debt-free net working capital as a percentage of revenue, capital expenditures as a percentage of revenue, discount rate, selection of guideline public companies and revenue market multiples. The principal considerations for our determination that performing procedures relating to the goodwill and intangible asset impairment assessments of the entertainment reporting unit is a critical audit matter because (i) the significant judgment used by management when determining the fair value estimates of the reporting units; (ii) the high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating the significant assumptions used in management’s fair value estimates; and (iii) the audit effort involved in the use of professionals with specialized skill and knowledge. How the Critical Audit Matter Was Addressed in the Audit Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the financial statements. ● These procedures included, among others, (i) testing management’s process for determining the fair value estimates of the entertainment segment; (ii) testing the completeness and accuracy of the underlying data used in the income and market approach; and (iii) evaluating the reasonableness of the significant assumptions used by management related to future levels of revenue growth, gross profit margin, EBITDA as a percentage of revenue, cash-free debt-free net working capital as a percentage of revenue, capital expenditures as a percentage of revenue, discount rate, selection of guideline public companies and revenue market multiples. ● Evaluating management’s assumptions related to the future levels of revenue growth, gross profit margin, EBITDA as a percentage of revenue, cash-free debt-free net working capital as a percentage of revenue, capital expenditures as a percentage of revenue, discount rate, selection of guideline public companies and revenue market multiples and involved evaluating whether the assumptions were reasonable considering (i) current and past performance of the reporting units; (ii) the consistency with external market and industry data; and (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit. ● Professionals with specialized skill and knowledge were used to assist in evaluating (i) the appropriateness of the income and market approach and (ii) the reasonableness of significant assumptions related to the future levels of revenue growth, gross profit margin, EBITDA as a percentage of revenue, cash-free debt-free net working capital as a percentage of revenue, capital expenditures as a percentage of revenue, discount rate, selection of guideline public companies and revenue market multiples. Goodwill and Other Intangibles arising from the acquisition of Country Stampede – Refer to Notes 1 and 21 to the consolidated financial statements Critical Audit Matter Description As disclosed in Note 1, Goodwill arises in connection with acquisitions. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired is recorded as goodwill. As disclosed in Note 21, on March 1, 2024, the Company completed an acquisition referred to as the Country Stampede Acquisition in accordance with the asset purchase agreement. The consideration included payment of cash of $542,959 of which $400,000 was paid on March 1, 2024 and remainder on or before thirty days. Auditing the accounting for the acquisition was complex due to the significant estimation uncertainty in determining the fair values of identified intangible assets, which consisted of trademarks and trade names of $300,000 and Goodwill of $225,959. The principal considerations for our determination that performing procedures relating to the intangible assets acquired with the Country Stampede Acquisition is a critical audit matter because (i) the significant judgment used by management when determining the fair value estimates of the intangible assets acquired; (ii) the high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating the significant assumptions used in management’s fair value estimates; and (iii) the audit effort involved in the use of professionals with specialized skill and knowledge. How the Critical Audit Matter Was Addressed in the Audit ● We utilized personnel with specialized knowledge and skill in valuation to assist in: a) assessing the appropriateness of valuation methodology for the trademarks and trade names using Relief from Royalty, b) evaluating the reasonableness of the growth rates, percent of revenues lost without existing agreements, discount rate used in the income approach. ● Evaluate the reasonableness of management’s significant estimates and assumptions including revenue growth rates, percent of revenues lost without existing agreements and discount rate in the valuation of the trademarks and trade names. ● Evaluate if there have been events and circumstances that might indicate that intangible asset and goodwill has been impaired. /s/ RBSM LLP We have served as the Company’s auditor since 2019. New York, NY May 2, 2025 PCAOB ID Number 587 F- 5 KUSTOM ENTERTAINMENT, INC. (formerly Digital Ally, Inc.) CONSOLIDATED BALANCE SHEETS December 31, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 757,369 $ 219,311 Accounts receivable-trade, less allowance for doubtful accounts of $ 10,262 – 2025 and $ 208,458 – 2024 479,559 751,743 Subscriptions receivables, net of $ 75,000 allowance – 2025 and $ 25,000 – 2024 3,219,647 3,988,994 Other receivables 292,503 155,851 Inventories, net 2,330,492 2,586,066 Prepaid expenses 1,052,415 1,786,146 Assets of revenue-cycle management business held-for-sale 911,753 865,625 Total current assets 9,043,738 10,353,736 Property, plant, and equipment, net 402,226 338,561 Goodwill and other intangible assets, net 5,031,633 8,822,996 Operating lease right of use assets, net 1,104,784 276,940 Subscriptions receivables – long term 2,976,758 4,889,289 Other assets 355,636 754,857 Assets of revenue-cycle management business held-for-sale 413,752 2,300,194 Total assets $ 19,328,527 $ 27,736,573 Liabilities and Equity Current liabilities: Accounts payable $ 4,278,633 $ 11,170,465 Accrued expenses 592,685 1,497,589 Current portion of operating lease obligations 180,900 90,656 Deferred revenue – current 3,778,967 4,215,401 Notes payable – related party – current — 2,840,000 Debt obligations – current 707,826 4,961,443 Warrant derivative liabilities 852,844 4,554,640 Income taxes payable 10,441 — Liabilities of revenue-cycle management business held for sale 138,029 401,049 Total current liabilities 10,540,325 29,731,243 Long-term liabilities: Debt obligations – long term 137,541 141,083 Operating lease obligation – long term 841,516 186,284 Deferred revenue – long term 4,739,356 6,317,472 Notes payable – related party – long term 400,110 — Liabilities of revenue-cycle management business held for sale 299,723 373,921 Total liabilities 16,958,571 36,750,003 Commitments and contingencies (Note 15) - - Stockholders’ Equity (Deficit): Preferred stock, $ 0.001 par value per share, 10,000,000 shares authorized; none issued or outstanding – 2025 and 2024 Common stock, $ 0.001 par value; 66,666,667 – 2025 and 200,000,000 – 2024 shares authorized; shares issued: 690,022 – 2025 and 1,068 – 2024 690 1 Additional paid in capital 148,439,504 129,697,783 Noncontrolling interest in consolidated subsidiary ( 1,885,802 ) ( 1,198,286 ) Accumulated deficit ( 144,184,436 ) ( 137,512,928 ) Total equity (deficit): 2,369,956 ( 9,013,430 ) Total liabilities and equity (deficit) $ 19,328,527 $ 27,736,573 The accompanying notes are an integral part of these financial statements F- 6 KUSTOM ENTERTAINMENT, INC. (formerly Digital Ally, Inc.) CONSOLIDATED STATEMENTS OF OPERATIONS December 31, 2025 December 31, 2024 Revenue: Product $ 4,337,276 $ 5,404,317 Service and other 9,416,879 8,114,835 Total revenue 13,754,155 13,519,152 Cost of revenue: Product 6,333,622 5,899,130 Service and other 6,071,478 4,496,004 Total cost of revenue 12,405,100 10,395,134 Gross profit 1,349,055 3,124,018 Selling, general and administrative expenses: Research and development expense 551,447 1,339,673 Selling, advertising and promotional expense 721,690 2,120,965 General and administrative expense 8,424,672 10,538,306 Goodwill and intangible asset impairment charge 2,533,667 508,000 Total selling, general and administrative expenses 12,231,476 14,506,944 Operating loss ( 10,882,421 ) ( 11,382,926 ) Other income (expense): Interest income 116,545 69,509 Interest expense ( 1,102,352 ) ( 3,816,317 ) Other income 346,024 26,733 Loss on litigation — ( 1,959,396 ) Loss on disposal of intangibles — ( 119,979 ) Change in fair value of warrant derivative liabilities 3,331,616 ( 1,240,407 ) Gain on the extinguishment of liabilities 2,234,658 917,935 Loss on extinguishment of debt — ( 753,339 ) Gain on sale of property, plant and equipment — 360,082 Total other income (expense) from continuing operations 4,926,491 ( 6,515,179 ) Loss before income tax benefit (provision) from continuing operations ( 5,955,930 ) ( 17,898,105 ) Income tax expense benefit (provision) — — Net loss from continuing operations ( 5,955,930 ) ( 17,898,105 ) Discontinued operations: Loss from discontinued operations (including impairment charge on disposal of $ 1,527,634 as of December 31, 2025) ( 1,403,094 ) ( 3,817,620 ) Income tax expense benefit (provision) — — Net loss from discontinued operations ( 1,403,094 ) ( 3,817,620 ) Net loss ( 7,359,024 ) ( 21,715,725 ) Net income attributable to noncontrolling interests 687,516 1,871,578 Net loss attributable to common stockholders $ ( 6,671,508 ) $ ( 19,844,147 ) Net loss per share attributable to common stockholders’ information: Basic: Continuing operations $ ( 15.38 ) $ ( 30,204.62 ) Discontinued operations ( 1.85 ) ( 3,284.12 ) Net loss attributable to common stockholders per share – basic $ ( 17.23 ) $ ( 33,488.74 ) Diluted: Continuing operations $ ( 15.38 ) $ ( 30,204.62 ) Discontinued operations ( 1.85 ) ( 3,284.12 ) Net loss attributable to common stockholders per share – diluted $ ( 17.23 ) $ ( 33,488.74 ) Weighted average shares outstanding: Basic 387,144 593 Diluted 387,144 593 The accompanying notes are an integral part of these financial statements. F- 7 KUSTOM ENTERTAINMENT, INC. (formerly Digital Ally, Inc.) CONSOLIDATED STATEMENTS OF EQUITY(DEFICIT) YEARS ENDED DECEMBER 31, 2025 AND 2024 Shares Amount Capital subsidiary Deficit Total Noncontrolling Additional Interest in Common Stock Paid In consolidated Accumulated Shares Amount Capital subsidiary Deficit Total Balance, December 31, 2023 567 $ 1 $ 128,443,883 $ 673,292 $ ( 117,668,781 ) $ 11,448,395 Stock-based compensation — — 128,519 — — 128,519 Restricted common stock grant 14 — — — — — Restricted common stock forfeitures ( 9 ) — — — — — Fair value of pre-funded warrants issued along with sale of common stock Transition of warrant derivative liability to equity upon exercise of pre-funded warrants Sale of common stock and pre-funded warrants, net of offering costs 103 — 2,529,448 — — 2,529,448 Issuance of common stock upon exercise of February 2025 Series B common stock purchase warrants Transition of warrant derivative liability to equity upon exercise of Series B warrants issued along with February 2025 sale of common stock Transition of warrant derivative liability to equity of Series A warrants issued along with February 2025 sale of common stock Deemed capital contribution related to modification of notes payable - related party Detachable warrants issued in connection with Senior Notes in September and December 2025 Issuance of commitment shares in conjunction with the Committed Equity Financing Agreement Round up of fractional shares resulting from the reverse stock splits Fair value of warrants issued along with sale of common stock — — ( 2,075,300 ) — — ( 2,075,300 ) Issuance of commitment shares in connection with bridge financing 135 — 539,455 — — 539,455 Issuance of common stock upon exercise of pre-funded warrants 96 — — — — — Allocation of fair value of Series B warrants approved by shareholders — — ( 454,150 ) — — ( 454,150 ) Transition of warrant derivative liability to equity upon exercise of Series B warrants — — 584,955 — — 584,955 Issuance of common stock upon exercise of Series B common stock purchase warrants 162 973 — — 973 Net loss — — — ( 1,871,578 ) ( 19,844,147 ) ( 21,715,725 ) Balance, December 31, 2024 1,068 $ 1 $ 129,697,783 $ ( 1,198,286 ) $ ( 137,512,928 ) $ ( 9,013,430 ) Balance 1,068 $ 1 $ 129,697,783 $ ( 1,198,286 ) $ ( 137,512,928 ) $ ( 9,013,430 ) Stock-based compensation — — 39,622 — — 39,622 Fair value of pre-funded warrants issued along with sale of common stock — — ( 1,803 ) — — ( 1,803 ) Transition of warrant derivative liability to equity upon exercise of pre-funded warrants — — 1,803 — — 1,803 Sale of common stock and pre-funded warrants, net of offering costs 17,667 18 14,308,282 — — 14,308,300 Issuance of common stock upon exercise of June 2024 Series B common stock purchase warrants 632 1 3,792 — — 3,793 Issuance of common stock upon exercise of Series B common stock purchase warrants 632 1 3,792 — — 3,793 Transition of warrant derivative liability to equity upon exercise of Series B warrants — — 1,989,806 — — 1,989,806 Fair value of Series A warrants issued along with sale of common stock — — ( 1,340,214 ) — — ( 1,340,214 ) Fair value of Series B warrants issued along with sale of common stock — — ( 5,406,408 ) — — ( 5,406,408 ) Issuance of common stock upon exercise of February 2025 Series B common stock purchase warrants 556,439 556 ( 556 ) — — — Transition of warrant derivative liability to equity upon exercise of Series B warrants issued along with February 2025 sale of common stock — — 5,406,320 — — 5,406,320 Transition of warrant derivative liability to equity of Series A warrants issued along with February 2025 sale of common stock — — 530,101 — — 530,101 Deemed capital contribution related to modification of notes payable - related party — — 2,983,298 — — 2,983,298 Issuance of commitment shares in conjunction with the Committed Equity Financing Agreement 114,010 114 227,678 — — 227,792 Round up of fractional shares resulting from the reverse stock splits 206 — — — — — Net loss — — — ( 687,516 ) ( 6,671,508 ) ( 7,359,024 ) Balance, December 31, 2025 690,022 $ 690 $ 148,439,504 $ ( 1,885,802 ) $ ( 144,184,436 ) $ 2,369,956 Balance 690,022 $ 690 $ 148,439,504 $ ( 1,885,802 ) $ ( 144,184,436 ) $ 2,369,956 The accompanying notes are an integral part of these financial statements. F- 8 KUSTOM ENTERTAINMENT, INC. (formerly Digital Ally, Inc.) CONSOLIDATED STATEMENTS OF CASH FLOWS December 31, 2025 December 31, 2024 Cash Flows from Operating Activities: Net loss $ ( 7,359,024 ) $ ( 21,715,725 ) Less: net (loss) from discontinued operations, net of tax ( 1,403,094 ) ( 3,817,620 ) Net loss from continuing operations ( 5,955,930 ) ( 17,898,105 ) Adjustments to reconcile net loss to net cash flows used in operating activities: Depreciation and amortization 1,544,767 1,915,436 Gain on sale of property, plant and equipment — ( 360,082 ) Loss on disposal of intangible assets — 119,979 Goodwill and intangible asset impairment charge 2,533,667 508,000 Stock based compensation 39,622 128,519 Non-cash interest expense 856,260 2,968,938 Gain on extinguishment of liabilities ( 2,234,658 ) ( 917,935 ) Loss on extinguishment of convertible debt — 753,339 Loss on litigation — 1,959,396 Provision for doubtful accounts receivable ( 198,196 ) 111,655 Provision for doubtful lease receivable ( 2,356 ) 20,000 Derivative liability at issuance 809,425 — Change in fair value of warrant derivative liability ( 3,331,616 ) 1,240,407 Provision for inventory obsolescence ( 250,715 ) ( 2,372,806 ) Provision for loss on litigation settlement receivable 289,445 — Change in operating assets and liabilities: (Increase) decrease in: Accounts receivable – trade 470,380 ( 1,268,318 ) Accounts receivable – other (including related party) 2,258,137 ( 1,057,211 ) Inventories 506,289 3,673,021 Prepaid expenses 717,106 4,858,468 Operating lease right of use assets ( 827,844 ) 15,772 Other assets 415,845 817,786 Increase (decrease) in: Accounts payable ( 4,403,298 ) 2,999,078 Accrued expenses ( 519,588 ) ( 3,974,349 ) Accrued interest - related party 177,899 397,146 Income taxes payable 10,441 — Lease deposit 101,387 ( 10,445 ) Operating lease obligations 597,076 ( 23,102 ) Deferred revenues ( 2,014,550 ) ( 22,054 ) Net cash used in operating activities – continuing operation ( 8,411,005 ) ( 5,417,467 ) Net cash provided by operating activities – discontinued operation 141,049 302,749 Cash Flows from Investing Activities: Purchases of property, plant and equipment ( 258,050 ) ( 28,795 ) Proceeds from sale of property, plant and equipment — 541,894 Purchases of intangible assets ( 92,686 ) ( 136,056 ) Proceeds from sale of intangible assets — 90,535 Cash paid for acquisition of Country Stampede — ( 514,432 ) Proceeds from sale of land and building — 425,653 Net cash provided by (used) in investing activities – continuing operation ( 350,736 ) 378,799 Net cash provided by (used) in investing activities – discontinued operation ( 16,748 ) 8,750 Cash Flows from Financing Activities: Net proceeds of February 2025 public equity offering with detachable warrants 14,308,300 2,194,745 Net proceeds of senior promissory notes with commitment shares 2,669,252 Net proceeds from September 2025 issuance of senior secured convertible notes with detachable warrants 23,075 — Net proceeds of unsecured promissory note – entertainment segment 600,000 — Net proceeds of related party note payable — 140,000 Payments of related party note payable ( 162,000 ) — Proceeds – Commercial Extension of Credit – Entertainment Segment — 1,475,000 Payments on Commercial Extension of Credit – Entertainment Segment ( 100,000 ) ( 275,000 ) Proceeds – Merchant Advances – Video Solutions Segment — 1,144,000 Payments on Merchant Advances – Video Solutions Segment ( 1,922,750 ) ( 1,551,250 ) Payments on Senior Secured Promissory Notes – Video Solutions Segment ( 3,675,000 ) — Proceeds – Merchant Advances – Entertainment Segment — 1,511,826 Payments on Merchant Advances – Entertainment Segment — ( 2,714,456 ) Principal payment on EIDL loan ( 3,412 ) ( 3,286 ) Issuance of common stock under equity line of credit agreement 227,792 — Proceeds from issuance of common shares upon exercise of Series B warrants 3,793 973 Net cash provided by financing activities – continuing operation 9,299,798 4,591,804 Net cash used in financing activities – discontinued operation — ( 188,470 ) Net increase (decrease) in cash, cash equivalents and restricted cash 662,359 ( 323,835 ) Cash and cash equivalents, beginning of year 454,314 778,149 Cash and cash equivalents, end of year $ 1,116,673 $ 454,314 Supplemental disclosures of cash flow information: Cash payments for interest $ 45,306 $ 753,569 Cash payments for income taxes $ 6,962 $ 8,006 Supplemental disclosures of non-cash investing and financing activities: Restricted common stock grant $ — $ — Restricted common stock forfeitures $ — $ — Commercial extension of credit repaid through accrued revenue – Entertainment segment $ — $ 1,187,928 ROU and lease liability recorded on extension (termination) of lease $ — $ 234,633 Assets acquired in business acquisitions $ — $ 605,000 Goodwill acquired in business acquisitions $ — $ 225,959 Liabilities assumed in business acquisitions $ — $ 288,000 Adjustments of accounts payable with the sale proceeds of property, plant and equipment $ — $ 549,356 Deemed capital contribution related to modification of notes payable - related party $ 2,983,298 $ — Fair value of warrants issued with sale of shares $ 6,748,425 $ 2,529,450 Transition of warrant derivative liability to equity upon exercise of warrants $ 7,928,030 $ 584,955 Issuance of commitment shares in connection with ELOC purchase agreement $ 227,792 $ — Issuance of common stock upon exercise of pre-funded warrants $ — $ 573 Reduction in proceeds from sale of building for loan, prepaid rent, and other accrued expenses $ — $ 5,474,347 Payments to vendors directly from proceeds of sale of common stock $ — $ 334,703 Issuance of commitment shares in connection with bridge financing $ — $ 539,455 F- 9 KUSTOM ENTERTAINMENT, INC. (formerly Digital Ally, Inc.) NOTES TO CONSOLIDATED FINANCIAL STATEMENTS NOTE 1. NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Business: Kustom Entertainment, Inc. (formerly Digital Ally, Inc.) was originally incorporated in Nevada on December 13, 2000 as Vegas Petra, Inc. and had no operations until 2004. On November 30, 2004, Vegas Petra, Inc. entered into a Plan of Merger with Digital Ally, Inc., at which time the merged entity was renamed Digital Ally, Inc. On January 8, 2026, the Company changed its legal name from Digital Ally, Inc. to Kustom Entertainment, Inc. pursuant to a Certificate of Amendment to its Articles of Incorporation filed with the Secretary of State of the State of Nevada. The name change became effective on January 8, 2026, and the Company began trading on the Nasdaq Capital Market under its new name at the start of trading on January 8, 2026. In connection with the name change, the Company also changed its Nasdaq trading symbol from “DGLY” to “KUST.” The name change and symbol change did not affect the Company’s assets, liabilities, operations, or capital structure, and stockholders were not required to take any action with respect to their stock certificates. The Board of Directors also approved a conforming amendment to the Company’s Amended and Restated Bylaws solely to reflect the new corporate name. Unless the context otherwise requires, references in these consolidated financial statements to the “Company,” “Digital Ally,” “Digital,” “Kustom” or similar terms refer to Kustom Entertainment, Inc. and its consolidated subsidiaries. The Company formed Digital Ally International, Inc. in August 2009 to facilitate the export sales of its digital video imaging and storage products. The Company formed TicketSmarter, Inc. on September 1, 2021, upon its acquisition of Goody Tickets, LLC and TicketSmarter, LLC, to facilitate its global ticketing operations. The Company formed Kustom Entertainment, Inc. and Kustom 440, Inc. in 2022 to create and produce live entertainment experiences directly for consumers. The business of the Registrant, Kustom Entertainment, Inc. (formerly Digital Ally, Inc.), together with its wholly owned subsidiaries Digital Ally International, Inc., Digital Ally Healthcare, LLC, TicketSmarter, Inc., Kustom 440, Inc., and Kustom Entertainment, Inc., collectively referred to as the “Company,” is divided into two reportable operating segments: (1) Video Solutions and (2) Entertainment. The Company previously operated a third reportable segment, the Revenue Cycle Management segment, which reflected the operations of Nobility Healthcare, LLC. Following the sale of Nobility Healthcare on January 8, 2026, the results of this segment have been classified as discontinued operations for all periods presented and are no longer reported as a separate segment. The Video Solutions Segment is the Company’s legacy business that produces digital video imaging, storage products, and related security and commercial applications. This segment includes both service and product revenues through subscription models offering cloud-based services and warranty solutions, as well as hardware sales for video and safety solutions. The Entertainment Segment generates revenue through the production of live events and concerts, including the Company’s annual Country Stampede music festival. This segment also acts as an intermediary between ticket buyers and sellers through the Company’s secondary ticketing platform, TicketSmarter.com, and includes the acquisition of tickets from primary sellers for resale through various platforms. The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information about those segments to be presented. Such required segment information is included in Note 22. Reverse Stock Splits The Company retroactively adjusts all historical share and per-share amounts reflected throughout the consolidated financial statements and other financial information to reflect reverse stock splits as if they had occurred as of the earliest period presented. The par value per share of the Company’s Common Stock is not affected by reverse stock splits. See Note 18 for details regarding each reverse stock split effectuated during and subsequent to the periods presented. Discontinued Operations and Held for Sale The Company classified Nobility Healthcare, LLC (“Nobility”) as a discontinued operation and held for sale as of December 31, 2025, in accordance with ASC 205-20. The results of Nobility are reported net of tax as discontinued operations, with prior periods retrospectively reclassified. A goodwill impairment loss of $1,527,634 was recognized upon classification. The sale of Nobility was completed on January 8, 2026. Unless otherwise indicated, all Notes to the Consolidated Financial Statements exclude Nobility’s assets, liabilities, results of operations, and cash flows. See Note 23. DISCONTINUED OPERATIONS for further details. F- 10 Going Concern Matters and Management’s Plans The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred substantial operating losses in the year ended December 31, 2025, primarily due to reduced gross margins caused by a combination of competitors’ introduction of newer products with more advanced features together with significant price cutting of their products and recent acquisitions with much smaller margins than the video solutions segment, historically. The Company incurred an operating loss of $ 10,882,421 for the year ended December 31, 2025, and had an accumulated deficit of $ 144,184,436 as of December 31, 2025. These matters raise substantial doubt about the Company’s ability to continue as a going concern. In fiscal year 2025, the Company accessed the public and private capital markets to raise funding through the issuance of debt and equity, raising $ 15,740,800 through private placement transactions and an underwritten public offering. In February 2025, the Company completed an underwritten public offering, including the underwriter’s exercise of its overallotment option, for aggregate net proceeds of $ 14,308,300 , and issued an unsecured promissory note generating additional net cash proceeds of $ 600,000 . In September and December 2025, the Company issued senior secured convertible notes with detachable warrants in two closings, resulting in aggregate net cash proceeds of $ 832,500 . These financing activities provided additional liquidity to execute the Company’s business plans and were used to repay debt obligations, settle accounts payable, and fund operations. Management expects to continue accessing the capital markets until the Company achieves consistent positive cash flow from operations; however, there can be no assurance as to the timing or availability of such financing. The Company will have to restore positive operating cash flows and profitability over the next year and/or raise additional capital to fund its operational plans, meet its customary payment obligations, and otherwise execute its business plan. There can be no assurance that it will be successful in restoring positive cash flows and profitability, or that it can raise additional financing when needed and obtain it on terms acceptable or favorable to the Company. During fiscal year 2025, the Company implemented a cost-reduction program and enhanced its short- and long-term liquidity through (i) the February 2025 public equity offering, (ii) the issuance of senior secured convertible notes, and (iii) entry into a committed equity facility (the “ELOC”). Within the entertainment segment, the Company exited several large partnerships and sponsorships that did not meet expected returns; management does not expect discontinuing these arrangements to materially hinder total revenues in 2026 or thereafter. In the video segment, the Company reduced headcount and relocated to smaller, lower-cost facilities following the sale of its warehouse/office building. The Company has successfully recorded $ 8,518,323 in deferred revenue as of December 31, 2025, which results in recurring revenue during the period of 2026 to 2030. The Company believes that its quality control and cost-cutting initiatives, expansion to non-law enforcement sales channels, and new product introduction will eventually restore positive operating cash flows and profitability, although it can offer no assurances in this regard. As a result of the Company’s implementation of cost-cutting measures and liquidity generated by its recent public and private financing activities, the Company significantly improved its financial position during fiscal year 2025. As of December 31, 2025, the Company had a working capital deficit of $ 1,496,587 and total stockholders’ equity of $ 2,369,956 . Notwithstanding these improvements, the Company recorded a net loss attributable to common stockholders of $ 6,671,508 for the year ended December 31, 2025. F- 11 The accompanying consolidated financial statements have been prepared on a going concern basis. As described above, the Company has incurred operating losses and negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern within one year from the date of issuance of these consolidated financial statements. In response, management has implemented and continues to implement plans intended to mitigate these conditions, including (i) the February 2025 public equity offering generating net proceeds of $14,308,300, (ii) the issuance of senior secured convertible notes generating aggregate net proceeds of $832,500, (iii) entry into a committed equity financing facility providing access to up to $25,000,000 over a 36-month term, (iv) the issuance of an unsecured promissory note generating net proceeds of $600,000, (v) ongoing cost-reduction initiatives including headcount reductions and facility consolidations, and (vi) the divestiture of the Revenue Cycle Management segment. Notwithstanding these measures, substantial doubt about the Company’s ability to continue as a going concern has not been alleviated as of the date of issuance of these consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments related to the recoverability and classification of asset amounts or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The following is a summary of the Company’s Significant Accounting Policies: Basis of Consolidation : The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, including Digital Ally International, Inc., Digital Ally Healthcare, LLC, TicketSmarter, Inc., and Kustom 440, Inc. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates : The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management utilizes various other estimates, including but not limited to, determining the estimated lives of long-lived assets, determining the potential impairment of long-lived assets, the fair value of warrants, options, the recognition of revenue, inventory valuation reserve, allowances for doubtful accounts and other receivables, incremental borrowing rate on leases, the valuation allowance for deferred tax assets and other legal claims and contingencies. The results of any changes in accounting estimates are reflected in the financial statements in the period in which the changes become evident. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period that they are determined to be necessary. Fair Value of Financial Instruments : The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and subordinated notes payable approximate fair value because of the short-term nature of these items. F- 12 Revenue Recognition : The Company applies the provisions of Accounting Standards Codification (ASC) 606-10, Revenue from Contracts with Customers , and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. The Company generates revenue from both product and service offerings across its two reportable segments. The Company reports all revenues on a gross basis, except for certain service revenues within the Entertainment segment, and all revenues are reported net of sales taxes. Video Solutions Segment The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company has concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refunds or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are generally less than one year for product sales (although some subscriptions for services may reach out 3-5 years), it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price, as specified on the purchase order, is considered the stand-alone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e. when the Company’s performance obligations is satisfied), which typically occurs at shipment. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement products. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year. Service and other revenue is comprised of revenues from extended warranties, repair services, cloud revenue and software revenue. Revenue is recognized upon shipment of the product and acceptance of the service or materials by the end customer for repair services. Revenue for extended warranty, cloud service or other software-based products is over the term of the contract warranty or service period. A time-elapsed method is used to measure progress because the Company transfers control evenly over the contractual period. Accordingly, the fixed consideration related to these revenues is generally recognized on a straight-line basis over the contract term, as long as the other revenue recognition criteria have been met. The Company’s multiple performance obligations may include future body-worn camera devices to be delivered at defined points within a multi-year contract, and in those arrangements, the Company allocates total arrangement consideration over the life of the multi-year contract to future deliverables using management’s best estimate of selling price. Entertainment Segment The Company reports ticketing revenue on a gross or net basis based on management’s assessment of whether the Company is acting as a principal or agent in the transaction. The determination is based upon the evaluation of control over the underlying ticket, including the right to sell the ticket, prior to its transfer to the ticket buyer. F- 13 The Company sells tickets held in inventory, which consists of one performance obligation, being to transfer control of an event ticket to the buyer upon confirmation of the order. The Company acts as the principal in these transactions as the ticket is owned by the Company at the time of the sale, therefore controlling the ticket prior to transferring to the customer. In these transactions, revenue is recorded on a gross basis based on the value of the ticket and is recognized when an order is confirmed. Payment is typically due upon delivery of the ticket. The Company also acts as an intermediary between buyers and sellers through online secondary marketplace. Revenues derived from this marketplace primarily consist of service fees from ticketing operations, and consists of one primary performance obligation, which is facilitating the transaction between the buyer and seller, being satisfied at the time the order has been confirmed. As the Company does not control the ticket prior to the transfer, the Company acts as an agent in these transactions. Revenue is recognized on a net basis, net of the amount due to the seller when an order is confirmed, the seller is then obligated to deliver the tickets to the buyer per the seller’s listing. Payment is due at the time of sale. Deferred Revenue Deferred revenue includes payments received in advance of the Company’s performance obligations and is presented as current and non-current liabilities in the consolidated balance sheets. Revenue is recognized as the related performance obligations are satisfied over time. See Note 24, Deferred Revenue, for additional information regarding the composition, activity, and expected future recognition of deferred revenue balances. Litigation : From time to time, the Company is notified that they may be a party to a lawsuit or that a claim is being made against them. It is their policy not to disclose the specifics of any claim or threatened lawsuit until the summons and complaint are served on them. After carefully assessing the claim, and assuming they determine that they are not at fault or they disagree with the damage or relief demanded, they vigorously defend any lawsuit filed against them. The Company records a liability when losses are deemed probable and reasonably estimable. When losses are deemed reasonably possible but not probable, they determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, they take into consideration factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of our prevailing, the availability of insurance, and the severity of any potential loss. The Company reevaluates and updates accruals as matters progress over time. F- 14 Cash and cash equivalents : Cash and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC). At times, account balances may exceed the federally insured limit of $ 250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At December 31, 2025 and December 31, 2024, the balance in excess of the federally insured limit amounted to $304,653 and $- 0 -, respectively. Accounts Receivable : Accounts receivables are carried at original invoice amount less an allowance for doubtful accounts, which is estimated in accordance with ASC 326, Financial Instruments — Credit Losses. The Company determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, current economic conditions, and reasonable and supportable forecasts of future conditions that may affect the collectability of the reported amount. Trade receivables are written off when deemed uncollectible, and recoveries of trade receivables previously written off are recorded when received. A trade receivable is considered past due if any portion of the receivable balance is outstanding for more than thirty (30) days beyond terms. No interest is charged on overdue trade receivables. Goodwill and Other Intangibles : Goodwill - In connection with acquisitions, the Company applies the provisions of ASC 805, Business Combinations, using the acquisition method of accounting. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired is recorded as goodwill. In accordance with ASC 350, Intangibles — Goodwill and Other, the Company assesses goodwill for impairment annually as of December 31st, and more frequently if events and circumstances indicate that goodwill might be impaired. Goodwill impairment testing is performed at the reporting unit level. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or internally generated, are available to support the value of the goodwill. The Company has adopted ASU 2017-04, which simplifies goodwill impairment measurement by eliminating the second step from the goodwill impairment test. As a result, the Company compares the fair value of a reporting unit with its respective carrying value and recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The Company determines the fair value of its reporting units using a weighting of the income and market valuation approaches. The income approach applies a fair value methodology to each reporting unit based on discounted cash flows. This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internally-developed forecasts of revenue and profitability, estimation of the long-term rate of growth for the business, estimation of the useful life over which cash flows will occur, and determination of the weighted average cost of capital, which is risk-adjusted to reflect the specific risk profile of the reporting unit being tested. Under the market approach, The Company estimates the fair value based on multiples of comparable public companies and precedent transactions. Significant estimates in the income and market approach include: future levels of revenue growth, gross profit margin, EBITDA as a percentage of revenue, cash-free debt-free net working capital as a percentage of revenue, capital expenditures as a percentage of revenue, discount rate, selection of guideline public companies, and revenue market multiples. F- 15 Long-lived and Other Intangible Assets - The Company periodically assesses potential impairments of its long-lived assets in accordance with the provisions of ASC 360, Accounting for the Impairment or Disposal of Long-lived Assets. An impairment review is performed whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. The Company groups its assets at the lowest level for which identifiable cash flows are largely independent of the cash flows of the other assets and liabilities. The Company has determined that the lowest level for which identifiable cash flows are available is the operating segment level. Factors considered by the Company include, but are not limited to, significant underperformance relative to historical or projected operating results; significant changes in the manner of use of the acquired assets or the strategy for the overall business; and significant negative industry or economic trends. When the carrying value of a long-lived asset may not be recoverable based upon the existence of one or more of the above indicators of impairment, the Company estimates the future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected future undiscounted cash flows and eventual disposition is less than the carrying amount of the asset, the Company recognizes an impairment loss. An impairment loss is reflected as the amount by which the carrying amount of the asset exceeds the fair value of the asset, based on the fair value if available, or discounted cash flows, if fair value is not available. During the third fiscal quarter of 2024, management identified triggering events, including an additional decline in demand for services, prolonged economic uncertainty, the failure of a planned split-off transaction to occur when and as expected, and a further decrease in the Company’s stock price. As a result, the Company performed an interim impairment test as of September 30, 2024. Based on that interim test, the Company recorded total impairment charges of $ 4,830,000 consisting of $ 307,000 of TicketSmarter goodwill impairment, $ 201,000 of TicketSmarter trademark impairment, and $ 4,322,000 of revenue cycle management segment goodwill impairment. The Company also assessed potential impairments of its long-lived assets as of December 31, 2024 and concluded that no additional impairment was required beyond the amounts recorded at September 30, 2024. The Company performed its annual goodwill and intangible asset impairment test as of December 31, 2025 on a full quantitative basis, given the prior-year impairment history and continued operating losses across certain segments. The Revenue Cycle Management segment (Nobility Healthcare) was classified as discontinued operations prior to the measurement date and was excluded from the annual impairment analysis. Based on the results of the annual test, the Company concluded that no impairment existed with respect to the Video Solutions Segment, where the indicated fair value of equity of $ 2,580,000 exceeded the segment’s carrying value of approximately $ 595,000 . With respect to the Entertainment Segment, the Company recorded total impairment charges of $ 2,533,667 for the year ended December 31, 2025, consisting of: $ 1,428,000 of goodwill impairment; $ 746,667 representing the full write-off of the Sponsorship Agreement Network intangible asset, which failed the ASC 360 recoverability test; $ 189,000 of TicketSmarter trademark impairment; and $ 170,000 of Country Stampede trademark impairment. These charges are included in the goodwill and intangible asset impairment line in the consolidated statements of operations for the year ended December 31, 2025. Refer to Note 8, Goodwill and Other Intangible Assets, for additional details on the valuation methodologies and inputs used in the fair value measurements. Intangible assets include deferred patent costs, license agreements, trademarks and trade names. Legal expenses incurred in preparation of patent application have been deferred and will be amortized over the useful life of granted patents. Costs incurred in preparation of applications that are not granted will be charged to expense at that time. The Company has entered into several sublicense agreements under which it has been assigned the exclusive rights to certain licensed materials used in its products. These sublicense agreements generally require upfront payments to obtain exclusive rights to such material. The Company capitalizes the upfront payments as intangible assets and amortizes such costs over their estimated useful life on a straight-line method. F- 16 Fair value of assets and liabilities acquired in business combinations : The Company accounts for business combinations using the acquisition method of accounting, under which the purchase price is allocated to the assets acquired and liabilities assumed based on their estimated fair values at the acquisition date, with any excess recorded as goodwill. Transaction costs associated with acquisitions are expensed as incurred and included in selling, general and administrative expenses in the consolidated statements of operations. Inventories : Inventories for the video solutions segment consist of electronic parts, circuitry boards, camera parts and ancillary parts (collectively, “components”), work-in-process and finished goods. Finished goods that are manufactured and assembled by the Company are carried at the lower-of-cost or net realizable value, with cost determined by standard cost methods, which approximate the first-in, first-out method. Inventory costs include material, labor and manufacturing overhead. Inventories for the entertainment segment consist of tickets to live events purchased, which are held at lower of cost or net realizable value and written-off after the event has occurred. Event tickets for the entertainment segment are carried at lower of cost or net realizable value and fully written off at the time the event occurs if the ticket is unsold and remains in inventory after the completion of the event. Management has established inventory reserves based on estimates of excess and/or obsolete current inventory. Manufacturing inventory for the video solutions segment is reviewed for obsolescence and excess quantities on a quarterly basis, based on estimated future use of quantities on hand, which is determined based on past usage, planned changes to products and known trends in markets and technology. Changes in support plans or technology could have a significant impact on obsolescence. To support its world-wide service operations for the video solutions segment, the Company maintains service spare parts inventory, which consists of both consumable and repairable spare parts. Consumable service spare parts are used within its service business to replace worn or damaged parts in a system during a service call and are generally classified in current inventory as its stock of this inventory turns relatively quickly. However, if there has been no recent usage for a consumable service spare part, but the part is still necessary to support systems under service contracts, the part is non-current and included within non-current inventories within its consolidated balance sheet. Consumables are charged to cost of goods sold when issued during the service call. As these service parts age over the related product group’s post-production service life, the Company reduces the net carrying value of its repairable spare part inventory on the consolidated balance sheet to account for the excess that builds over the service life. The post-production service life of its systems is generally seven to twelve years and, at the end of twelve years, the carrying value for these parts in its consolidated balance sheet is reduced to zero. The Company also performs periodic monitoring of its installed base for premature end of service life events and expenses, through cost of sales, the remaining net carrying value of any related spare parts inventory in the period incurred. Prepaid inventory represents advance payments made to suppliers for inventory not yet received. The Company periodically evaluates the recoverability of prepaid inventory balances and records an allowance when amounts are not expected to be fully realized. Property, plant and equipment : Property, plant and equipment is stated at cost net of accumulated depreciation. Additions and improvements are capitalized while ordinary maintenance and repair expenditures are charged to expense as incurred. Depreciation is recorded by the straight-line method over the estimated useful life of the asset, which ranges from three to thirty years, other than the infinite useful life of land. Amortization expense on capitalized leases is included with depreciation expense. The cost and accumulated depreciation related to assets sold or retired are removed from the accounts and any gain or loss is credited or charged to income. F- 17 Leases : The Company determines if an arrangement contains a lease at inception. For arrangements where the Company is the lessee, the Company will evaluate whether to account for the lease as an operating or finance lease. Operating leases are included in the right of use assets (ROU) and operating lease liabilities on the consolidated balance sheet as of December 31, 2025 and 2024. Finance leases would be included in property, plant and equipment, net and long-term debt and finance lease obligations on the balance sheet. The Company had operating leases for copiers, offices and warehouse space on December 31, 2025 and 2024 but no financing leases. ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the operating lease liabilities if the operating lease does not provide an implicit rate. Lease terms may include the option to extend when Company is reasonably certain that the option will be exercised. Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for short term leases. Warranties : The Company’s video solutions segment products carry explicit product warranties that extend up to two years from the date of shipment. The Company records a provision for estimated warranty costs based upon historical warranty loss experience and periodically adjusts these provisions to reflect actual experience. Accrued warranty costs are included in accrued expenses. Extended warranties are offered on selected products and when a customer purchases an extended warranty the associated proceeds are treated as contract liabilities and recognized over the term of the extended warranty. Shipping and Handling Costs : Shipping and handling costs video solutions segment for outbound sales orders totaled $ 19,622 and $ 38,143 for the years ended December 31, 2025 and 2024, respectively. Such costs are included in selling, general and administrative expenses in the Consolidated Statements of Operations. Advertising Costs : Advertising expense for the video solutions segment and entertainment segments includes costs related to trade shows and conventions, promotional material and supplies, and media costs. Advertising costs are expensed in the period in which they are incurred. The Company incurred total advertising expenses of $ 309,630 and $ 1,121,116 for the years ended December 31, 2025 and 2024, respectively. Such costs are included in selling, advertising and promotional expenses in the Consolidated Statements of Operations. Income Taxes : Deferred taxes are provided for by the liability method in which deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company applies the provisions of the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) No. 740 - Income Taxes that provides a framework for accounting for uncertainty in income taxes and provided a comprehensive model to recognize, measure, present, and disclose in its financial statements uncertain tax positions taken or expected to be taken on a tax return. It initially recognizes tax positions in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions are initially and subsequently measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and all relevant facts. Application requires numerous estimates based on available information. The Company considers many factors when evaluating and estimating its tax positions and tax benefits, and it recognized tax positions and tax benefits may not accurately anticipate actual outcomes. As it obtains additional information, the Company may need to periodically adjust its recognized tax positions and tax benefits. These periodic adjustments may have a material impact on its Consolidated Statements of Operations. F- 18 The Company’s policy is to record estimated interest and penalties related to the underpayment of income taxes as income tax expense in the Consolidated Statements of Operations. There was no interest expense related to the underpayment of estimated taxes during the years ended December 31, 2025 and 2024. There were no penalties in 2025 and 2024. The Company is subject to taxation in the United States and various states. The Company’s 2022 federal tax return was recently examined by the Internal Revenue Service resulting in no proposed adjustments. Therefore, the Company’s federal and state income tax returns are closed for examination purposes by relevant statute and by examination for 2022 and all prior tax years for federal tax purposes and 2023 and all prior years for state tax purposes. Research and Development Expenses : The Company expenses all research and development costs as incurred, which is generally incurred by the video solutions segment. Development costs of computer software to be sold, leased, or otherwise marketed are subject to capitalization beginning when a product’s technological feasibility has been established and ending when a product is available for general release to customers. In most instances, the Company’s products are released soon after technological feasibility has been established. Costs incurred after achievement of technological feasibility were not significant, and software development costs were expensed as incurred during 2025 and 2024. Warrant Derivative Liabilities and Bifurcated Embedded Derivatives : In accordance with ASC 815-40, Derivatives and Hedging: Contracts in an Entity’s Own Equity , entities must consider whether to classify contracts that may be settled in its own stock, such as warrants to purchase shares of Common Stock, as equity of the entity or as an asset or liability. If an event that is not within the entity’s control could require net cash settlement, then the contract should be classified as an asset or a liability rather than as equity. The Company has determined that because the terms of the various warrants issued and remaining outstanding include a provision that entitles all the warrant holders to receive cash for their warrants in the event of a qualifying cash tender offer, while only certain of the holders of the underlying shares of common stock would be entitled to cash, its warrants should be classified as a liability measured at fair value, with changes in fair value each period reported in earnings. In addition, the Company evaluates the terms of its debt instruments for embedded features that require bifurcation under ASC 815-15, Derivatives and Hedging: Embedded Derivatives . When a convertible note contains a conversion feature or other embedded derivative that is not clearly and closely related to the host debt instrument, and meets the definition of a derivative, the Company bifurcates the embedded feature from the host instrument and records it as a separate derivative liability measured at fair value. The host debt instrument is recorded at its residual carrying value after the bifurcation. The bifurcated embedded derivative and any detachable warrants issued in connection with the same debt instrument are initially recorded at their respective fair values, with any excess of the aggregate fair value over the proceeds allocated to the host note recognized immediately in earnings as a day-one loss. Subsequent changes in fair value of both the warrant derivative liabilities and bifurcated embedded derivatives are reported in earnings each period. Volatility in the price of the Company’s common stock may result in significant changes in the value of these derivatives and resulting gains and losses on its consolidated statements of operations. Stock-Based Compensation : The Company grants stock-based compensation to its employees, board of directors and certain third-party contractors. Share-based compensation arrangements may include the issuance of options to purchase common stock in the future or the issuance of restricted stock, which generally are subject to vesting requirements. The Company records stock-based compensation expense for all stock-based compensation granted based on the grant-date fair value. The Company recognizes these compensation costs on a straight-line basis over the requisite service period of the award. The Company estimates the grant-date fair value of stock-based compensation using the Black-Scholes valuation model. Assumptions used to estimate compensation expense are determined as follows: ● Expected term is determined using the contractual term and vesting period of the award; ● Expected volatility of award grants made in the Company’s plan is measured using the weighted average of historical daily changes in the market price of the Company’s common stock over the period equal to the expected term of the award; ● Expected dividend rate is determined based on expected dividends to be declared; ● Risk-free interest rate is equivalent to the implied yield on zero-coupon U.S. Treasury bonds with a maturity equal to the expected term of the awards; and ● Forfeitures are accounted for as they occur. F- 19 Employee benefit plans : 401 (k) Plan. The Company sponsors a 401(k) retirement savings plan for the benefit of its employees. The plan, as amended, requires it to provide 100% matching contributions for employees, who elect to contribute up to 3% of their compensation to the plan and 50 % matching contributions for employee’s elective deferrals on the next 2% of their contributions. The Company made matching contributions totaling $ 80,083 and $ 144,589 for the years ended December 31, 2025 and 2024, respectively. Each participant is 100 % vested at all times in employee and employer matching contributions. Segment Reporting: The accounting guidance on Segment Reporting establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information about those segments to be presented in the consolidated financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision maker (the Company’s Chief Executive Officer, or “CODM”) in making decisions about how to allocate resources and assess performance. The Company’s two operating segments are Video Solutions and Entertainment, each of which has dedicated personnel responsible for those businesses and each of which reports directly to the CODM. Corporate expenses represent the Company’s corporate administrative activities and are included in segment information but are not considered a separate reportable segment for financial reporting purposes. The Company adopted ASU 2023-07 in 2024 and applied the amendment retrospectively to all periods presented in the Company’s consolidated financial statements. See Note 22, Operating Segments, for additional information. Contingent Consideration In circumstances where an acquisition involves a contingent consideration arrangement that meets the definition of a liability under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity, the Company recognizes a liability equal to the fair value of the contingent payments the Company expects to make as of the acquisition date. The Company remeasures this liability for each reporting period and records changes in the fair value through the consolidated statement of operations. Non-Controlling Interests Non-controlling interests in the Company’s consolidated financial statements represent the ownership interests in subsidiaries not attributable, directly or indirectly, to the Company. During the periods presented, the Company held a 51% equity interest in Nobility Healthcare, LLC (“Nobility”), with the remaining 49% held by third-party venture partners. Because Nobility represents the Company’s entire discontinued operation, the non-controlling interest related to Nobility is fully included within discontinued operations and is not included in income or loss from continuing operations. The non-controlling owners’ share of Nobility’s results of operations is presented within net income (loss) from discontinued operations in the consolidated statements of operations. Prior to its classification as held for sale and discontinued operations, the Company consolidated Nobility based on its controlling financial interest. Upon classification as a discontinued operation, Nobility’s assets, liabilities, results of operations, and the related non-controlling interest are presented separately from the Company’s continuing operations. F- 20 Redeemable Preferred Stock Preferred stock may be classified as a liability, temporary equity (i.e., mezzanine equity) or permanent equity. To determine the appropriate classification, an evaluation of the cash redemption features is required. Where there exists an absolute right of redemption presently or in the future, the preferred stock would be classified as a liability. If redemption is contingently redeemable upon the occurrence of an event that is outside of the issuer’s control, it should be classified as mezzanine equity. The probability that the redemption event will occur does not impact the classification. If no redemption features exist, or if a contingent redemption feature is within the Company’s control, the preferred stock would be considered equity. Lease Receivable Lease receivables are carried at the original invoice amount less the total payments received pertaining to each individual customer’s lease agreement. These agreements range from three to five years and are removed from lease receivable upon termination of the agreement. The Company determines an allowance for doubtful accounts by regularly evaluating individual customer lease receivables and considering a customer’s financial condition, credit history, and current economic conditions. The allowance for doubtful accounts was $ 75,000 and $ 25,000 as of December 31, 2025 and 2024, respectively. Discontinued Operations and Held for Sale Under ASC 205-20, Discontinued Operations , the results of a disposed business are reported as discontinued operations when the held-for-sale and strategic shift criteria are met. When a business is classified as a discontinued operation, (i) its results of operations are presented in a single line, net of tax, in the consolidated statements of operations, (ii) its assets and liabilities are classified as held for sale in the consolidated balance sheets in the period of classification, and (iii) prior-period financial statements are retrospectively reclassified to conform to the current-period presentation. See Note 23. DISCONTINUED OPERATIONS for further details regarding the Company’s discontinued operations. New Accounting Standards Recently Adopted Accounting Standard Updates. ASU 2023-07, Improvements to Reportable Segment Disclosures , which requires companies to disclose significant segment expenses provided to the chief operating decision maker (“CODM”) and a description of other segment items. Additionally, all existing annual disclosures must be provided on an interim basis. This ASU is effective for annual periods beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. This ASU is required to be applied retrospectively to all prior periods presented in the consolidated financial statements. The Company adopted ASU 2023-07 in 2024 and applied the amendment retrospectively to all periods presented in the Company’s consolidated financial statements. See Note 22, Operating Segments, for more information. ASU 2023-09, Improvements to Income Tax Disclosures, requires improved disclosures related to the rate reconciliation and income taxes paid. This ASU requires companies to reconcile the income tax expense attributable to continuing operations to the U.S. statutory federal income tax rate applied to pre-tax income from continuing operations. Additionally, this ASU requires companies to disclose the total amount of income taxes paid during the period. This ASU became effective for the Company’s consolidated financial statements as of and for the year ended December 31, 2025. The guidance is required to be applied on a prospective basis with the option to apply retrospectively to all prior periods presented in the consolidated financial statements. The Company applied this guidance on a prospective basis only with no significant impact to the consolidated financial statements as of and for the year ended December 31, 2025. F- 21 Recently Issued Accounting Pronouncements. ASU 2024-03, Disaggregation of Income Statement Expenses, requires disaggregated disclosures in the notes to the consolidated financial statements of certain categories of expenses that are included in expense line items on the Consolidated Statement of Income. This ASU is effective for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The guidance is required to be applied on a prospective basis with the option to apply retrospectively to all prior periods presented in the consolidated financial statements. The Company is currently evaluating the impact to the Company’s consolidated financial statements. ASU 2024-04, Induced Conversions of Convertible Debt Instruments, clarifies the requirement for determining whether certain settlements of convertible debt instruments should be accounted for as induced conversions or extinguishments. This ASU is effective for annual periods beginning after December 15, 2025. Early adoption is permitted and can be applied either on a prospective basis or retrospective basis. The Company is currently evaluating the impact of this ASU to the Company’s consolidated financial statements, however the Company does not anticipate this guidance having a material impact to the consolidated financial statements. In March 2024, the SEC adopted rules to develop standardized climate-related disclosures by publicly traded companies including the emission of greenhouse gases. The rules are currently effective for the Company in the fiscal year beginning in 2027. However, as a result of pending legal challenges, the actual timing of effectiveness of the rules and applicable phase-in periods, as well as whether portions of the rules remain in effect after the legal challenges, are uncertain. The Company is currently evaluating the guidance and its impact on the financial statements. The other recent accounting pronouncements issued by the Financial Accounting Standards Board (“FASB”) are not expected to have a significant impact on the Company’s consolidated financial statements and related disclosures. NOTE 2. CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS Financial instruments that potentially subject the Company to concentration of credit risk consist of accounts receivable. Sales to domestic customers are typically made on credit and the Company generally does not require collateral while sales to international customers require payment before shipment or backing by an irrevocable letter of credit. The Company performs ongoing credit evaluations of its customers’ financial condition and maintains an allowance for estimated losses. Accounts are written off when deemed uncollectible and accounts receivable are presented net of an allowance for doubtful accounts. The allowance for doubtful accounts totaled $ 10,262 as of December 31, 2025 and $ 208,458 as of December 31, 2024. The Company evaluated concentration of credit risk across all receivable balances, including trade accounts receivable and subscription receivables, as of December 31, 2025 and 2024. No individual customer balance exceeded 10% of total trade accounts receivable or total subscription receivables as of either date. No individual customer, event, venue, or counterparty within the Entertainment segment exceeded 10 % of total revenues from continuing operations for the years ended December 31, 2025 and 2024. No international distributor individually exceeded 10 % of total revenues from continuing operations for the years ended December 31, 2025 and 2024. The Company’s video solutions segment purchases finished circuit boards and other proprietary component parts from suppliers located in the United States and on a limited basis from Asia. Although the Company obtains certain of these components from single source suppliers, it generally owns all tooling and management has located alternative suppliers to reduce the risk in most cases to supplier problems that could result in significant production delays. The Company has not historically experienced significant supply disruptions from any of its principal vendors and does not anticipate future supply disruptions. The Company acquires most of its components on a purchase order basis and does not have long-term contracts with its suppliers. F- 22 NOTE 3. ACCOUNTS RECEIVABLE AND SUBSCRIPTION RECEIVABLES ACCOUNTS RECEIVABLE AND SUBSCRIPTION RECEIVABLES December 31, 2025 December 31, 2024 Accounts receivable – trade, gross $ 489,821 $ 960,201 Less: allowance for doubtful accounts ( 10,262 ) ( 208,458 ) Accounts receivable – trade, net $ 479,559 $ 751,743 Subscription receivables, gross – current $ 3,294,647 $ 4,013,994 Less: allowance for doubtful accounts ( 75,000 ) ( 25,000 ) Subscription receivables, net – current 3,219,647 3,988,994 Subscription receivables – long term 2,976,758 4,889,289 Total subscription receivables, net $ 6,196,405 $ 8,878,283 The allowance for doubtful accounts receivable was comprised of the following for the years ended December 31, 2025 and 2024: SCHEDULE OF ALLOWANCE FOR DOUBTFUL ACCOUNTS December 31, 2025 December 31, 2024 Beginning balance $ 208,458 $ 96,803 Provision for bad debts — 109,422 Charge-offs to allowance, net of recoveries ( 198,196 ) 2,233 Ending balance $ 10,262 $ 208,458 NOTE 4. OTHER RECEIVABLES Other receivables were the following at December 31, 2025 and 2024: SCHEDULE OF OTHER RECEIVABLES December 31, 2025 December 31, 2024 Notes receivable $ — $ 150,154 Litigation receivables 578,890 — Allowance for loss on litigation receivables ( 289,445 ) — Other 3,058 5,697 Total other receivables $ 292,503 $ 155,851 As of December 31, 2025, the Company recorded litigation receivables of $ 578,890 related to amounts owed pursuant to the pending default judgment against Pharmaxx Medical, Inc. The Company established an allowance of $ 289,445 against these receivables based on management’s assessment that full collection is uncertain given the status of the proceedings and the defendant’s financial condition and ability to satisfy the judgment. The Company has engaged legal counsel and is actively pursuing recovery of these amounts. See Note 15, Commitments and Contingencies, for additional information regarding the Company’s legal proceedings against Pharmaxx Medical, Inc. NOTE 5. INVENTORIES Inventories consisted of the following at December 31, 2025 and 2024: SCHEDULE OF INVENTORIES December 31, 2025 December 31, 2024 Raw material and component parts– video solutions segment $ 2,829,039 $ 2,589,804 Work-in-process– video solutions segment — 4,906 Finished goods – video solutions segment 1,149,538 1,655,317 Finished goods – entertainment segment 270,856 505,694 Subtotal 4,249,433 4,755,721 Reserve for excess and obsolete inventory– video solutions segment ( 1,849,124 ) ( 2,037,252 ) Reserve for excess and obsolete inventory – entertainment segment ( 69,817 ) ( 132,403 ) Total inventories $ 2,330,492 $ 2,586,066 Finished goods inventory includes units held by potential customers and sales agents for test and evaluation purposes. The cost of such units totaled $ 35,742 and $ 36,080 as of December 31, 2025 and 2024, respectively. NOTE 6. PREPAID EXPENSES Prepaid expenses were the following at December 31, 2025 and 2024: SCHEDULE OF PREPAID EXPENSE December 31, 2025 December 31, 2024 Prepaid inventory $ 534,539 $ 1,158,867 Prepaid advertising 6,214 334,882 Other 511,662 292,397 Total prepaid expenses $ 1,052,415 $ 1,786,146 F- 23 NOTE 7. PROPERTY, PLANT AND EQUIPMENT Property, plant and equipment consisted of the following at December 31, 2025 and 2024: SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT Estimated Useful Life December 31, 2025 December 31, 2024 Office furniture, fixtures, equipment, and aircraft 3 - 20 years $ 437,515 $ 743,853 Warehouse and production equipment 3 - 7 years 482,153 237,141 Demonstration and tradeshow equipment 3 - 7 years 77,791 77,791 Building improvements 5 - 7 years 22,648 12,185 Total cost 1,020,107 1,070,970 Less: accumulated depreciation and amortization ( 617,881 ) ( 732,409 ) Net property, plant and equipment $ 402,226 $ 338,561 Depreciation and amortization of property, plant and equipment aggregated $ 194,385 and $ 537,627 for the years ended December 31, 2025 and 2024, respectively. The cost and accumulated depreciation related to assets sold or retired are removed from the accounts and any gain or loss is credited or charged to income. During the year ended December 31, 2024 the Company sold its aircraft for $ 1,100,000 less closing costs of $ 1,500 . The carrying amount of the aircraft on the date of sale was $ 1,141,661 . As a result of the sale the Company recorded a loss of $ 41,661 in the Consolidated Statement of Operations. In addition, during the year ended December 31, 2024 the Company sold its building for $ 5,900,000 less closing costs of $ 36,634 . The carrying amount of the building on the date of sale was $ 5,461,623 . As a result of the sale the Company recorded a gain of $ 401,743 in the Consolidated Statement of Operations during the year ended December 31, 2024. NOTE 8. GOODWILL AND OTHER INTANGIBLE ASSETS Intangible assets consisted of the following as of December 31, 2025 and December 31, 2024: SCHEDULE OF INTANGIBLE ASSETS December 31, 2025 Gross value Accumulated amortization Accumulated impairment Net carrying value Amortized intangible assets: Patents and trademarks (video solutions segment) $ 224,851 $ 187,350 $ — $ 37,501 Sponsorship agreement network (entertainment segment) 5,600,000 4,853,333 746,667 — SEO content (entertainment segment) 600,000 600,000 — — Personal seat licenses (entertainment segment) 117,339 16,949 — 100,390 Website enhancements (entertainment segment) 54,908 23,383 — 31,525 6,597,098 5,681,015 746,667 169,416 Indefinite life intangible assets: Goodwill (Entertainment segment) 6,112,507 — 1,735,000 4,377,507 Trade name and trademarks (entertainment segment) 900,000 — 560,000 340,000 Patents and trademarks pending (video solutions segment) 144,710 — — 144,710 Total $ 13,754,315 $ 5,681,015 $ 3,041,667 $ 5,031,633 F- 24 December 31, 2024 Gross value Accumulated amortization Accumulated impairment Net carrying value Amortized intangible assets: Patents and trademarks (video solutions segment) $ 483,521 $ 377,459 $ — $ 106,062 Sponsorship agreement network (entertainment segment) 5,600,000 3,733,333 — 1,866,667 SEO content (entertainment segment) 600,000 500,000 — 100,000 Personal seat licenses (entertainment segment) 117,339 13,037 — 104,302 Software 23,653 — — 23,653 Website enhancements (entertainment segment) 35,900 9,833 — 26,067 6,860,413 4,633,662 — 2,226,751 Indefinite life intangible assets: Goodwill (Entertainment segment) 6,112,507 — 307,000 5,805,507 Trade name and trademarks (entertainment segment) 900,000 — 201,000 699,000 Patents and trademarks pending (video solutions segment) 91,738 — — 91,738 Total $ 13,964,658 $ 4,633,662 $ 508,000 $ 8,822,996 Patents and trademarks pending will be amortized beginning at the time they are issued by the appropriate authorities. If issuance of the final patent or trademark is denied, then the amount deferred will be immediately charged to expense. Other intangible assets consist of sponsorship agreement network, SEO content, personal seat licenses, website enhancements and client agreements. These assets are recorded at cost and amortized on a straight-line basis over their estimated useful lives. SCHEDULE OF INTANGIBLE ASSETS USEFUL LIFE Intangible Asset Useful Life Patents and trademarks (video solutions segment) $ 3 years Sponsorship agreement network (entertainment segment) 5 years SEO content (entertainment segment) 4 years Personal seat licenses (entertainment segment) 30 years Software 3 years Website enhancements (entertainment segment) 3 years Amortization for the years ended December 31, 2025 and 2024 was $ 1,350,382 and $ 1,377,809 , respectively. Estimated amortization for intangible assets with definite lives for the next five years ending December 31 and thereafter is as follows: SCHEDULE OF ESTIMATED AMORTIZATION FOR INTANGIBLE ASSETS Year ending December 31: 2026 $ 59,715 2027 12,382 2028 8,663 2029 3,911 2030 3,911 2031 and thereafter 80,834 Total $ 169,416 F- 25 Annual impairment test The company performed its annual goodwill and intangible asset impairment test as of December 31, 2025 on a full quantitative basis, given its prior-year impairment history and continued operating losses across certain segments. The Revenue Cycle Management segment (Nobility Healthcare) was classified as discontinued operations prior to the measurement date and was excluded from the annual impairment analysis. The fair value of each continuing reporting unit was estimated using a weighting of the income and market valuation approaches. The income approach applied a fair value methodology to each reporting unit based on discounted cash flows. This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internally-developed forecasts of revenue and profitability, estimation of the long-term rate of growth for our business, estimation of the useful life over which cash flows will occur, and determination of its weighted average cost of capital, which is risk-adjusted to reflect the specific risk profile of the reporting unit being tested. The weighted average cost of capital used in its December 31, 2025 annual impairment test ranged from 18.4 % to 22.7 %. The company also applied a market approach, which develops a value correlation based on the market capitalization of similar publicly traded companies, referred to as a multiple, to apply to the operating results of the reporting units. The primary market multiples used are revenue and earnings before interest, taxes, depreciation, and amortization. The income and market approaches were equally weighted for all reporting units. The combined fair values for all reporting units were then reconciled to the company’s aggregate market value of its shares of Common Stock on the date of valuation, while considering a reasonable control premium. The Company considers a reporting unit’s fair value to be substantially in excess of the reporting unit’s carrying value at a 20 % premium or greater. Based on the company’s December 31, 2025 annual impairment test, the Video Solutions Segment’s fair value was substantially in excess of its carrying value, with an indicated equity fair value of $ 2,580,000 compared to a carrying value of approximately $ 595,000 . The Video Solutions Segment carries no goodwill. The Entertainment Segment was determined to be impaired. The company held total goodwill of approximately $ 5,805,507 related to businesses within its Entertainment Segment prior to December 31, 2025 annual impairment test, consisting of $ 5,579,548 attributable to TicketSmarter and $ 225,959 attributable to Country Stampede. As a result of its December 31, 2025 annual impairment test, the company concluded that the carrying amount of the Entertainment Segment’s equity exceeded its estimated fair value and recorded a non-cash goodwill impairment charge of $ 1,428,000 , which is included in goodwill and intangible asset impairment charge on its consolidated statements of operations for the year ended December 31, 2025. The remaining goodwill balance for the Entertainment Segment was approximately $ 4,377,507 as of December 31, 2025. The goodwill impairment was primarily driven by the segment’s continued operating losses, the fixed cost structure of festival operations, and the structural cost challenges within certain Entertainment Segment revenue streams. Indefinite-lived intangible assets The Company held indefinite-lived trade names and trademarks with an aggregate carrying value of $ 340,000 as of December 31, 2025, consisting of the TicketSmarter trade name $ 210,000 and the Country Stampede trade name $ 130,000 , each related to businesses within its Entertainment Segment. F- 26 As a result of its December 31, 2025 annual impairment test, the company concluded that the carrying amounts of both trade names exceeded their estimated fair values and recorded non-cash impairment charges totaling $ 359,000 , which are included in goodwill and intangible asset impairment charge on its consolidated statements of operations for the year ended December 31, 2025. The company recorded a $ 189,000 impairment charge related to the TicketSmarter trade name, reducing its carrying value from $ 399,000 to $ 210,000 , and a $ 170,000 impairment charge related to the Country Stampede trade name, reducing its carrying value from $ 300,000 to $ 130,000 . The charges were primarily driven by the Entertainment Segment’s continued operating losses, declining revenue performance within the related businesses, and the overall challenging economic environment. In addition, The Company recorded a non-cash impairment charge of $ 746,667 related to the sponsorship agreement network intangible asset within the Entertainment Segment, reducing its net carrying value to - 0 - as of December 31, 2025. The total goodwill and intangible asset impairment charge recorded for the year ended December 31, 2025 was $ 2,533,667 . NOTE 9. OTHER ASSETS Other assets were the following at December 31, 2025 and 2024: SCHEDULE OF OTHER ASSETS December 31, 2025 December 31, 2024 Deposits $ 27,252 $ 549,272 Prepaid commissions 125,249 205,585 Other 203,135 — Total other assets $ 355,636 $ 754,857 NOTE 10. DEBT OBLIGATIONS Debt obligations is comprised of the following: SCHEDULE OF DEBT OBLIGATIONS December 31, 2025 December 31, 2024 Economic injury disaster loan (EIDL) $ 141,083 $ 144,495 Unsecured Promissory note – Entertainment Segment 525,000 — 2025 Secured Notes 1,070,000 — Commercial Extension of Credit- Entertainment Segment — 100,000 Merchant Cash Advances – Video Solutions Segment — 1,922,750 Senior Secured Promissory Notes-Issued November 2024 — 3,600,000 Total gross principal 1,736,083 5,767,245 Unamortized debt issuance costs ( 890,716 ) ( 664,719 ) Debt obligations 845,367 5,102,526 Less: current maturities of debt obligations 707,826 4,961,443 Debt obligations, long-term $ 137,541 $ 141,083 Debt obligations mature on an annual basis as follows as of December 31, 2025: SCHEDULE OF MATURITY OF DEBT OBLIGATIONS Gross Principal Unamortized Discount Net Carrying Value 2026 $ 1,598,542 $ ( 890,716 ) $ 707,826 2027 3,677 - 3,677 2028 3,817 - 3,817 2029 3,963 - 3,963 2030 and thereafter 126,084 - 126,084 Total $ 1,736,083 $ ( 890,716 ) $ 845,367 F- 27 2020 Small Business Administration Notes . On May 12, 2020, the Company received $ 150,000 in loan funding from the SBA under the Economic Injury Disaster Loan (“EIDL”) program administered by the SBA, which program was expanded pursuant to the recently enacted CARES Act. The EIDL is evidenced by a secured promissory note, dated May 8, 2020, in the original principal amount of $ 150,000 with the SBA, the lender. Under the terms of the note issued under the EIDL program, interest accrues on the outstanding principal at the rate of 3.75 % per annum. The term of such note is thirty years, though it may be payable sooner upon an event of default under such note. Monthly principal and interest payments began in November 2022, after being deferred for thirty months after the date of disbursement and total $ 731 per month thereafter. Such note may be prepaid in part or in full, at any time, without penalty. The Company granted the SBA a continuing interest in and to any and all collateral, including but not limited to tangible and intangible personal property. Unsecured Promissory Note On February 1, 2025, the Company’s Entertainment Segment entered into a $ 600,000 unsecured promissory note with a third party. The promissory note bears an interest rate of 10.0 % per annum, compounded monthly. Payments of principal and interest were originally due on May 5, 2025 , however the parties agreed to extend the term for payments of principal and interest to begin July 1, 2025 . The remaining outstanding balance totaled $ 525,000 as of December 31, 2025. 2024 Commercial Extension of Credit On January 22, 2024, the Company’s Entertainment segment entered into an extension of credit in the form of a loan to use in marketing and operating its business in accordance with the Ticket Solution Agreement. The Lender, Ticket Evolution, Inc., agreed to extend, subject to the conditions hereof, and Borrower agreed to take, an advance for a sum of $ 75,000 with monthly advances of $ 100,000 . The advances made are recoupable from client service fees with no more than $ 25,000 being recouped in any one week. The total advances received for the year ended December 31, 2024 were $ 1,275,000 and payments made totaled $ 1,175,000 . The outstanding balance as of December 31, 2024 was $ 100,000 . On August 7, 2024 and as amended on September 25, 2024, the Company’s Entertainment segment entered into an extension of credit (the “Agreement”) with Vegas Tickets in the form of a prepayment for the rights to acquire certain Major League Baseball and National Football League playoff and season tickets. Vegas Tickets agreed to advance, subject to the conditions of the Agreement, and the Company’s Entertainment segment agreed to take, an advance for a sum of $200,000. Under the Agreement, the Company’s Entertainment segment has the right to reacquire the tickets for a cash amount of $220,000 by November 1, 2024. The repurchase date was extended to December 1, 2024 by an amendment dated October 31, 2024. The repurchase was completed and the remaining balance is $-0- as of December 31, 2024. Merchant Cash Advances – Video Solutions Segment In November 2023, the Company obtained a short-term merchant advance, which totaled $ 1,050,000 , from a single lender to fund operations. These advances included origination fees totaling $ 50,000 for net proceeds of $ 1,000,000 . The advance is, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. The Company will repay an aggregate of $ 1,512,000 to the lender. The loan bears interest at 2.9 % per week. During the year ended December 31, 2024, the Company made repayments totaling $ 1,551,250 and received additional proceeds of $ 1,144,000 and recorded additional discount of $ 980,000 . The Company refinanced this loan in April 2024 resulting in the additional proceeds received during the year ended December 31, 2024. The refinancing was deemed to be an extinguishment of debt and a loss on extinguishment of debt was recorded during the year ended December 31, 2024 of $ 68,827 . The Company paid the outstanding balance of $ 1,922,750 in full during the year ended December 31, 2025 and the merchant advance arrangement was subsequently terminated. There were no amounts outstanding or available under this arrangement as of December 31, 2025. Merchant Cash Advances – Entertainment Segment On March 1, 2024, the Company obtained a short-term merchant advance, which totaled $ 1,000,000 , from a single lender to fund operations. These advances included origination and issuance fees totaling $ 85,000 for net proceeds of $ 915,000 . The advance is, for the most part, secured by expected future sales transactions of the Company with expected payments on a weekly basis. The Company will repay an aggregate of $ 1,425,000 to the lender. The loan bears interest at a 40.4523 % annual effective rate based on latest debt modification. The Company entered into the original agreement on March 1, 2024. On July 13, 2024, the Company entered into a letter agreement with the Purchaser, amending the terms of the note agreement, and on September 12, 2024, the Company entered into a second letter agreement further amending the terms of the note agreement. The two amendments to the underlying loan agreement, resulting in additional proceeds totaling $ 393,836 . The modifications were both deemed to be extinguishments of debt resulting in a $ 310,505 loss on the extinguishment of debt during the year ended December 31, 2024. On July 13, 2024, the Company entered into a Letter Agreement with the note holder, which modified the note payable by increasing the principal amount of the note payable from $ 1,425,000 to $ 1,725,000 ; provided, however, that if the Borrowers repay the Note in full on or before August 15, 2024, then the principal amount of the Note shall be reduced automatically by $ 100,000 . Pursuant to the Letter Agreement, the Borrowers’ failure to adhere to certain repayment requirements of the underlying note purchase agreement did not constitute an event of default, as defined in the note purchase agreement. Pursuant to the modified/amended note, the Company agreed to make a cash payment to the note holder in the amount of $ 150,000 on or before July 26, 2024. The Company also agreed to sell or enter into a firm commitment to sell the office building owned by the Company and pay to the Purchaser: (i) $ 325,000 , if the Company sells or enters into a firm commitment to sell the building on or before August 7, 2024; or (ii) $ 400,000 , if the Company sells or enters into a firm commitment to sell the building after August 7, 2024. Pursuant to the modified/amended note, the Company’s failure to sell or enter into a firm commitment to sell the building prior to September 1, 2024 shall constitute an event of default, as defined in the note purchase agreement. The Company also agreed to pay to the note holder $ 100,000 per month until the modified/amended note is repaid in full, with the first such payment occurring on August 12, 2024, and each subsequent payment occurring on the 12th calendar day of each month thereafter. F- 28 On September 25, 2024, the Company and the note holder agreed to an amended and restated senior secured promissory note with a new principal amount of up to $ 2,000,000 . The amended note evidences the new principal amount and amends and restates in its entirety, the terms and provisions of the Note. Pursuant to the amended note the Company promised to pay to the note holder the new principal amount, together with accrued interest or the amount outstanding under the amended note from time to time, to be computed from the date of the amended note at the rates and in the amounts set forth in the amended note. The amount of the unpaid balance, including such interest, that shall be due and payable under the Amended Note may increase and decrease as advances and payments are made thereunder. The Amended Note bears interest at a rate of 1.58% per month. The Company can request advances in writing to the note holder and upon approval by the note holder to be determined in its sole discretion, (but which shall not be unreasonably withheld), the note holder can either make payment directly to specified vendor(s) or other creditors on behalf of the Company or deposit the advance into the Company’s account. The amended note, requires the Company to repay the amended note, in full, on the earlier of (i) November 1, 2024, and (ii) the consummation of the merger between Kustom Entertainment and CL Merger Sub, Inc. (“CL Merger Sub”) pursuant to the merger agreement among the Company, Kustom Entertainment, Clover Leaf Capital Corp. the Company is also required to pay in arrears in cash an amount equal to 50% of revenues from all ticket sales generated by Kustom Entertainment, up to nine thousand tickets sold, and thereafter equal to 10% of all revenues from all ticket sales until the earlier of the date on which the amended note is repaid in full or the November 1, 2024 maturity date. The Company has the right, but not the obligation, under the amended note to prepay the amended note, upon written notice to the Company, by payment in full of the entire outstanding principal balance plus interest. Furthermore, pursuant to the amended note, the parties agreed to extend the repayment date of $ 100,000 , by the Company to the note holder, from September 26, 2024, to October 10, 2024. The Company was unable to make certain required payments under the terms of the amended note. On October 22, 2024, the Company received a Default and Reservation Letter (the “Default Notice”) from counsel for the administrative agent for the amended note, (i) notifying the Company that it was in default under the amended note for, among other reasons, failing to make a $ 100,000 payment that was due on October 10, 2024, (ii) accelerating all principal and interest payments due under the amended note, and (iii) demanding the Borrowers enter into a lockbox control agreement within ten (10) business days of the date of the Default Notice. As of the date of the Default Notice, the outstanding obligation of the Company under the amended note was approximately $ 1,600,000 . On October 24, 2024, the Company received a Notice of UCC Article 9 Public Sale (the “Sale Notice”) from counsel to the administrative agent for the amended note notifying the Company that it intended to conduct a public sale of the collateral securing the Company’s obligations under the Note and Security Agreement on November 5, 2024. As further described below (see Securities Purchase Agreement and Senior Secured Promissory Notes ), the Company raised sufficient funds through a private placement which closed on November 7, 2024, to repay the amended note in full. The Company’s full repayment of the outstanding obligations under such amended note effectively cured all defaults under the Agreement and terminated the public sale process of the collateral securing the Borrowers’ obligations thereunder. During the year ended December 31, 2024, the Company amortized $ 384,302 of debt discount under interest expense. The Company recorded total losses of $ 684,512 from the extinguishments of such debt during the year ended December 31, 2024. 2024 Securities Purchase Agreement and Senior Secured Promissory Notes On November 6, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell to such Purchasers, in a private placement transaction, (i) senior secured promissory notes in aggregate principal amount of $ 3,600,000 (the “Notes”), and (ii) 135 shares (the “Commitment Shares”) of the Company’s Common Stock, for aggregate gross proceeds of approximately $ 3.0 million, before deducting placement agent fees and other offering expenses payable by the Company. This private placement closed on November 7, 2024 (the “Closing Date”). F- 29 Pursuant to the SPA, the Company was required to use approximately $ 2,015,623 of the net proceeds from the private placement to pay, in full, all liabilities, obligations and indebtedness owing by the Company and its subsidiary, Kustom Entertainment, Inc., to Mosh Man, LLC (the “Borrower”). See Merchant Cash Advances – Entertainment Segment. The Company’s full repayment of the outstanding obligations under such promissory note effectively cured all defaults under the promissory note and terminated the public sale process of the collateral securing the Borrowers’ obligations thereunder. The Company’s recorded a loss of $ 374,007 from the extinguishment of such debt during the year ended December 31, 2024. Pursuant to the SPA, the Company was required to file within 30 days of the Closing Date a registration statement with the SEC for a public offering and use its reasonable best efforts to pursue and consummate a follow-on financing transaction within 90 days of the Closing Date. The proceeds of the public offering were first used for the repayment of the principal amounts of the Notes. The Company was also required to file within 30 days of the Closing Date a registration statement on Form S-1 (or other appropriate form if the Company is not then S-1 eligible) providing for the resale by the Purchasers of the Commitment Shares issued under the SPA. The Company is required to use commercially reasonable efforts to cause such registration statement to become effective within 60 days following the filing thereof and to keep such registration statement effective at all times until no Purchaser owns any Commitment Shares. Furthermore, pursuant to the SPA, the Company was required to complete the following: (i) the Company’s board of directors approved an amendment to the Company’s bylaws setting the quorum required for a special meeting of stockholders to one-third of all stockholders entitled to vote at such special meeting and (ii) the Company filed with the SEC a preliminary proxy statement on Schedule 14A announcing a meeting of stockholders for the purpose of approving the Series A and Series B warrants issued by the Company on June 25, 2024. See Note 17, Common Stock Purchase Warrants. The senior secured promissory notes mature ninety (90) days following their issuance date (the “Maturity Date”) and shall accrue no interest unless and until an Event of Default (as defined in the senior secured promissory notes) has occurred, in which case interest shall accrue at a rate of 14% per annum during the pendency of such Event of Default. In addition, upon customary Events of Default, the Purchasers may require the Company to redeem all or any portion of the senior secured promissory notes in cash with a 125% redemption premium. The Purchasers may also require the Company to redeem all or any portion of the senior secured promissory notes in cash upon a Change of Control, as defined in the senior secured promissory notes, at the prices set forth therein. Upon a Bankruptcy Event of Default (as defined in the senior secured promissory notes), the Company shall immediately pay to the Purchasers an amount in cash representing 100% of all outstanding principal, accrued and unpaid interest , if any, in addition to any and all other amounts due under the senior secured promissory notes, without the requirement for any notice or demand or other action by the Purchaser or any other person. If the Company engages in one or more subsequent financings while the senior secured promissory notes are outstanding, the Company will be required to use at least 100 % of the gross proceeds of such financing to redeem all or any portion of the senior secured promissory notes outstanding. The Company may also prepay the senior secured promissory notes in whole or in part at any time or from time to time. The senior secured promissory notes also contain customary representations and warranties and covenants of each of the parties. Subject to certain exceptions, the senior secured promissory notes are secured by a first lien and continuing security interest in and to the Collateral (as defined in the senior secured promissory notes). The net proceeds of the private placement on November 7, 2024 was $ 2,669,250 (after $ 330,750 deduction of costs of the offering). The Company allocated the net proceeds from the private placement of the senior secured promissory notes and the commitment shares based upon their relative fair values as of the date of issuance as follows: SCHEDULE OF ALLOCATED NET PROCEEDS FROM PRIVATE PLACEMENT OF SENIOR SECURED PROMISSORY NOTES AND COMMITMENT SHARES Amount Allocated to the following: Senior secured promissory notes $ 2,129,795 Commitment shares 539,455 Total $ 2,669,250 F- 30 The Company paid the senior secured promissory notes off in full on February 13, 2025 with funds generated by the February 2025 public equity offering (See Note 12). Following is an analysis of the senior secured promissory notes balance: SCHEDULE OF SENIOR SECURED PROMISSORY NOTES BALANCE Amount Balance, as of December 31, 2023 $ — Principal payment - Issuance of senior secured promissory notes, at par 3,600,000 Discount recognized at issuance date ( 1,470,205 ) Amortization of discount 805,486 Balance, as of December 31, 2024 2,935,281 Amortization of discount 664,719 Principal payment ( 3,600,000 ) Balance, as of December 31, 2025 $ — 2025 Senior Secured Convertible Note and Committed Equity Financing On September 15, 2025, the Company entered into a Securities Purchase Agreement with an institutional investor (the “Purchaser”), pursuant to which the Company issued Senior Secured Convertible Notes (the “2025 Secured Notes”) with an aggregate original principal amount of $ 802,500 , which reflects a 7 % original issue discount applied to gross proceeds of $ 750,000 , and detachable common stock purchase warrants to purchase 158,856 shares of the Company’s common stock at an exercise price of $ 6.372 per share. See Note 17, Common Stock Purchase Warrants. The 2025 Secured Notes bear interest at 8 % per annum. The 2025 Secured Notes are convertible at the investor’s option at any time at a conversion price equal to a 10 % discount to the five-day volume-weighted average price (VWAP) preceding conversion, subject to customary anti-dilution and price-based adjustment provisions. The Company may, subject to certain conditions, redeem all or a portion of the Notes at 110 % of the outstanding principal amount. A second closing of Senior Secured Convertible Notes with an original principal balance of $ 267,500 occurred on December 16, 2025, with 49,043 detachable common stock purchase warrants to purchase shares of the Company’s common stock at an exercise price of $ 6.372 per share. See Note 17, Common Stock Purchase Warrants . The second closing of the 2025 Secured Notes were issued at a 7 % original issue discount, providing gross proceeds of $ 250,000 , and bear interest at 8 % per annum. The 2025 Secured Notes are senior secured obligations, ranking senior to all existing and future indebtedness of the Company, except for specified subsidiaries that provide either a second-priority or no security interest. The Notes are secured by substantially all of the Company’s assets and guaranteed by certain subsidiaries. In connection with the transaction, the Company also entered into a Registration Rights Agreement and a Leak-Out Agreement with customary terms and conditions. The conversion price of the 2025 Secured Notes is variable, equal to a 10% discount to the five-day VWAP preceding conversion, and accordingly does not meet the fixed-for-fixed requirement under ASC 815-40, Derivatives and Hedging: Contracts in an Entity’s Own Equity . As a result, the conversion feature was bifurcated from the host debt instrument and recognized as a derivative liability at fair value under ASC 815-15 , Derivatives and Hedging: Embedded Derivatives . The detachable warrants were similarly classified as derivative liabilities at fair value under ASC 815-40, as their terms include provisions that could require net cash settlement upon a qualifying tender offer. Upon issuance, the aggregate fair value of these derivative liabilities was $ 852,675 . Both derivative liabilities are remeasured at fair value each reporting period, with changes recognized in earnings. See Note 11, Fair Value Measurement , for the Level 3 derivative liability activity related to the bifurcated conversion feature and detachable warrants during the year ended December 31, 2025. At the September 2025 closing, the fair value of the bifurcated conversion feature exceeded the net proceeds of $ 610,000 ; accordingly, no proceeds were allocated to the host debt instrument or the detachable warrants, and the excess of $ 128,246 was recognized immediately as a day-one charge within the change in fair value of derivative liabilities in the consolidated statements of operations. The full face value of $ 802,500 was recorded as a debt discount at the September 2025 closing. At the December 2025 closing, a debt discount of $ 244,425 was recorded. The debt discounts are amortized to interest expense over the term of the 2025 Secured Notes using the effective-interest method. F- 31 The aggregate original principal amount of the 2025 Secured Notes of $ 1,070,000 represents the combined face value of both closings. The combined net proceeds were $ 832,500 , consisting of $ 610,000 from the September 2025 closing, net of $ 140,000 in transaction costs, and $ 222,500 from the December 2025 closing, net of $ 27,500 in transaction costs. Following is an analysis of the 2025 Senior Notes balance: SCHEDULE OF SENIOR NOTES BALANCE Amount Balance, as of December 31, 2024 $ — Issuance of 2025 Senior Notes, at par 1,070,000 Discount recognized at issuance date ( 1,046,925 ) Amortization of discount 156,209 Balance, as of December 31, 2025 $ 179,284 NOTE 11. FAIR VALUE MEASUREMENT In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business. ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: ● Level 1 — Quoted prices in active markets for identical assets and liabilities ● Level 2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities) ● Level 3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value) The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 and December 31, 2024: SCHEDULE OF FINANCIAL ASSETS AND LIABILITIES MEASURED AT FAIR VALUE ON RECURRING BASIS December 31, 2025 Level 1 Level 2 Level 3 Total Liabilities: Warrant derivative liabilities $ — $ — $ 852,844 $ 852,844 $ — $ — $ 852,844 $ 852,844 December 31, 2024 Level 1 Level 2 Level 3 Total Liabilities: Warrant derivative liabilities $ — $ — $ 4,554,640 $ 4,554,640 $ — $ — $ 4,554,640 $ 4,554,640 F- 32 The following table represents the change in Level 3 tier value measurements for warrant derivative liabilities: SCHEDULE OF FAIR VALUE MEASUREMENTS CHANGE IN LEVEL 3 INPUTS Year Ended December 31, 2025 Balance, December 31, 2024 $ 4,554,640 Issuance of pre-funded warrant derivative liabilities in February 2025 public equity offering 1,803 Issuance/Activation of Series A Warrants issued in connection with the February 2025 public equity offering 1,340,214 Issuance/Activation of Series B Warrants issued in connection with the February 2025 public equity offering 5,406,408 Issuance of derivative liabilities in connection with the 2025 Senior Secured Convertible Notes 852,675 Transition of warrant derivative liability to equity due to exercise of pre-funded warrant derivative liabilities in February 2025 public equity offering ( 1,803 ) Transition of warrant derivative liability to equity due to exercise of Series B common stock purchase warrants issued in June 2024 Private Placement ( 1,989,806 ) Transition of warrant derivative liability to equity due to exercise of Series B common stock purchase warrants issued in February 2025 Public Equity Offering ( 5,406,320 ) Transition of warrant derivative liability to equity due to elimination of net cash settlement provisions relative to the Series A common stock purchase warrants issued in February 2025 Public Equity Offering ( 530,101 ) Change in fair value of bifurcated embedded derivative liabilities ( 43,250 ) 2,075,300 454,150 ( 584,955 ) Change in fair value of warrant derivative liabilities ( 3,331,616 ) Balance, December 31, 2025 $ 852,844 Year Ended December 31, 2024 Balance, December 31, 2023 $ 1,369,738 Issuance of Series A and pre-funded warrant derivative liabilities in June 2024 Private Placement 2,075,300 Issuance of Series B warrant derivative liabilities in June 2024 Private Placement upon Stockholder Approval 454,150 Transition of warrant derivative liability to equity due to exercise of common stock purchase warrants ( 584,955 ) Change in fair value of warrant derivative liabilities 1,240,407 Balance, December 31, 2024 $ 4,554,640 F- 33 NOTE 12. ACCRUED EXPENSES Accrued expenses consisted of the following at December 31, 2025 and 2024: SCHEDULE OF ACCRUED EXPENSES December 31, 2025 December 31, 2024 Accrued warranty expense $ — $ 11,615 Accrued payroll and related fringes 94,120 428,380 Accrued sales returns and allowances — 93,170 Accrued taxes 117,145 104,404 Accrued interest - related party — 492,177 Accrued interest 51,300 — Accrued board of directors’ fees 160,000 197,000 Customer deposits 101,387 165,779 General accrued expense 68,733 5,064 Total accrued expenses $ 592,685 $ 1,497,589 Accrued warranty expense was comprised of the following for the years ended December 31, 2025 and 2024: SCHEDULE OF ACCRUED WARRANTY EXPENSE 2025 2024 Beginning balance $ 11,615 $ 17,699 Provision for warranty expense — 38,898 Charges applied to warranty reserve ( 11,615 ) ( 44,982 ) Ending balance $ — $ 11,615 NOTE 13. INCOME TAXES The components of income tax provision (benefit) for the years ended December 31, 2025 and 2024 are as follows: SCHEDULE OF COMPONENTS OF INCOME TAX PROVISION (BENEFIT) 2025 2024 Current taxes: Federal $ — $ — State — — Total current taxes — — Deferred tax provision (benefit) — — Income tax provision (benefit) $ — $ — Allocated to: Continuing operations $ — $ — Discontinued operations — — Total $ — $ — F- 34 A reconciliation of the income tax (provision) benefit at the statutory rate of 21% for the years ended December 31, 2025, and 2024 to the Company’s effective tax rate is as follows: SCHEDULE OF RECONCILIATION OF INCOME TAX (PROVISION) BENEFIT 2025 2024 U.S. Statutory tax rate 21.0 % 21.0 % State taxes, net of Federal benefit 6.0 % 6.0 % Change in valuation reserve on deferred tax assets ( 28.0 )% ( 21.6 )% Non allowable expenses and excludable income ( 0.3 )% — % Expiring net operating loss and tax credit carryforwards ( 2.2 )% — % Other, net 3.5 % ( 5.4 )% Income tax (provision) benefit — % — % The effective tax rate for the years ended December 31, 2025, and 2024 varied from the expected statutory rate due to the Company continuing to provide a 100 % valuation allowance on net deferred tax assets. The Company determined that it was appropriate to continue the full valuation allowance on net deferred tax assets as of December 31, 2025, primarily because of the current year operating losses. Significant components of the Company’s deferred tax assets (liabilities) as of December 31, 2025 and 2024 are as follows: SCHEDULE OF SIGNIFICANT COMPONENTS OF DEFERRED TAX ASSETS (LIABILITIES) 2025 2024 Deferred tax assets: Stock-based compensation $ 50,000 $ 540,000 Start-up costs 110,000 110,000 Inventory reserves 475,000 535,000 - Investment in subsidiaries — 185,000 Intangible assets 175,000 — Research & development expenses 845,000 1,030,000 Allowance for doubtful accounts receivable 20,000 60,000 Property, plant and equipment depreciation — 90,000 Deferred revenue 2,100,000 2,340,000 Accrued litigation reserve 1,060,000 985,000 Accrued expenses 15,000 60,000 Net operating loss carryforward 41,530,000 39,275,000 Research and development tax credit carryforward 1,685,000 1,740,000 State jobs credit carryforward 235,000 230,000 Charitable contributions carryforward 115,000 115,000 Uniform capitalization of inventory costs 15,000 15,000 Total deferred tax assets 48,430,000 47,310,000 Valuation reserve ( 47,955,000 ) ( 46,290,000 ) Total deferred tax assets 475,000 1,020,000 Deferred tax liabilities: Investment in subsidiaries ( 305,000 ) — Property, plant and equipment depreciation ( 30,000 ) — Warrant derivative liabilities — ( 650,000 ) Intangible assets — ( 230,000 ) Domestic international sales company ( 140,000 ) ( 140,000 ) Total deferred tax liabilities ( 475,000 ) ( 1,020,000 ) Net deferred tax assets (liability) $ — $ — The valuation allowance on deferred tax assets totaled $ 47,955,000 and $ 46,290,000 as of December 31, 2025, and 2024, respectively. The Company records the benefit it will derive in future accounting periods from tax losses and credits and deductible temporary differences as “deferred tax assets.” In accordance with ASC 740, “Income Taxes,” the Company records a valuation allowance to reduce the carrying value of our deferred tax assets if, based on all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company incurred operating losses in 2025 and 2024 and it continues to be in a three-year cumulative loss position at December 31, 2025 and 2024. Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it determined to fully reserve its deferred tax assets at December 31, 2025. The Company expects to continue to maintain a full valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets. To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed. Such a reversal would be recorded as an income tax benefit and, for some portion related to deductions for stock option exercises, an increase in shareholders’ equity. As of December 31, 2025, the Company had the following estimated Federal net operating loss carry-forwards available to offset future taxable income: SCHEDULE OF FEDERAL NET OPERATING LOSS CARRY FORWARDS Amount Tax years generated: 2017 and before $ 48,890,000 2018 and after 119,515,000 Federal net operating loss carry-forwards available $ 168,405,000 Such tax net operating loss carry-forwards expire between 2026 and 2037 relative to Federal net operating loss carry-forwards generated in tax years 2017 and prior. Federal net operating loss carry-forwards generated in tax years 2018 and after cannot be carried back to prior years and have an indefinite life since the enactment of the Tax Cuts and Jobs Act of 2017. The Tax Cuts and Jobs Act of 2017 further provides for an annual limitation on usage equivalent to 80% of taxable income. In addition, the Company had research and development tax credit carry-forwards totaling $ 1,685,000 available as of December 31, 2025, which expire between 2026 and 2037 . In July 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted into law in the U.S. The OBBBA includes numerous provisions that affect corporate taxation, including changes to bonus depreciation, the expensing of domestic research costs, and modifications to certain U.S. international tax rules. The Company has analyzed the impacts of the OBBBA and reflected them in the current period. These impacts do not have a material effect on the tax rate for the year ended December 31, 2025. The majority of the tax law changes will take effect in future years. The Company’s 2022 federal tax return was recently examined by the Internal Revenue Service resulting in no proposed adjustments. F- 35 NOTE 14. OPERATING LEASE On May 8, 2025, the Company entered into an operating lease with a third party for a warehouse and office used by the Entertainment segment. The lease has a five 5 -year term expiring in May 2030 and provides for base monthly rent of $ 16,035 , subject to annual increases of 2.5%, with May 2025 rent prorated. The Company prepaid one year of rent, real estate taxes, and insurance totaling $ 247,105 , which is applied to the first and final six months of the lease term, and also provided a $ 20,000 security deposit. The lease is structured as a triple-net lease, under which the Company is responsible for all real estate taxes, insurance, utilities, and other operating costs associated with the premises; real estate taxes for the period from lease commencement through December 31, 2025 were approximately $ 3,748 per month and insurance costs were approximately $ 432 per month, both subject to annual adjustment. The lease includes renewal options and an option to purchase the property after the 33rd month of the lease term. As of December 31, 2025, the remaining lease term was approximately 52 months. In October 2023, the Company entered into an operating lease with a third party for copiers used for office and warehouse purposes. The lease originally provided for 48 monthly payments of $ 1,786 with a scheduled maturity in October 2027 and included an option to purchase the equipment at fair market value at maturity. The lease was terminated effective December 15, 2025, and accordingly, there was no remaining lease term outstanding as of December 31, 2025. On November 27, 2024, the Company entered into an operating lease with a third party for a copier used for office purposes. The lease provides for 36 monthly payments of $ 90 and matures on November 27, 2027 . The Company has the option to purchase the equipment at its estimated fair market value at maturity. As of December 31, 2025, the remaining lease term was approximately twenty-three 23 months. On October 16, 2024, the Company entered into an operating lease with a third party for office space used by the Entertainment segment and temporarily by the Video Solutions segment. The lease provides for 36 monthly payments of $ 7,251.92 and matures on October 31, 2027 . As of December 31, 2025, the remaining lease term was approximately twenty-two 22 months. On May 13, 2020, the Company entered into an operating lease for warehouse and office space that served as its principal executive office and primary business location. On September 16, 2024, the Company and the landlord agreed to terminate the lease, and the Company recognized a net gain on lease extinguishment of $ 9,385 for the year ended December 31, 2024. In connection with the September 2021 acquisition of Goody Tickets, LLC and TicketSmarter, LLC, the Company assumed responsibility for TicketSmarter’s office space lease. The lease was formally terminated in September 2025, and no separate lease obligation related to this location remained outstanding as of December 31, 2025. Lease expense related to the Company’s office space and copier operating leases was recorded on a straight-line basis over the lease term. Total lease expense of $ 274,272 for the year ended December 31, 2025 includes expense under all operating leases active during the period, including partial-year expense under the copier lease that was terminated effective December 15, 2025. F- 36 The weighted-average remaining lease-term related to the Company’s lease liabilities as of December 31, 2025 and December 31, 2024 were 3.6 years and 2.8 years, respectively. The discount rate implicit within the Company’s operating leases was not generally determinable, and therefore, the Company determined the discount rate based on its incremental borrowing rate on the information available at commencement date. As of the commencement date, the operating lease liabilities reflect a weighted average discount rate of 8 %. The following sets forth the operating lease right of use assets and liabilities as of December 31, 2025: SCHEDULE OF OPERATING LEASES RIGHT OF USE ASSETS AND LIABILITIES Assets: Operating lease right of use assets, net $ 1,022,416 Prepayment of rent 82,368 Total operating lease right of use asset $ 1,104,784 Liabilities: Operating lease obligations-current portion 180,900 Operating lease obligations-less current portion 841,516 Total operating lease obligations $ 1,022,416 Following are the minimum lease payments for each year and in total. SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS Year ending December 31: 2026 $ 258,429 2027 332,285 2028 263,789 2029 268,927 2030 and thereafter 90,218 Total undiscounted minimum future lease payments 1,213,648 Imputed interest ( 191,232 ) Total operating lease liability $ 1,022,416 NOTE 15. COMMITMENTS AND CONTINGENCIES Litigation. From time to time, the Company is notified that the Company may be a party to a lawsuit or that a claim is being made against them. It is its policy not to disclose the specifics of any claim or threatened lawsuit until the summons and complaint are actually served on the Company. After carefully assessing the claim, and assuming the Company determines that they are not at fault or disagrees with the damage or relief demanded, they vigorously defend any lawsuit filed against them. The Company records a liability when losses are deemed probable and reasonably estimable. When losses are deemed reasonably possible but not probable, they determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, they take into consideration factors such as its historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood of its prevailing, the availability of insurance, and the severity of any potential loss. The Company reevaluates and update accruals as matters progress over time. Culp McAuley, Inc. et al. On May 31, 2022, the Company filed a lawsuit against Culp McAuley, Inc. (“Culp McAuley”) and four individuals (Brandon Culp, Campbell McAuley, Mark Depew and Larry Roberts) (collectively the “defendants”) in the United States District Court for the District of Kansas, seeking monetary damages and injunctive relief based on certain conduct by the defendants. On July 18, 2022, Culp McAuley filed its Answer to the Company’s Verified Complaint and included Counterclaims alleging breach of contract and seeking monetary damages. On August 8, 2022, the Company filed its Reply and Affirmative Defenses to the Counterclaims by, among other things, denying the allegations and any and all liability. F- 37 On December 20, 2022, the Company filed a motion for leave to file a second amended complaint to add additional claims against the defendants to avoid fraudulent transfers, to pierce the corporate veil of Culp McAuley, and for remedies related to the claims for fraudulent transfers and piercing the corporate veil. On December 22, 2022, the Court issued an Order granting the Company’s motion for leave to file a second amended complaint, which was filed with the Court on December 27, 2022. Because Culp McAuley’s original counsel withdrew, Culp McAuley was ordered to obtain new counsel on or before December 2, 2022. On December 5, 2022, the Court ordered that Culp McAuley show cause in writing by December 21, 2022, why the Court should not direct the Clerk to enter default against it. On December 22, 2022, the Court directed the Clerk to enter default against Culp McAuley. On February 21, 2023, the Clerk entered default against Culp McAuley. In February and March, 2023, defendants Larry Roberts and Mark Depew filed separate motions to dismiss, respectively. The Company opposed both motions. On July 7, 2023, the Court issued an Order granting Roberts’ motion to dismiss and denying Depew’s motion to dismiss. On December 7, 2023, the Company filed an application for the Clerk’s entry of default against defendant Brandon Culp. On December 13, 2023, the Clerk entered default against Brandon Culp. On January 5, 2024, the Company filed a motion for summary judgment against defendants Campbell McAuley and Mark Depew. On the same date, the Company also filed separate motions for default judgment against Culp McAuley and Brandon Culp, respectively. On January 5, 2024, defendant Mark Depew filed a motion for summary judgment against the Company. On May 17, 2024, the Court issued Orders which, respectively, (i) granted defendant Mark Depew’s motion for summary judgment against the Company; (ii) denied the Company’s motion for summary judgment against Depew; (iii) granted the Company’s motion for summary judgment against defendant Campbell McAuley; and (iv) granted the Company’s motions for default judgment against defendants Culp McAuley and Brandon Culp. Finding that defendants Brandon Culp and Campbell McAuley were each the alter ego of Culp McAuley, on June 4, 2024, the Court entered judgment in favor of the Company in the amount of $ 3,999,984 against Culp McAuley, Brandon Culp, and Campbell McAuley, jointly and severally (the “judgment”). The Company is currently uncertain as to what amount, if any, of the judgment amount it will ultimately be able to recover. The Company continues to explore for sources of assets as a possible source of collection from the judgment debtors. On June 14, 2024, the Company filed a Notice of Appeal to the United States Court of Appeals for the Tenth Circuit from the Court’s May 17, 2024 Order that granted summary judgment in favor of Mark Depew. On December 10, 2024, the Company and Depew filed a Stipulation of Dismissal in the Tenth Circuit that ended the appeal after the Company and Depew reached a settlement. As of December 31, 2025, the Company holds an unsatisfied judgment of $ 3,999,984 against Culp McAuley, Brandon Culp, and Campbell McAuley, jointly and severally. The Company continues to explore available sources of assets from the judgment debtors; however, collection of the judgment remains uncertain and no assurance can be given that any amounts will be recovered. The Company recorded a loss of $ 1,959,396 on this matter during the year ended December 31, 2024, which, together with losses recorded in prior years, reduced the Company’s cumulative net exposure to zero as of December 31, 2024. No additional losses were recorded on this matter during the year ended December 31, 2025, and the Company’s net exposure remained zero as of December 31, 2025. The Company’s estimate with respect to the aggregate reasonably possible loss is based upon currently available information and is subject to significant judgment and a variety of assumptions and known and unknown uncertainties. As a result, actual results may vary significantly from the current estimate. Larry Roberts In March 2024, the Company filed a complaint against Larry Roberts in the Superior Court of the State of California, County of Orange, Case No. 30-2024-01385012-CU-FR-CJC. The lawsuit arises from the defendant’s alleged theft and misapplication of funds that were intended for the purchase of goods on behalf of the Company. The Company seeks monetary damages based on certain conduct by the defendant. On May 28, 2024, the defendant filed a motion to strike portions of the complaint and a motion for demurrer. On October 4, 2024, the Court sustained in part and overruled in part defendant’s motion for demurrer. The Court further denied the defendant’s motion to strike in its entirety. Discovery is ongoing. A jury trial has been scheduled for October 19, 2026. The Company is not able to provide an estimate of the likelihood of success at this time. The matter remains open. Pharmaxx Medical, Inc. The Company filed a complaint against Pharmaxx Medical, Inc. in the Superior Court of the State of California, County of Riverside, Case No. CVSW2300198, alleging breach of contract arising from the failure to deliver pharmaceutical gloves. After the court struck the defendant’s answer, the Company submitted the default package to obtain a default judgment against the defendant. The default package remains pending with the court. As of December 31, 2025, the Company recorded a litigation receivable of $ 578,890 related to this matter, against which an allowance of $ 289,445 has been established. See Note 4. Other Receivable F- 38 First Insurance Funding Corp. — Johnson County Collection Case The Company is a defendant in a collection case filed in the District Court of Johnson County, Kansas limited actions department. This is a collection lawsuit claiming the Company owed money for insurance premium funding on a cancelled policy totaling $165,890.08. Digital disputed it owes the money as they cancelled the insurance policy through their insurance broker. An answer was filed denying the claim. The matter remains open. Gregory Johnson — Kansas Department of Labor Gregory Johnson filed a claim with the State of Kansas, Wage and Hour Division, Claim No. 240591, seeking $30,000 for alleged severance pay. Mr. Johnson was laid off in a reduction in force and did not have a severance agreement. An answer denying the claim has been filed. A hearing was held on October 27, 2025 before an Administrative Law Judge, with the matter being dismissed in the Company’s favor. Kustom 440 — Former Consultant A former consultant has filed a claim against Kustom 440, Inc., a wholly owned subsidiary of the Company, seeking to compel payment under an alleged consulting agreement. The Company is currently engaged in settlement negotiations. The matter remains open. Artist Performance Commitments In January 2026, Kustom 440, Inc., a wholly owned subsidiary of the Company, entered into a performance agreement with a headlining artist for the 2026 Country Stampede music festival scheduled for June 27, 2026. The agreement provides for a flat performance guarantee of $750,000, payable in installments consisting of a deposit of $187,500 paid upon execution, a second deposit of $187,500 due no later than May 27, 2026, and a remaining balance of $375,000 payable following the performance. The agreement does not provide for cancellation except in the event of force majeure or material breach by either party. As of December 31, 2025, no amounts had been paid or accrued under this agreement. NOTE 16. STOCK-BASED COMPENSATION The Company recorded pre-tax compensation expense related to the grant of stock options and restricted stock issued of $ 39,622 and $ 128,519 for the years ended December 31, 2025 and 2024, respectively. As of December 31, 2025, the Company has adopted various stock option and restricted stock plans which are referred to as the “Plans.” The Company registers all shares of common stock that are issuable under its Plans with the SEC. A total of 125,021 shares remain available for awards under the various Plans as of December 31, 2025. Stock option grants. The Company believes that award of stock options better align the interests of our employees with those of its stockholders. Option awards have been granted with an exercise price equal to the market price of its stock at the date of grant with such option awards which generally vest based on the completion of continuous service and have ten-year contractual terms. These option awards typically provide for accelerated vesting if there is a change in control (as defined in the Plans). F- 39 The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model. Activity involving the award of stock options during the years ended December 31, 2025 and 2024 is reflected in the following table: SCHEDULE OF STOCK OPTIONS OUTSTANDING Options Number of Shares Weighted Average Exercise Price Outstanding at January 1, 2025 9 $ 270,840 Granted — — Exercised — — Forfeited — — Outstanding at December 31, 2025 9 $ 270,840 Exercisable at December 31, 2025 9 $ 270,840 Options Number of Shares Weighted Average Exercise Price Outstanding at January 1, 2024 10 $ 273,300 Granted — — Exercised — — Forfeited ( 1 ) ( 390,000 ) Outstanding at December 31, 2024 9 $ 270,840 Exercisable at December 31, 2024 9 $ 270,840 The fair value of each option award is estimated on the date of grant using a Black-Scholes option valuation model. The Plans allow for the cashless exercise of stock options. This provision allows the option holder to surrender/cancel options with an intrinsic value equivalent to the purchase/exercise price of other options exercised. There were no shares surrendered pursuant to cashless exercises during the years ended December 31, 2025 and 2024. No compensation expense was recognized for stock options during the years ended December 31, 2025 and 2024, as all outstanding options were fully vested in prior periods. As of December 31, 2025 and 2024, no outstanding or exercisable options had intrinsic value, as all exercise prices exceeded the market price of the Company’s common stock on those dates. The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of December 31, 2025: SCHEDULE OF SHARES AUTHORIZED UNDER STOCK OPTION PLANS BY EXERCISE PRICE RANGE Outstanding options Weighted average Exercisable options Weighted average Exercise price range Number of options remaining contractual life Number of options remaining contractual life $ 0.01 to $ 249,999 3 5.5 years 3 5.5 years $ 250,000 to $ 349,999 3 4.0 years 3 4.0 years $ 350,000 to $ 364,000 3 2.8 years 3 2.8 years Total 9 4.1 years 9 4.1 years Restricted stock grants. The Board of Directors has granted restricted stock awards under the Plans. Restricted stock awards are valued on the date of grant and have no purchase price for the recipient. Restricted stock awards typically vest over one to four years corresponding to anniversaries of the grant date. Under the Plans, unvested shares of restricted stock awards may be forfeited upon the termination of service to or employment with the Company, depending upon the circumstances of termination. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive cash dividends. F- 40 A summary of all restricted stock activity under the equity compensation plans for the years ended December 31, 2025 and 2024 is as follows: SCHEDULE OF RESTRICTED STOCK ACTIVITY Number of Restricted shares Weighted average grant date fair value Nonvested balance, January 1, 2025 20 $ 13,916 Granted — — Vested ( 10 ) ( 16,024 ) Forfeited — — Nonvested balance, December 31, 2025 10 $ 11,807 Number of Restricted shares Weighted average grant date fair value Nonvested balance, January 1, 2024 21 $ 67,620 Granted 14 12,720 Vested ( 6 ) ( 60,360 ) Forfeited ( 9 ) ( 133,200 ) Nonvested balance, December 31, 2024 20 $ 13,916 The Company estimated the fair market value of these restricted stock grants based on the closing market price on the date of the grant. As of December 31, 2025, there was $ 18,912 of total unrecognized compensation costs related to all remaining non-vested restricted stock grants, which will be amortized over the next twenty-five months in accordance with their respective vesting scale. The nonvested balance of restricted stock vests as follows: SCHEDULE OF NON-VESTED BALANCE OF RESTRICTED STOCK Years ended Number of shares 2027 5 2028 3 2029 2 2030 — 2031 — NOTE 17. COMMON STOCK PURCHASE WARRANTS The following table summarizes information about shares issuable under warrants outstanding during the years ended December 31, 2025 and 2024: SCHEDULE OF WARRANT ACTIVITY Warrants Weighted average exercise price Balance, January 1, 2025 1,813 $ 5,700.00 Issuance February 2025 – Prefunded Warrants 16,358 0.001 Issuance/activation of February 2025 – Series A Warrants 115,946 186.00 Issuance of September 2025 – Detachable Warrants 158,856 6.372 Issuance of December 2025 – Detachable Warrants 49,043 6.372 Issuance/activation of February 2025 – Series B Warrants 556,452 — Exercise February 2025 – Prefunded Warrants ( 16,358 ) 0.001 Exercised June 2024 - Series B warrants ( 632 ) 0.001 Exercised February 2025 – Series B Warrants ( 556,439 ) 0.001 Terminated/Cancelled — — Balance, December 31, 2025 325,039 $ 101.78 F- 41 Warrants Weighted average exercise price Balance, January 1, 2024 184 $ 39,000.00 Issuance – Series A and prefunded warrants 295 15,060.00 Issuance – Series B warrants 795 0.001 Issuance – Series A warrant reset provisions 797 3,012.00 Exercised ( 258 ) ( 5,580.00 ) Terminated/Cancelled — — Balance, December 31, 2024 1,813 $ 5,700.00 The total intrinsic value of all outstanding warrants aggregated $ 25 and $ 2,128,320 as of December 31, 2025 and December 31, 2024, respectively and the weighted average remaining term was 55.4 and 52.3 months as of December 31, 2025 and 2024, respectively. The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares of Common Stock as of December 31, 2025: SCHEDULE OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS Outstanding and exercisable warrants Exercise price Number of warrants Weighted average remaining contractual life $ — 13 1.8 years $ 6.372 207,899 4.8 years $ 186.00 115,946 4.4 years $ 3,012.00 997 3.5 years $ 33,000.00 62 2.3 years $ 39,000.00 62 2.3 years $ 45,000.00 60 2.3 years 325,039 4.6 years September and December 2025 Detachable Purchase Warrants On September 15, 2025, the Company entered into a Securities Purchase Agreement with an institutional investor pursuant to which the Company issued Senior Secured Convertible Notes (the “September 2025 Notes”) (See Note 10) with an aggregate original principal amount of $ 802,500 and detachable common stock purchase warrants to purchase 158,856 shares of the Company’s common stock at an exercise price of $ 6.372 per share. The detachable warrants issued in connection with the September 2025 Notes have a term of five years from the date of issuance. On December 16, 2025, the Company completed the second closing under the Securities Purchase Agreement and issued additional Senior Secured Convertible Notes with an aggregate original principal amount of $ 267,500 together with detachable common stock purchase warrants to purchase 49,043 shares of the Company’s common stock at an exercise price of $ 6.372 per share. The detachable warrants issued in the December 2025 closing also have a five-year term from the date of issuance. F- 42 Accordingly, as of December 31, 2025, the Company had a total of 207,899 detachable warrants outstanding related to the September and December 2025 financings, each exercisable at $ 6.372 per share. See Note 10, Debt Obligations , and Note 11, Fair Value Measurement , for additional details regarding these warrants during the year ended December 31, 2025. February 2025 Purchase Warrants On February 13, 2025, the Company issued 16,358 pre-funded units, each consisting of one-prefunded warrant (to purchase a total of 16,358 shares of Common Stock, inclusive of the underwriter’s overallotment exercise), one Series A warrant and one Series B warrant along with the sale of 1,309 units, each consisting of one share of Common Stock, one Series A warrant and one Series B warrant, for an aggregate issuance of 16,667 Series A warrants and 16,667 Series B warrants prior to the application of reset provisions. The Series A and Series B warrants were exercisable only upon receipt of stockholder approval to approve each of (i) certain terms in the Series A warrants and Series B warrants and the issuance of the shares of Common Stock issuable upon the exercise of such warrants, as may be required by the applicable rules and regulations of The Nasdaq Stock Market LLC and (ii) if necessary, a proposal to amend the Company’s Articles of Incorporation, as amended, to increase the authorized share capital of the Company to an amount sufficient to cover the shares of Common Stock issuable upon the exercise of the Series A warrants and Series B warrants. The Series A Warrants were exercisable commencing upon the date of public notice of the Stockholder Approval (the “Warrant Stockholder Approval Date”) until five years after the Warrant Stockholder Approval Date, and the Series B Warrants were exercisable commencing upon the Warrant Stockholder Approval Date until two and one-half years after the Warrant Stockholder Approval Date. Both the Series A and Series B warrants contain reset provisions that are activated upon the date Stockholder Approval is obtained. The Company’s Shareholders approved the issuance of the Series A and B warrants at a Special Meeting of Shareholders on May 6, 2025 which serves as the Warrant Stockholder Approval Date. The Series A and B warrant terms provide for net cash settlement outside the control of the Company under certain circumstances. As such, the Company is required to treat the Series A and B warrants as derivative liabilities until such time as the circumstances which allow for settlement outside the control of the Company are terminated or no longer applicable. Warrant derivative liabilities treatment of the Series A and B warrants to be valued at their estimated fair value at their issuance/activation date and at each reporting date with any subsequent changes reported in the consolidated statements of operations as the change in fair value of warrant derivative liabilities. Furthermore, the Company re-values the fair value of warrant derivative liability as of the date the warrant is exercised with the resulting warrant derivative liability transitioned to change in fair value of warrant derivative liabilities through the consolidated statement of operations. The pre-funded warrants were all exercised within days of their issuance. The aggregate fair value of the pre-funded warrants was estimated at $ 1,803 in total, or approximately $ 0.11 per warrant, reflecting the minimal time value associated with the warrants given their $ 0.001 exercise price and extremely short contractual term of approximately 11 days. This fair value at the time of exercise remained the same as their fair value as of the date of issuance. The following are the assumptions used in calculating the estimated fair value of the pre-funded warrants to purchase Common Stock which were effective and exercisable upon issuance on February 13, 2025: SCHEDULE OF WARRANT MODIFICATION Pre funded warrants issuance date – February 13, 2025 assumptions Volatility – range 110.1 % Risk-free rate 4.27 % Dividend — % Remaining contractual term 0.03 years Exercise price $ 0.001 Common stock issuable under the warrants 16,358 As of December 31, 2025, in conjunction with the exercise of the pre-funded warrants, the Company transitioned the related warrant derivative liability totaling $ 1,803 to equity as of their exercise date. The warrant derivative liability related to the pre-funded warrants was $- 0 - as of December 31, 2025. F- 43 The Series A warrants were issued and activated on the Warrant Stockholder Approval Date of May 6, 2025. A total of 115,946 Series A warrants were issued, reflecting the application of reset provisions upon stockholder approval. The aggregate fair value of the Series A warrants was estimated at $ 1,340,214 , or approximately $ 11.56 per warrant, at the time of their issuance and activation. Upon issuance, the $ 1,340,214 fair value was recorded as a warrant derivative liability with a corresponding charge to additional paid-in capital, as the Series A warrants were classified as derivative liabilities due to the net cash settlement provisions described above. The following are the assumptions used in calculating the estimated fair value of the Series A warrants to purchase Common Stock which were effective and exercisable upon the Warrant Stockholder Approval Date of May 6, 2025: Series A warrants issuance/activation date – May 6, 2025 assumptions Volatility – range 158.07 % Risk-free rate 3.87 % Dividend — % Remaining contractual term 5.0 years Exercise price $ 186.00 Common stock issuable under the warrants 115,946 On June 27, 2025, the circumstances under which the Series A warrant terms allow for settlement outside the control of the Company were terminated and no longer applicable. As of that date, 115,932 Series A warrants remained outstanding. The Company determined the fair value of the warrant derivative liability as of June 27, 2025 to be $ 530,101 , or approximately $ 4.57 per warrant, and transitioned that value to equity as the Series A warrants were no longer treated as warrant derivative liabilities. The decline in fair value from $ 1,340,214 at issuance on May 6, 2025 to $ 530,101 at the transition date on June 27, 2025 reflects the decrease in the Company’s common stock price and changes in volatility assumptions over the intervening period, with the $ 810,113 change in fair value recognized as a gain in the consolidated statement of operations during the year ended December 31, 2025. See Note 11 , Fair Value Measurement , for the Level 3 warrant derivative liability activity, including the issuance, fair value changes, and transition to equity of the Series A warrants during the year ended December 31, 2025. The following are the assumptions used in calculating the estimated fair value of the Series A warrants as of the transition date of June 27, 2025: Series A warrants transition date – June 27, 2025 assumptions Volatility – range 154.71 % Risk-free rate 3.79 % Dividend — % Remaining contractual term 4.86 years Exercise price $ 186.00 Common stock issuable under the warrants 115,932 The Series B warrants were issued and activated on the Warrant Stockholder Approval Date of May 6, 2025. Based on the application of reset provisions upon stockholder approval, a total of 556,452 Series B warrants were issued at a zero exercise price. The aggregate fair value of the Series B warrants was estimated at $ 5,406,408 , or approximately $ 9.72 per warrant, at the time of their issuance and activation. Upon issuance, the $ 5,406,408 fair value was recorded as a warrant derivative liability with a corresponding charge to additional paid-in capital. The Series B Warrants contain a zero-exercise price option at the holder’s election. Under the zero-exercise price option, a holder of the Series B Warrant has the right to receive an aggregate number of shares equal to the product of (x) the aggregate number of shares of common stock that would be issuable upon a cash exercise of the Series B Warrant and (y) three (3.0). As a result of this feature, the Company did not receive nor did it expect to receive any cash proceeds from the exercise of the Series B Warrants because it is highly unlikely that a Series B Warrant holder would elect to pay an exercise price in cash to receive one share of common stock when they could elect the alternate cashless exercise option and pay no exercise price to receive more shares of common stock than they would receive if they did pay an exercise price. The following are the assumptions used in calculating the estimated fair value of the Series B warrants as of the Warrant Stockholder Approval Date of May 6, 2025: Series B warrants issuance/activation date – May 6, 2025 assumptions Volatility – range 195.04 % Risk-free rate 3.87 % Dividend — % Remaining contractual term 2.5 years Exercise price $ 0.00 Common stock issuable under the warrants 556,452 F- 44 Of the 556,452 total Series B warrants issued on May 6, 2025, a total of 556,439 warrants were immediately exercised by their holders at a combined fair value of $ 5,406,320 , or approximately $ 9.72 per warrant, and transitioned to equity during the year ended December 31, 2025. As of December 31, 2025, 13 Series B warrants remained outstanding and were remeasured at a fair value of $ 25 in the aggregate, or approximately $ 1.92 per warrant, based on the Company’s closing stock price on December 31, 2025 applied to the shares receivable under the cashless exercise multiplier of 3.0. See Note 11, Fair Value Measurement , for the Level 3 warrant derivative liability activity, including the issuance, fair value changes, and transition to equity of the Series B warrants during the year ended December 31, 2025. 2024 Purchase Warrants On June 25, 2024, the Company issued Series A and prefunded warrants to purchase a total of 295 shares of Common Stock along with the sale of common stock. The Company also issued Series B Warrants that will be issuable and exercisable at any time or times on or after the date Stockholder Approval is obtained in addition to the Series A warrants that are not included in outstanding warrants until such time as Stockholder Approval is obtained. Both the Series A and Series B warrants have reset provisions that are activated upon the date Stockholder Approval is obtained. The warrant terms provide for net cash settlement outside the control of the Company under certain circumstances. As such, the Company is required to treat these warrants as derivative liabilities which are valued at their estimated fair value at their issuance date and at each reporting date with any subsequent changes reported in the consolidated statements of operations as the change in fair value of warrant derivative liabilities. Furthermore, the Company re-values the fair value of warrant derivative liability as of the date the warrant is exercised with the resulting warrant derivative liability transitioned to change in fair value of warrant derivative liabilities through the consolidated statement of operations. During the year ended December 31, 2024, prefunded warrants to purchase 96 shares of common stock were fully exercised. The Series B warrants issued in this transaction became issuable and exercisable on the date Stockholder Approval is obtained. Stockholder approval was obtained on December 17, 2024 which activated the Series B warrants. Both the Series A and Series B warrants also contain price and warrant reset provisions that were activated upon the date of Stockholder Approval. The reset provisions increased the number of common shares issuable under the Series A warrant from 199 to 997 shares and the exercise price per Series A warrant was reduced from $ 3,012.00 to $ 1,004.00 per share effective December 17, 2024. In addition, the Series B warrants became effective and exercisable upon Stockholder Approval on December 17, 2024 which resulted in 795 common shares issuable under the Series B warrants with an exercise price of zero per share effective December 17, 2024. The Company recognized the full Series B warrant derivative liability value of $ 2,865,727 as of the date of Stockholder Approval when it became effective and exercisable of which $ 454,150 was recorded in equity and $ 2,411,577 was charged as a loss in the statement of operations for the year ended December 31, 2024. The following are the assumptions used in calculating the estimated fair value of the detachable Series B warrants to purchase common stock which became effective and exercisable upon Stockholder Approval on December 17, 2024 and on December 31, 2024: Series B issuance date - December 17, 2024 assumptions Series B - December 31, 2024 assumptions Volatility – range 105.5 % 105.7 % Risk-free rate 4.26 % 4.38 % Dividend — % — % Remaining contractual term 4.5 years 4.48 years Exercise price $ 3,000.00 $ 0.001 Common stock issuable under the warrants 795 633 F- 45 During the year ended December 31, 2024, Series B warrants to purchase 162 shares of common stock were fully exercised. In conjunction with the exercise of the Series B warrants, the Company transitioned the related warrant derivative liability totaling $ 584,955 to equity as of their exercise date. The warrant derivative liability related to the Series B warrants was $ 1,989,806 as of December 31, 2024. The change in fair value of the Series B warrant derivative liability from their issuance date through December 31, 2024 totaled $ 290,965 which was included as a loss in the statement of operations for the year ended December 31, 2024. See Note 11, Fair Value Measurement , for the Level 3 warrant derivative liability activity, including the issuance, fair value changes, and transition to equity of the Series B warrants during the year ended December 31, 2024. The Company has utilized the following assumptions in its Black-Scholes option valuation model to calculate the estimated fair value of the derivative liability relative to the prefunded warrants and Series A warrants as of their date of issuance and as of December 31, 2024: Issuance date assumptions December 31, 2024 assumptions Volatility – range 72.1 - 101.1 % 105.7 % Risk-free rate 4.25 – 5.46 % 4.38 % Dividend — % — % Remaining contractual term 0.1 - 5.0 years 4.5 years Exercise price $ 15,060.00 $ 3,012.00 Common stock issuable under the warrants 295 997 The Company recognized the fair value of the Series A warrants of $ 1,998,074 as a warrant derivative liability as of the date of issuance. During the year ended December 31, 2024, there were no Series A warrants exercised. The fair value of the warrant derivative liability related to the Series A warrants was $ 2,408,598 as of December 31, 2024. The change in fair value of the Series A warrant derivative liability from their issuance date through December 31, 2024 totaled $ 410,524 which was included as a loss in the statement of operations for the year ended December 31, 2024. See Note 11, Fair Value Measurement , for the Level 3 warrant derivative liability activity, including the issuance and fair value changes of the Series A warrants during the year ended December 31, 2024. 2023 Purchase Warrants On April 5, 2023, the Company issued warrants to purchase 184 shares of Common Stock, which are classified as derivative liabilities due to net cash settlement provisions outside the control of the Company and are marked to market at each reporting date. As of December 31, 2025, all 184 warrants remain outstanding with exercise prices ranging from $ 33,000.00 to $ 45,000.00 per share and a remaining contractual term of approximately 2.5 years, and are valued at an aggregate fair value of $ 169 , reflecting the significant decline in the Company’s stock price relative to the exercise prices of these warrants. See Note 11, Fair Value Measurement , for the Level 3 warrant derivative liability activity related to these warrants during the year ended December 31, 2025. NOTE 18 - STOCKHOLDERS’ EQUITY 2025 Senior Secured Convertible Notes In September and December 2025, the Company issued Senior Secured Convertible Notes with detachable warrants in two closings. For a full description of the terms, proceeds allocation, and warrant valuation, see Note 10, Debt Obligations, and Note 17, Common Stock Purchase Warrants. Committed Equity Financing (ELOC) On September 15, 2025 (the “Closing Date”), the Company entered into a Common Stock Purchase Agreement (the “ELOC Purchase Agreement”) with an institutional investor (the “ELOC Investor”), providing a committed equity financing facility of up to $ 25 million (the “Total Commitment”) over a 36-month term. Under the agreement, and subject to certain conditions and limitations, the Company may, at its sole discretion, direct the ELOC Investor to purchase shares of its common stock (“Purchase Shares”) from time to time during the term of the facility. There have been no draws under the ELOC facility as of December 31, 2025. F- 46 In connection with the ELOC Purchase Agreement, the Company agreed to pay a total commitment fee of 3 % of the $ 25 million facility or a total of $ 750,000 . In that regard, the Company issued a total of 114,010 common shares valued at $ 227,792 during 2025. The remaining commitment fee of $ 522,208 will be paid through the issuance of additional common shares or through deductions from future cash proceeds from ELOC draws under the facility. February 2025 Public Equity Offering On February 13, 2025, the Company completed an underwritten public offering pursuant to an underwriting agreement with Aegis Capital Corp. The offering consisted of 1,309 units at a public offering price of $ 900.00 per unit and 16,358 pre-funded units at a public offering price of $ 894.00 per pre-funded unit. Each unit consisted of one share of Common Stock, one Series A warrant, and one Series B warrant. Each pre-funded unit consisted of one pre-funded warrant, one Series A warrant, and one Series B warrant. The offering closed on February 14, 2025, with aggregate net proceeds of $ 13,480,000 . The underwriter subsequently exercised its overallotment option, resulting in total aggregate net proceeds of $ 14,308,300 after deducting underwriter fees and other offering expenses. For a description of the Series A and Series B warrant terms and valuation, see Note 17, Common Stock Purchase Warrants. 2024 Issuance of Restricted Common Stock In January 2024, the board of directors approved the grant of 9 shares of common stock to officers of the Company. Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates. Additionally, the board of directors approved the grant of 5 restricted common shares to certain new employees of the Company. Such shares will generally vest over a period of one 1 to two years on their respective anniversary dates in January through January 2026, provided that each grantee remains an employee of the company on such dates. 2024 Private Placement Transaction On June 25, 2024, the Company entered into a private placement transaction (the “Private Placement”), pursuant to a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain institutional investors (the “Purchasers”) for aggregate gross proceeds of approximately $ 2.9 million, before deducting fees to the placement agent and other expenses payable by the Company in connection with the Private Placement. As part of the Private Placement, the Company issued an aggregate of 199 units and pre-funded units (collectively, the “June Units”) at a purchase price of $ 15,060.00 per unit (less $ 0.0001 per pre-funded unit). Each June Unit consists of (i) one share of common stock, par value $ 0.001 per share, of the Company (the “Common Stock”) (or one pre-funded warrant to purchase one share of Common Stock (the “Pre-Funded Warrants”)), (ii) one Series A warrant to purchase one share of Common Stock (the “Series A Warrant”) and (iii) one Series B warrant to purchase such number of shares of Common Stock as will be determined on the Reset Date and in accordance with the terms therein (the “Series B Warrant”, and together with the Series A Warrant, the “Warrants”). Securities Purchase Agreement and Senior Secured Promissory Notes On November 6, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain institutional investors, pursuant to which the Company agreed to issue and sell to such investors, in a private placement transaction, (i) senior secured promissory notes in aggregate principal amount of $ 3,600,000 , and (ii) 135 shares (the “Commitment Shares”) of the Company’s common stock, for aggregate gross proceeds of approximately $ 3.0 million, before deducting placement agent fees and other offering expenses payable by the Company. This private placement closed on November 7, 2024. The net proceeds of the private placement on November 7, 2024 was $ 2,669,250 (after $ 330,750 deduction of costs of the offering). The Company allocated the net proceeds from the private placement of the senior secured promissory notes and the commitment shares based upon their relative fair values as of the date of issuance as follows: Amount Allocated to the following: Senior secured promissory notes $ 2,129,795 Commitment shares 539,455 Total $ 2,669,250 F- 47 Deemed Capital Contribution — Modification of Related Party Notes Payable During the year ended December 31, 2025, the Company recorded an aggregate deemed capital contribution of $ 2,983,298 to additional paid-in capital in connection with three modifications of related party promissory notes. The March 2025 modification of the TicketSmarter related party promissory note eliminated accrued interest of $ 582,203 and resulted in a deemed capital contribution of $ 1,249,372 , and the June 2025 modification of the TicketSmarter related party promissory note reduced the outstanding principal balance and eliminated accrued interest of $ 43,515 , resulting in an additional deemed capital contribution of $ 622,622 . In addition, on June 4, 2025, the Company modified the Goodman Trust related party promissory note, which extended the repayment terms and subordinated all payments to the line of credit, deferring payments to 2037. As a result of the modification, the correct fair value of the debt at the modification date was determined to be $ 372,548 , resulting in a discount of $ 1,627,452 and an additional deemed capital contribution of $ 1,111,304 . Because the holders of these notes are related parties, the forgiveness of accrued interest, principal reductions, and discount adjustments arising from the modifications were treated as capital contributions rather than recognized as income. These transactions are reflected as increases to additional paid-in capital in the consolidated statements of stockholders’ equity for the year ended December 31, 2025. See Note 19, Related Party Transactions, for additional details regarding the terms of each modification. Cancellation of Restricted Stock During the years ended December 31, 2025 and 2024, the Company cancelled - 0 - and 9 shares due to termination of employees, respectively. Exercise of Warrants During the years ended December 31, 2025 and 2024, Series B warrants to purchase 632 shares of Common Stock that were issued in conjunction with the June 2024 public equity offering of Common Stock, were fully exercised for total proceeds of $ 3,793 . In conjunction with the exercise of the Series B warrants, the Company transitioned the related warrant derivative liability totaling $ 1,989,806 to equity as of their exercise date. Reverse Stock Split On May 6, 2025, the Company, acting pursuant to authority received at an annual meeting of its stockholders on December 17, 2024, filed with the Secretary of State of the State of Nevada a certificate of amendment (the “Charter Amendment”) to its articles of incorporation, as amended (the “Articles of Incorporation”), which effected a one-for-twenty reverse stock split (the “Reverse Stock Split”) of all of the Company’s outstanding shares of common stock, par value $ 0.001 per share (the “Common Stock”). Pursuant to the Charter Amendment, the Reverse Stock Split became effective on May 6, 2025. As a result of the Reverse Stock Split, every twenty (20) shares of Common Stock were exchanged for one (1) share of Common Stock. The Common Stock began trading on the Nasdaq Capital Market on a split-adjusted basis at the start of trading on May 7, 2025. The Reverse Stock Split did not affect the total number of shares of capital stock, including the Common Stock, that the Company is authorized to issue, which remain as set forth pursuant to the Articles of Incorporation. No fractional shares of Common Stock were issued in connection with the Reverse Stock Split. Stockholders who otherwise were entitled to receive fractional shares of Common Stock were automatically entitled to receive an additional fraction of a share of Common Stock to round up to the next whole share, at a participant level. The Reverse Stock Split also had a proportionate effect on all other options and warrants of the Company outstanding as of the effective date of the Reverse Stock Split. All historical share and per-share amounts reflected throughout the Company’s consolidated financial statements and other financial information in this Report have been adjusted to reflect the Reverse Stock Split as if the split occurred as of the earliest period presented. The par value per share of the Company’s Common Stock was not affected by the Reverse Stock Split. On May 22, 2025, the Company, acting pursuant to authority received at a special meeting of its stockholders on May 6, 2025, filed with the Secretary of State of the State of Nevada a certificate of amendment (the “May 22, 2025 Charter Amendment”) to its articles of incorporation, as amended, to effect a one (1)-for-one hundred (100) share reverse split (the “May 22, 2025 Reverse Stock Split”) of all of the Company’s outstanding shares of Common Stock, par value $ 0.001 per share. Pursuant to the May 22, 2025 Charter Amendment, the Reverse Stock Split became effective on May 22, 2025. As a result of the May 22, 2025 Reverse Stock Split, every one hundred (100) shares of Common Stock were exchanged for one (1) share of Common Stock. The Common Stock will begin trading on a split-adjusted basis on Nasdaq effective with the open of the market on Friday, May 23, 2025. The May 22, 2025 Reverse Stock Split did not affect the total number of shares of capital stock, including the Common Stock, that the Company is authorized to issue, which remain as set forth pursuant to the Articles of Incorporation. No fractional shares of Common Stock were issued in connection with the May 22, 2025 Reverse Stock Split. Stockholders who otherwise were entitled to receive fractional shares of Common Stock were automatically entitled to receive an additional fraction of a share of Common Stock to round up to the next whole share, at a participant level. The May 22, 2025 Reverse Stock Split also had a proportionate effect on all other options and warrants of the Company outstanding as of the effective date of the May 22, 2025 Reverse Stock Split. All historical share and per-share amounts reflected throughout the Company’s consolidated financial statements and other financial information in this Report have been adjusted to reflect the May 22, 2025 Reverse Stock Split as if the split occurred as of the earliest period presented. The par value per share of the Company’s Common Stock was not affected by the May 22, 2025 Reverse Stock Split. F- 48 On January 8, 2026, the Company, acting pursuant to a resolution of its Board of Directors, filed with the Secretary of State of the State of Nevada a certificate of amendment (the “January 8, 2026 Charter Amendment”) to its articles of incorporation, as amended, to effect a one (1)-for-three (3) share reverse split (the “January 8, 2026 Reverse Stock Split”) of all of the Company’s outstanding shares of Common Stock, par value $ 0.001 per share. Pursuant to the January 8, 2026 Charter Amendment, the Reverse Stock Split became effective on January 8, 2026. As a result of the January 8, 2026 Reverse Stock Split, every three (3) shares of Common Stock were exchanged for one (1) share of Common Stock. The Common Stock will begin trading on a split-adjusted basis on Nasdaq effective with the open of the market on January 9, 2026. The January 8, 2026 Reverse Stock Split had a proportionate affect on the total number of shares of capital stock, including the Common Stock, that the Company is authorized to issue, which resulted in a reduction of authorized common shares from 200,000,000 to 66,666,667 as set forth pursuant to the Articles of Incorporation. No fractional shares of Common Stock were issued in connection with the January 8, 2026 Reverse Stock Split. Stockholders who otherwise were entitled to receive fractional shares of Common Stock were automatically entitled to receive an additional fraction of a share of Common Stock to round up to the next whole share, at a participant level. The January 8, 2026 Reverse Stock Split also had a proportionate effect on all other options and warrants of the Company outstanding as of the effective date of the January 8, 2026 Reverse Stock Split. All historical share and per-share amounts reflected throughout the Company’s consolidated financial statements and other financial information in this Report have been adjusted to reflect the January 8, 2026 Reverse Stock Split as if the split occurred as of the earliest period presented. Nasdaq Notifications On October 17, 2025, the Company received notice from Nasdaq that notified the Company that it had regained full compliance with the Minimum Bid Price Requirement and Stockholders’ Equity Requirement. The Nasdaq has now placed the Company under a one-year Discretionary Panel Monitor. Under the Discretionary Panel Monitor, the Company will not be permitted to request additional time to regain compliance with any deficiencies that occur within the one-year period regarding noncompliance with the Periodic Filing or Bid Price Rules. Such one-year period expires on July 31, 2026 with regard to the Periodic Filing Rules and September 2, 2026 regarding the Bid Price Rules. Noncontrolling Interests For information regarding the noncontrolling interest in Nobility Healthcare, LLC, see Note 1 and Note 23, Discontinued Operations. NOTE 19. RELATED PARTY TRANSACTIONS Transactions with Related Party of TicketSmarter Note payable – related party is comprised of the following: SCHEDULE OF NOTE PAYABLE RELATED PARTY December 31, 2025 December 31, 2024 Note payable – related party $ 2,000,000 $ 2,840,000 Unamortized discount ( 1,599,890 ) — Debt obligations 400,110 2,840,000 Less: current maturities of note payable-related party — 2,840,000 Note payable -related party, long-term $ 400,110 $ — Accrued interest – related party was $ 0 and $ 492,176 at December 31, 2025 and 2024, respectively. Debt obligations mature on an annual basis as follows as of December 31, 2025: SCHEDULE OF MATURITY DEBT OBLIGATIONS Gross Principal Unamortized Discount Net Carrying Value 2026 $ — $ — $ — 2027 — — — 2028 — — — 2029 — — — 2030 and thereafter 2,000,000 ( 1,599,890 ) 400,110 Total $ 2,000,000 $ ( 1,599,890 ) $ 400,110 Original Loan and Amendments On September 22, 2023 and October 2, 2023, a trust (the “Goodman Trust”), the beneficiaries of which are an officer of TicketSmarter, Inc. (“TicketSmarter”) and his spouse, advanced a total of $ 2,700,000 to TicketSmarter to resolve outstanding payables at discounted rates. The officer serves as CEO of TicketSmarter and continues in that capacity as of December 31, 2025. The officer has no role at the parent company and is not an officer or director of Kustom Entertainment, Inc. The note originally bore interest at 13.25 % per annum with weekly principal payments of $ 54,000 beginning January 2, 2024. The proceeds were used to settle outstanding vendor payables at negotiated discounts; the discounts received were recognized as a gain on extinguishment of liabilities in the consolidated statement of operations for the year ended December 31, 2023. The note was amended four times between August 2024 and June 2025: Amendment 1 (August 19, 2024). The repayment start date was extended to January 2, 2025. All other terms, including the 13.25 % interest rate and $ 54,000 weekly payment, remained unchanged. The Company determined the change in present value of cash flows was less than 10% and accordingly accounted for the amendment as a modification with no gain or loss recognized. The effective interest rate was adjusted prospectively. Payments of $ 22,000 were made during the year ended December 31, 2024. Amendment 2 (March 20, 2025). The interest rate was reduced from 13.25 % to 8 % per annum, weekly payments were reduced from $ 54,000 to $ 11,000 , the repayment term was extended to 247 weeks, and all accrued interest of $ 582,203 was eliminated. The change in present value of cash flows exceeded 10% and accordingly the amendment was accounted for as an extinguishment and reissuance of a new note. The new note was recorded at its estimated fair value of $ 2,032,831 , determined as the present value of future cash flows discounted at 13.5 %, resulting in a debt discount of $ 667,169 . Because the holder is a related party, the difference between the carrying amount of the old note and the fair value of the new note, together with the forgiven accrued interest, was recognized as a deemed capital contribution of $ 1,249,372 to additional paid-in capital rather than as a gain in earnings. Amendment 3 ( April 18, 2025) and Amendment 4 (June 4,2025). On April 18, 2025, the outstanding principal was reduced from $ 2,678,000 to $ 2,000,000 , weekly payments were reduced from $ 11,000 to $ 9,600 , all accrued interest was eliminated, and the interest rate remained at 8 %. On June 4, 2025, a subordination clause was added providing that the note will only be repaid once the Company’s intercompany line of credit with TicketSmarter has been fully satisfied, effectively deferring all payments until satisfaction of that obligation (see “Subordination” below). Both amendments were accounted for as extinguishments and recorded as a combined entry on June 4, 2025, resulting in a deemed capital contribution of $ 622,622 to additional paid-in capital. F- 49 Subordination and Fair Value Amendment 4 subordinated all payments on the Goodman Trust note to the Company’s $ 3,000,000 line of credit with TicketSmarter, which was established in connection with the September 2021 acquisition and is secured by a first lien on all TicketSmarter assets. As of December 31, 2025, $ 2,743,179 was outstanding on the line of credit. Based on management’s cash flow projections for TicketSmarter, the line of credit is not expected to be fully satisfied until approximately 2036. Accordingly, the first payment on the Goodman Trust note is not expected until January 2037. The fair value of the note as of the modification date was determined to be $372,548, calculated as the present value of $9,600 per week for 209 weeks beginning January 2037, discounted at 13.25% per annum, which represents the Company’s estimated incremental borrowing rate for a subordinated obligation of similar credit quality and term. The resulting debt discount of $ 1,627,452 is being amortized to non-cash interest expense using the effective interest method over the remaining term of the note through 2041. An additional deemed capital contribution of $ 1,111,304 was recognized to additional paid-in capital to reflect the increase in discount resulting from the deferral of all payments to 2037. Non-Cash Interest Expense For the year ended December 31, 2025, the Company recognized total non-cash interest expense of $ 35,332 related to amortization of the debt discount on the Goodman Trust note, consisting of $ 7,770 for the period prior to the March 2025 amendment and $ 27,562 for the period following the June 2025 amendment. The unamortized discount balance was $ 1,599,890 as of December 31, 2025. Deemed Capital Contributions During the year ended December 31, 2025, the Company recognized total deemed capital contributions of $ 2,983,298 to additional paid-in capital arising from the modifications of the Goodman Trust note. The second amendment on March 20, 2025 resulted in a deemed capital contribution of $ 1,249,372 , representing the forgiveness of $ 582,203 in accrued interest and the economic benefit of the reduced interest rate. The combined third and fourth amendments, recorded on June 4, 2025, resulted in a deemed capital contribution of $ 622,622 , representing the excess of the carrying value of the extinguished note over the fair value of the restructured note after giving effect to the $ 678,000 principal reduction and $ 43,515 in accrued interest forgiveness. An additional deemed capital contribution of $ 1,111,304 was recognized at December 31, 2025 to reflect the increase in debt discount resulting from the subordination of all payments to 2037. Because the holder of the note is a related party, all amounts were recognized as equity contributions rather than gains in earnings, consistent with the accounting treatment for related party transactions. Balance Sheet Classification Because all payments under the note are subordinated to the intercompany line of credit and deferred to 2037, no amounts are classified as current as of December 31, 2025. The note is presented entirely within long-term liabilities at its net carrying value of $ 400,110 . No accrued interest was outstanding as of December 31, 2025, as all previously accrued interest was eliminated pursuant to the amendments described above. Company Related Party Note On August 22, 2024, the Company’s Chief Executive Officer, made a loan in the amount of $ 100,000 to the Company to support its operations. In addition, on October 24, 2024, the Company’s Chief Executive Officer, made an additional loan in the amount of $ 40,000 to the Company to support its operations. These transactions were recorded as related party notes payable (the “Company Related Party Notes”). The Company Related Party Notes bear interest at prime rate ( 8.00 % as of December 31, 2025 and 2024) per annum with repayment due on demand. The Company paid off the Company Related Party Notes in full during the year ended December 31, 2025. NOTE 20. NET LOSS PER SHARE The calculation of the weighted average number of shares outstanding and loss per share outstanding for the years ended December 31, 2025 and 2024 are as follows: SCHEDULE OF WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING AND LOSS PER SHARE OUTSTANDING 2025 2024 Year ended December 31, 2025 2024 Numerator for basic and diluted loss per share – Net loss attributable to common stockholders – continuing operations $ ( 5,955,930 ) $ ( 17,898,105 ) Numerator for basic and diluted loss per share – Net loss attributable to common stockholders – discontinued operations (net of noncontrolling interests) $ ( 715,578 ) $ ( 1,946,042 ) Denominator for basic loss per share – weighted average shares outstanding 387,144 593 Dilutive effect of shares issuable upon conversion of convertible debt and the exercise of stock options and warrants outstanding — — Denominator for diluted loss per share – adjusted weighted average shares outstanding 387,144 593 Net loss per share: Basic: $ ( 17.23 ) $ ( 33,488.74 ) Continuing operations ( 15.38 ) ( 30,204.62 ) Discontinued operations ( 1.85 ) ( 3,284.12 ) Diluted: $ ( 17.23 ) $ ( 33,488.74 ) Continuing operations ( 15.38 ) ( 30,204.62 ) Discontinued operations ( 1.85 ) ( 3,284.12 ) Basic loss per share is based upon the weighted average number of shares of common stock outstanding during the period. For the years ended December 31, 2025 and 2024, all shares issuable upon conversion of convertible debt and the exercise of outstanding stock options and warrants were antidilutive, and, therefore, not included in the computation of diluted loss per share. The following common stock equivalent shares were excluded from the computation of diluted loss per share for the years ended December 31, 2025 and 2024 as their effect would have been antidilutive: SCHEDULE OF ANTIDILUTIVE SECURITIES (1) Year ended December 31, 2025 (1) 2024 Stock options 9 9 Common stock purchase warrants 325,039 1,813 Total common stock equivalent shares excluded 325,048 1,822 (1) The 2025 Senior Secured Convertible Notes with an outstanding principal balance of $ 1,070,000 as of December 31, 2025 are excluded from the diluted loss per share calculation. The notes are convertible at a 10 % discount to the five-day volume-weighted average price preceding conversion; as the conversion price is variable, the number of shares issuable upon conversion is indeterminate and has been excluded from the table above. Subsequent to December 31, 2025, the holder of the Senior Secured Convertible Note exercised its right to convert $ 1,070,000 of the outstanding balance of the Senior Secured Convertible Notes into 558,041 shares of the Company’s common stock. There are no remaining balances under the Senior Secured Convertible Notes after consideration of such conversions. F- 50 NOTE 21. COUNTRY STAMPEDE ACQUISITION On March 1, 2024, Kustom 440, entered into an Asset Purchase Agreement (the “Acquisition Agreement”) with JC Entertainment, LLC, a Kansas limited liability company (“JC Entertainment”). Pursuant to the Acquisition Agreement, Kustom 440 acquired certain assets associated with a music entertainment event (“Country Stampede”), including all intellectual property arising out of and relating to Country Stampede (“Country Stampede Intellectual Property”) and certain contracts in which JC Entertainment is a party to host and operate the 2024 Country Stampede (the “Assumed Contracts”, and together with the Country Stampede Intellectual Property, the “Purchased Assets”). As consideration for acquiring the Purchased Assets, Kustom 440 paid JC Entertainment the aggregate purchase price amount $ 542,959 , with the sum of $ 400,000 paid at the time of closing (“Closing”), and the remainder to be paid on or before thirty days from the time of Closing. Kustom 440 shall receive a credit for all non-refunded festival ticket sales for the 2024 Country Stampede to be calculated immediately prior to Closing, and JC Entertainment shall be entitled to keep all ticket sale proceeds made and/or received prior to Closing. Kustom 440 shall be obligated, to the extent a refund is sought after Closing, to provide such refund, if appropriate, to the customer requesting a refund, and shall indemnify and hold harmless JC Entertainment from all claims, liabilities, costs, suits, or the like relating to such refund request. The Company accounts for business combinations using the acquisition method and the Company has early adopted the amendments of Regulation S-X dated May 21, 2020 and has concluded that this acquisition was not significant. Accordingly, the presentation of the assets acquired, historical financial statements under Rule 3-05 and related pro forma information under Article 11 of Regulation S-X, respectively, are not required to be presented. Under the acquisition method, the purchase price of the Country Stampede Acquisition has been allocated to the acquired tangible and identifiable intangible assets and assumed liabilities based on their estimated fair values at the time of the Country Stampede Acquisition. This allocation involves a number of assumptions, estimates, and judgments that could materially affect the timing or amounts recognized in our consolidated financial statements. The Country Stampede Acquisition was structured as an asset purchase; however the parties agreed to coordinate the election to invoke IRS Section 338(h)(10) in relation to this transaction for tax purposes. Therefore, the excess purchase price over the fair value of net tangible assets acquired was recorded as goodwill, which will be amortized over 15 years for income tax filing purposes. Likewise, the other acquired assets were stepped up to fair value and is deductible for income tax purposes. The results of operations of acquired businesses are included in the consolidated statement of operations from the acquisition date. The purchase price of the Country Stampede Acquisition was allocated to tangible assets, goodwill, identifiable intangible assets, and assumed liabilities based on their preliminary estimated fair values at the time of the acquisition. The Company retained the services of an independent valuation firm to determine the fair value of these identifiable intangible assets. The Company has finalized the estimated fair value of assets acquired, and liabilities assumed in the Country Stampede Acquisition which are as follows: SCHEDULE OF PRELIMINARY FAIR VALUE OF ASSETS ACQUIRED AND LIABILITIES ACQUISITION As allocated (Final) Description March 1, 2024 Assets acquired (provisional): Tangible assets acquired $ 305,000 Identifiable intangible assets acquired (Trademarks and trade names) 300,000 Goodwill 225,959 Liabilities assumed ( 288,000 ) Net assets acquired and liabilities assumed $ 542,959 Consideration: Cash paid at Country Stampede Acquisition date $ 400,000 Cash paid subsequent to closing 142,959 Total Country Stampede Acquisition purchase price $ 542,959 F- 51 During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date. There were no additional assets or liabilities recognized during the measurement period that ended March 1, 2025, the amounts of assets or liabilities previously recognized on a preliminary basis are now final. NOTE 22. OPERATING SEGMENTS The Company adopted ASU 2023-07 in 2024 and applied the amendment retrospectively to all periods presented in the Company’s consolidated financial statements. Segment financial information is prepared in accordance with GAAP and its significant accounting policies described in Note 1. Resources are allocated and performance is assessed using segment operating income by its Chief Executive Officer, whom the Company have determined to be its Chief Operating Decision Maker (“CODM”). The Company’s CODM utilizes segment operating income when making decisions about allocating capital and personnel to the segments, predominantly in the annual budget and quarterly forecasting processes. In addition, the Company’s CODM uses operating income, including comparison of actual results to budget and forecast, in assessing the performance of each segment and in evaluating product pricing, distribution strategies and marketing investments. The Company’s CODM reviews balance sheet information at a consolidated level. The Company computes segment operating income based on net sales revenue, less cost of goods sold, SG&A, asset impairment charges and restructuring charges. The SG&A used to compute each segment’s operating income is directly associated with the segment. The Company does not allocate non-operating income and expense, including interest or income taxes, to operating segments. As a result of the sale of its Revenue Cycle Management segment, the Company now operates in two reportable business segments. The Video Solutions Segment encompasses its law, commercial, and shield divisions. This segment includes both service and product revenues through its subscription models offering cloud and warranty solutions, and hardware sales for video and health safety solutions. The Entertainment segment includes the Company’s ticketing and live-event operations and generates both service and product revenues through its TicketSmarter platform and related entertainment brands, acting as an intermediary between ticket buyers and sellers and also purchasing ticket inventory from primary sources for resale through various channels. The Company’s corporate administration activities are reported in the corporate line item. These activities primarily include expense related to certain corporate officers and support staff, certain accounting staff, expense related to the Company’s Board of Directors, stock option expense for options granted to corporate administration employees, certain consulting expenses, investor relations activities, and a portion of the Company’s legal, auditing and professional fee expenses. Identifiable assets are those assets used by each segment in its operations. Corporate identifiable assets primarily consist of cash, goodwill, property, plant and equipment, accounts receivable, inventories, and other assets not directly attributable to the Video Solutions or Entertainment operating segments. Geographic Information - The Company generates revenue solely from domestic customers within the United States. All of the Company’s long-lived assets are located within the United States. Accordingly, no geographic segment information is presented. Summarized financial information for the Company’s reportable business segments is provided for the years ended December 31, 2025, and 2024: SCHEDULE OF SEGMENT REPORTING Year ended December 31, 2025 Video Solutions Entertainment Corporate and other Total Net revenues: Product $ 1,184,079 $ 3,153,197 $ — $ 4,337,276 Service 3,916,678 5,500,201 — 9,416,879 Total segment net revenues 5,100,757 8,653,398 — 13,754,155 Less significant segment expense Cost of Revenue - Product 1,523,613 4,810,009 — 6,333,622 Cost of Revenue – Service and other 1,259,293 4,812,185 — 6,071,478 Research and development expense 551,447 — — 551,447 Selling, advertising and promotional expense 426,048 295,642 — 721,690 Goodwill and intangible asset impairment charge — 2,533,667 — 2,533,667 General and administrative expense 887,454 3,267,526 4,269,692 8,424,672 Total segment operating income (loss) $ 452,902 $ ( 7,065,631 ) $ ( 4,269,692 ) $ ( 10,882,421 ) Non-operating (expenses) income: Interest income 116,545 Interest expense ( 1,102,352 ) Change in fair value of derivative liabilities 3,331,616 Gain on the extinguishment of liabilities 2,234,658 Other non-operating income (loss) 346,024 Total non-operating income (loss) 4,926,491 Income before income tax benefit (provision) $ ( 5,955,930 ) Depreciation and amortization expense $ 165,787 $ 1,378,980 $ — $ 1,544,767 Total identifiable assets, net of eliminations $ 10,359,085 $ 2,645,370 $ 6,324,072 $ 19,328,527 Video Solutions Entertainment Corporate and other Total Year ended December 31, 2024 Video Solutions Entertainment Corporate and other Total Net revenues: Product $ 1,997,389 $ 3,406,928 $ — $ 5,404,317 Service 3,758,002 4,356,833 — 8,114,835 Total segment net revenues 5,755,391 7,763,761 — $ 13,519,152 Less significant segment expenses: Cost of Revenue - Product 1,780,284 4,118,846 — 5,899,130 Cost of Revenue – Service and other 1,252,213 3,243,791 — 4,496,004 Research and development expense 1,339,673 — — 1,339,673 Selling, advertising and promotional expense 1,124,012 996,953 — 2,120,965 Goodwill and intangible asset impairment charge — 508,000 — 508,000 General and administrative expense 1,459,064 3,701,024 5,378,218 10,538,306 Total segment operating income (loss) $ ( 1,199,855 ) $ ( 4,804,853 ) $ ( 5,378,218 ) $ ( 11,382,926 ) Non-operating (expenses) income: Interest income 69,509 Interest expense ( 3,816,317 ) Loss on litigation ( 1,959,396 ) Change in fair value of derivative liabilities ( 1,240,407 ) Other non-operating income (loss) 26,733 Gain on the extinguishment of debt 917,935 Loss on extinguishment of debt ( 753,339 ) Loss on disposal of intangibles (119,979 ) Gain on sale of property, plant and equipment 360,082 Total non-operating income (loss) ( 6,515,179 ) Loss before income tax benefit (provision) $ ( 17,898,105 ) Depreciation and amortization expense $ 598,895 $ 1,316,541 $ — $ 1,915,436 Total identifiable assets, net of eliminations $ 12,804,820 $ 5,741,117 $ 9,190,636 $ 27,736,573 F- 52 Total identifiable assets for 2025 and 2024 include amounts related to the discontinued segment included in the “Corporate and Other” category. The segments recorded noncash items affecting the gross profit and operating income (loss) through the established inventory reserves based on estimates of excess and/or obsolete current and non-current inventory. The Company recorded a reserve for excess and obsolete inventory in the video solutions segment of $ 1,849,124 and $ 2,037,252 and a reserve for the entertainment segment of $ 69,817 and $ 132,403 as of December 31, 2025 and 2024. The segment net revenues reported above represent sales to external customers. Segment gross profit represents net revenues less cost of revenues. Segment operating income, which is used in management’s evaluation of segment performance, represents net revenues, less cost of revenues, less all operating expenses. Note 23. DISCONTINUED OPERATIONS On January 8, 2026, Digital Ally Healthcare, Inc. (the “Seller”), a Nevada corporation and a wholly-owned subsidiary of Kustom Entertainment, Inc. (the “Company”) entered into and closed a Unit Purchase Agreement (the “Agreement”) with Nobility LLC, an Arizona limited liability company (the “Buyer”), and Nobility Healthcare, LLC, a Kansas limited liability company (“Nobility Healthcare” and collectively with the Seller and the Buyer the “Parties”). Pursuant to the Agreement, the Buyer purchased all of the Seller’s units of ownership interest (“Units”) in Nobility Healthcare, for Closing Funds (as defined in the Agreement) and a promissory note (the “Note”), totaling $ 1,450,000 , due upon closing (the “Transaction”). The Note issued by the Buyer at closing is in the principal amount of $ 1,140,499 to the Seller. Nobility Healthcare has historically issued a total of one hundred thousand (100,000) Units with Seller owning fifty-one thousand (51,000) of such Units. The Buyer is an affiliate of the owner of the remaining forty-nine thousand (49,000) Units. The Closing Funds are equal to the sum of (i) $100,000 in immediately available funds to be paid to the Seller at closing and (ii) certain credits totaling $209,501, which closing credits consist of (a) $200,000, the total of two advances made by the Buyer to the Seller on December 18, 2024 and January 15, 2025 and (b) $9,501 due to the Buyer from Nobility Healthcare for net working capital advances paid to the Buyer upon signing. The effective date of the Agreement was January 1, 2026. The Parties made customary representations, warranties and covenants in the Agreement. There is no material relationship between the Company or its affiliates and any of the other Parties to the Agreement, other than in connection with Nobility Healthcare. The following table summarizes the assets and liabilities of Nobility Healthcare, LLC classified as discontinued operations as of December 31, 2025 and 2024: SCHEDULE OF ASSETS AND LIABILITIES AS DISCONTINUED OPERATIONS 2025 2024 Assets: Cash and cash equivalents $ 359,304 $ 235,003 Accounts receivable, net 497,713 549,510 Prepaid expenses 54,736 81,112 Current assets of revenue-cycle management business held-for-sale 911,753 865,625 Property, plant, and equipment, net 39,831 27,296 Goodwill and other intangible assets, net — 1,831,329 Operating lease right of use assets, net 373,921 441,569 Non-current assets of revenue-cycle management business held-for-sale 413,752 2,300,194 Total assets held-for-sale $ 1,325,505 $ 3,165,819 Liabilities: Accounts payable $ 52,102 $ 316,482 Accrued expenses 11,727 16,919 Operating lease obligation – short term 74,200 67,648 Current liabilities of revenue-cycle management business held-for-sale 138,029 401,049 Operating lease obligation – long term 299,723 373,921 Long-term liabilities of revenue-cycle management business held-for-sale 299,723 373,921 Total liabilities held-for-sale $ 437,752 $ 774,970 F- 53 The following table presents the results of Nobility Healthcare included in “Income (loss) from discontinued operations, net of tax” for the years ended December 31, 2025 and 2024. The carrying value of the Nobility Healthcare disposal group was measured at the lower of carrying amount or fair value less costs to sell, based on the $ 1,450,000 aggregate consideration established in the Unit Purchase Agreement dated January 8, 2026, resulting in a non-cash impairment loss on disposal of $ 1,527,634 recognized within the 2025 results below. SCHEDULE OF INCOME LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX 2025 2024 Revenues $ 5,427,796 $ 6,131,650 Cost of revenue 3,423,711 3,766,336 Gross profit 2,004,085 2,365,314 Operating expenses 1,670,170 6,183,929 Income (loss) from operations before impairment 333,915 ( 3,818,615 ) Impairment loss on disposal ( 1,527,634 ) — Income (loss) from operations ( 1,193,719 ) ( 3,818,615 ) Other income (expense) ( 209,375 ) 995 Income tax expense (benefit) — — Net income (loss) from discontinued operations $ ( 1,403,094 ) $ ( 3,817,620 ) The Company recognized an impairment loss of $ 1,527,634 during the year ended December 31, 2025 to write down the carrying amount of Nobility Healthcare to its estimated fair value less costs to sell. The Company subsequently completed the sale of its interest in Nobility Healthcare on January 8, 2026. For additional details regarding the terms of the closing and the resulting loss to be recognized in 2026, refer to Note 25, Subsequent Events. The following table summarizes the cash flow of Nobility Healthcare, LLC classified as discontinued operations as of December 31, 2025 and 2024: SCHEDULE OF CASH FLOW CLASSIFIED AS DISCONTINUES OPERATIONS December 31, 2025 December 31, 2024 Cash Flows from Operating Activities: Net Loss $ ( 1,403,094 ) $ ( 3,817,620 ) Adjustments to reconcile net loss to net cash flows used in operating activities: Depreciation and amortization 98,533 106,878 Goodwill and intangible asset impairment charge and amortization 1,737,009 4,322,000 Provision for doubtful accounts receivable ( 26,422 ) 1,981 Change in operating assets and liabilities: (Increase) decrease in: Accounts receivable – trade 78,219 250,163 Prepaid expenses 26,376 ( 20,960 ) Operating lease right of use assets 67,648 131,130 Increase (decrease) in: Accounts payable ( 364,380 ) ( 499,269 ) Accrued expenses ( 5,192 ) ( 29,663 ) Income taxes payable — ( 61 ) Deferred revenue ( 10,700 ) Operating lease obligations ( 67,648 ) ( 131,130 ) Net cash provided by operating activities – discontinued operation 141,049 302,749 Cash Flows from Investing Activities: Purchases of leasehold improvements ( 16,748 ) — Proceeds from improvement allowance — 8,750 Net cash provided (used) in investing activities – discontinued operation ( 16,748 ) 8,750 Cash Flows from Financing Activities: Payments of contingent consideration promissory notes — ( 188,470 ) Net cash used in financing activities – discontinued operation — ( 188,470 ) Net increase in cash, cash equivalents and restricted cash 124,301 123,029 Cash and cash equivalents, beginning of year 235,003 111,974 Cash and cash equivalents, end of year $ 359,304 $ 235,003 F- 54 Transactions with Managing Member of Nobility Healthcare The Company accrued reimbursable expenses payable to Nobility, LLC totaling $ 0 and $ 245,716 as of December 31, 2025 and 2024, respectively. Total management fees accrued and payable in accordance with the operating agreement totaled $ 19,496 and $ 38,625 as of December 31, 2025 and 2024, respectively. The Company recorded management fee expense of $ 0 and $ 67,905 for the years ended December 31, 2025 and 2024, respectively. Nobility Healthcare was classified as a discontinued operation as of December 31, 2025. Accordingly, amounts reflected for 2025 represent the full year of Nobility Healthcare’s operations, presented as discontinued operations following its classification as of December 31, 2025 and subsequent sale in January 2026. Note 24. DEFERRED REVENUE The Company recognizes deferred revenue when consideration is received or receivable in advance of the satisfaction of the related performance obligations. Deferred revenue is presented as a current liability to the extent the associated performance obligations are expected to be satisfied within twelve months of the balance sheet date, and as a non-current liability for the portion expected to be satisfied thereafter. Deferred revenue balances arise from the following sources across the Company’s operating segments: Video Solutions Segment - Deferred revenue within the Video Solutions segment consists principally of extended warranty contracts, prepaid cloud-based evidence management and storage subscriptions marketed under the EVO Web and FleetVu platforms, and prepaid installation services. Extended warranty and cloud subscription arrangements generally have contractual terms ranging from three to five years. Revenue associated with these arrangements is recognized on a straight-line basis over the respective contract term as the performance obligations are satisfied. Entertainment Segment - Deferred revenue within the Entertainment segment consists of advance ticket sales associated with the annual Country Stampede music festival. Amounts received from consumers for Country Stampede tickets in advance of the festival date are deferred until the performance obligation is satisfied upon completion of the festival, which generally occurs in the second quarter of the fiscal year. During the year ended December 31, 2025, the Company recognized $ 5,098,437 of revenue that was included in the deferred revenue balance as of December 31, 2024. Deferred revenue activity for the years ended December 31, 2025 and 2024 was as follows: SCHEDULE OF DEFERRED REVENUES December 31, 2025 December 31, 2024 Additions/Reclass Recognized Revenue December 31, 2025 Deferred revenue, current $ 4,215,401 $ 1,598,019 $ 2,034,453 $ 3,778,967 Deferred revenue, non-current 6,317,472 1,485,868 3,063,984 4,739,356 $ 10,532,873 $ 3,083,887 $ 5,098,437 $ 8,518,323 December 31, 2024 December 31, 2023 Additions/Reclass Recognized Revenue December 31, 2024 Deferred revenue, current $ 2,937,168 $ 2,799,956 $ 1,521,723 $ 4,215,401 Deferred revenue, non-current 7,340,459 1,814,351 2,837,338 6,317,472 $ 10,277,627 $ 4,614,307 $ 4,359,061 $ 10,532,873 F- 55 The following table presents the deferred revenue balance as of December 31, 2025, disaggregated by type and operating segment: SCHEDULE OF DEFERRED REVENUE BALANCE DISAGGREGATED BY TYPE AND OPERATING SEGMENT Video Solutions Entertainment Total Extended warranty contracts $ 2,461,161 $ — $ 2,461,161 Cloud subscription and evidence management services 5,510,365 — 5,510,365 Prepaid installation services 7,170 — 7,170 Advance ticket sales - Country Stampede — 539,627 539,627 Total deferred revenue $ 7,978,696 $ 539,627 $ 8,518,323 As of December 31, 2025, the Company expects to recognize the remaining deferred revenue balance as follows: SCHEDULE OF REMAINING DEFERRED REVENUE BALANCE December 31, 2025 2026 $ 3,778,967 2027 2,426,738 2028 1,359,610 2029 665,705 2030 and thereafter 287,303 Total $ 8,518,323 Note 25. SUBSEQUENT EVENTS Committed Equity Financing (ELOC) Subsequent to December 31, 2025, the Company has exercised its right to direct the ELOC Investor to purchase a total of 1,385,000 shares of its common stock. Such ELOC exercises generated gross proceeds of $ 2,306,532 (net proceeds of $ 1,726,661 ) to the Company. As of the date of this filing, the $ 750,000 commitment fee has been fully satisfied. There remains approximately $ 22,693,468 available under the ELOC Purchase Agreement for future exercises. 2025 Senior Secured Convertible Notes Subsequent to December 31, 2025, the institutional investor exercised its right to convert $ 1,070,000 of the outstanding balance of the Senior Secured Convertible Notes into 558,041 shares of the Company’s common stock. There are no remaining balances under the Senior Secured Convertible Notes after consideration of such conversions. Corporate Name Change Effective as of January 8, 2026, the Company changed its legal name from Digital Ally, Inc. to Kustom Entertainment, Inc. pursuant to a Certificate of Amendment to its Articles of Incorporation filed with the Secretary of State of the State of Nevada on January 8, 2026. The name change became effective on January 8, 2026, and the Company began trading on the Nasdaq Capital Market under its new corporate name at the start of trading on January 8, 2026, concurrently with the change of its Nasdaq trading symbol from “DGLY” to “KUST.” The name change and trading symbol change did not affect the Company’s assets, liabilities, operations, or capital structure, and stockholders were not required to take any action in connection with the name change. F- 56 Reverse Stock Split On January 8, 2026, the Company implemented a one (1)-for-three (3) reverse stock split (the “January 8, 2026 Reverse Stock Split”) of all of the Company’s outstanding shares of Common Stock. Effective at the close of business on January 8, 2026, every three (3) shares of Common Stock were exchanged for one (1) share of Common Stock. The Common Stock began trading on a split-adjusted basis on the Nasdaq Capital Market on January 9, 2026. The January 8, 2026 Reverse Stock Split proportionately reduced the total number of shares of capital stock, including the Common Stock, that the Company is authorized to issue, whereby the total number of Common Stock the Company is authorized to issue was reduced to 66,666,667 shares as set forth in the Company’s Articles of Incorporation. No fractional shares of Common Stock were issued in connection with the January 8, 2026 Reverse Stock Split. Stockholders who otherwise would have been entitled to receive a fractional share of Common Stock were automatically entitled to receive an additional fraction of a share of Common Stock to round up to the next whole share, at a participant level. The January 8, 2026 Reverse Stock Split also had a proportionate effect on all outstanding options, warrants, and other securities convertible into or exercisable for shares of Common Stock as of the effective date of the January 8, 2026 Reverse Stock Split. All historical share and per-share amounts reflected throughout the Company’s consolidated financial statements and other financial information have been adjusted to reflect the January 8, 2026 Reverse Stock Split as if it had occurred as of the earliest period presented. Sale of Nobility Healthcare On January 8, 2026, Digital Ally Healthcare, Inc. (the “Seller”), a wholly owned subsidiary of Kustom Entertainment, Inc. (the “Company”), entered into and closed a Unit Purchase Agreement (the “Agreement”) with Nobility LLC, an Arizona limited liability company (the “Buyer”), and Nobility Healthcare, LLC, a Kansas limited liability company (“Nobility Healthcare”). Pursuant to the Agreement, the Buyer purchased all of the Seller’s ownership interests in Nobility Healthcare, consisting of 51,000 of the 100,000 outstanding units, for total consideration of $ 1,450,000 . The aggregate purchase consideration consisted of $ 100,000 in cash paid at closing, $ 209,501 in credits related to prior advances and net working capital, and a promissory note in the principal amount of $ 1,140,499 issued by the Buyer to the Seller. The promissory note bears interest at 6 %, with quarterly payments commencing on the twentieth business day of July 2026, and is subject to certain earn-out provisions. The transaction closed effective January 8, 2026, with an effective date of January 1, 2026, and was completed pursuant to customary representations, warranties, and covenants. The Buyer is an affiliate of the owner of the remaining 49,000 units in Nobility Healthcare, and there is no material relationship between the Company or its affiliates and any of the other parties to the Agreement other than in connection with Nobility Healthcare. Artist Performance Commitment In January 2026, Kustom 440, Inc. entered into a non-cancellable artist performance agreement for the 2026 Country Stampede music festival with aggregate payment obligations totaling $ 750,000 . See Note 15, Commitments and Contingencies, for additional details. *********************** F- 57